ࡱ> aa-a.a/a0a1a2a3a4a5a6a7a8a9a:a;aa?a@aAaBaCaDaEaFaGaHaIaJaKaLaMaNaOaPaQaRaSaTaUaVaWaXaYaZa[a\a]a^a_a`aaabacadaeafagahaiajakalamanaoapaqarasatauavawaxayaza{a|a}a~aaaaaaaaaaaaaaaaaaaaaaaaaaaaa[ )bjbj *ΐΐd  $$$874,cCd$n<H@T;;;;;;;$Z>@>;i8  8 8 ;((<L L L 8 P;L 8 ;L L 79$X;9,;><0n<g9P:A:AX99n:A%:`8 8 L 8 8 8 8 8 ;;8 8 8 n<8 8 8 8 :A8 8 8 8 8 8 8 8 8  : E-Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 1 of 85   E-Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store TENDER DOCUMENT TENDER FOR SUPPLY OF COMMON DRUGS TO IGIMS, PATNA ON RATE CONTRACT BASIS FOR A PERIOD OF TWO YEARS FROM THE DATE OF AGREEMENT EXTENDABLE FOR ONE MORE YEAR ON MUTUALLY AGREED TERMS AND CONDITIONS.  INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES, SHEIKHPURA, PATNA 800 014 (Bihar, India) Tel.: 0612 2297631, 2297099; Fax: 0612 2297225; Website:  HYPERLINK "http://www.igims.org" www.igims.org; E-Mail:  HYPERLINK "mailto:director@igims.org" director@igims.org /  HYPERLINK "mailto:bme@igims.org" bme@igims.org /  HYPERLINK "mailto:storeofficer@igims.org" storeofficer@igims.org *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 2 of 85INDEXS.NODESCRIPTIONPAGE NO.1NOTICE INVITING TENDER2SECTION ITENDER SCHEDULE043SECTION IIINSTRUCTION TO BIDDERS05-064SECTION IIITWO BIDS SYSTEM07-085SECTION IVELIGIBILITY CRITERIA09-106SECTION VTECHNICAL SPECIFICATION OF ITEMS11-307SECTION VIGENERAL CONDITION OF CONTRACT31-378SECTION VIIINSTRUCTION TO BIDDERS FOR ONLINE REGISTRATION AND SUBMISSION OF BID38-419SECTION VIIICHECKLIST OF IMPORTANT DOCUMENTS42-4310SECTION IXFORMAT FOR FINANCIAL BID44-7411SECTION XFORMATS FOR BIDDERS75-85(ANNEXURES FOR TECHNICAL BID)*****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 3 of 85 Section-I TENDER SCHEDULE 1.1 Schedule of Tender The Director, I.G.I.M.S, Patna invites Bids in Two Bid System (i.e. Technical & Financial Bid) from Eligible manufacturers for Rate Contract for Supply of Common Drugs for their various medical and surgical departments as per following scheduled. The Rate Contract shall be for a period of two years extendable for another one year on mutually agreeable conditions. 1.Name & address of advertiser:Director, IGIMS, Sheikhpura, Patna -14 P.O.-B.V. College, Patna 800014 2. Date of issue of E-Tender notice : 08/ 09 / 2020 3. Period for download of tender document only on  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in. : From 14 /09 / 2020 to 20 / 10 / 2020 up to 12.00 hours through above website 4. Last Date of pre bid Clarifications: : In view of increased need to minimize possibility of community spread of ongoing COVID 19 epidemics, physically pre-bid meeting will not be held. In case the bidders requires any clarification regarding the tender documents, they are requested to contact our office (e-mail:  HYPERLINK "mailto:storeofficer@igims.org" storeofficer@igims.org) on or before 21 / 09 / 2020. 5.Last date & Time for submission / uploading of complete tender at  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in.:20 / 10 / 2020 up to 17.00 Hours 6. Last date, time and place for submission of hard copy of the Technical bid along with EMD & Tender Document Fee at Directors office, I.G.I.M.S., Patna by Speed / Registered post / Courier only : 21 / 10 / 2020 up to 16.00 Hours, at Director IGIMS,- Patna-800014, P/O-. B. V. College Patna 7. Date, Time and Place of opening of Techno Commercial bid only on  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in. : On  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in 22 / 10 / 2020 at 15.00 hours  8. Date, Time and Place of opening of price bid : Date & Time will be communicated later on subsequent to acceptance of techno- commercial bid at  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in  Sl. NoGroupDescriptionCost of Tender DocumentEarnest money to be Deposited.Bid processing fees to be paid on- line (non-refundable in Rs.)Completion period1ATENDER FOR SUPPLY OF COMMON DRUGS TO IGIMS, PATNA ON RATE CONTRACT BASIS FOR A PERIOD OF TWO YEARS FROM THE DATE OF AGREEMENT EXTENDABLE FOR ONE MORE YEAR ON MUTUALLY AGREED TERMS AND CONDITIONS. Rs. 2500/-00Rs. 3,00,000/ (Rs. Three Lakhs Only)Rs. 1180/-00  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 4 of 85 09. Earnest Money Deposit (EMD): Bidders needs to deposit the EMD amount of Rs.3,00,000/-00 (Rs. Three Lakhs only) in the form of Demand Draft favouring Director, I.G.I.M.S.- Patna, payable at Patna. The EMD can also be submitted in form of Bank Guarantee. The Detail of DD/BG is to be uploaded at  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in. Original copy of the Demand Draft / BG is to be attached with hard copy of the Technical Bid in a separate envelope and to be submitted with Technical Bid. If the details of the Demand Draft / BG (EMD) is not uploaded at  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in and original copy is not found with hard copy of Technical Bid, bid will be summarily rejected. 10. For participation in the above e- tender process the bidders are required to get themselves Registered as per details given at  HYPERLINK "http://www.eproc.bihar.gov.in" www.eproc.bihar.gov.in so that the user ID, Password and Digital signatures are issued to them and may please contacted on 7542028164, 0612-2523006 for any query. 11. Detailed NIT can be seen on website www.eproc.bihar.gov.in and on www.igims.org.  Director, I.G.I.M.S. - Patna.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 5 of 85 Section-II INSTRUCTION TO BIDDERS 2.1 The Bidder is expected to examine all instructions section wise. The bid should be precise, complete and in the prescribed format as per the requirement of the bid document. The bid should not be conditional. Failure to furnish all information required by the bidding document or submission of a bid not responsive to the bidding documents in every respect will be at the Bidders risk and may result in rejection of the bid. 2.2 Language of Bid: The Bid prepared by the Bidder and all correspondence and documents relating to the Bid exchanged by the Bidder and Tender inviting Authority, shall be in English language. Supporting documents and printed literature furnished by the Bidder may be written in another language provided that they are accompanied by an authenticated accurate translation of the relevant passages in the English Language in which case, for the purpose of interpretation of the Bid, the English translation shall prevail. 2.3 Exemption: Firms registered with NSIC are exempted from submission of EMD (subject to the financial limits indicated in the NSIC certificate). Govt. of India/State Government departments/Undertakings are also exempted from EMD. However, the respective manufacturers have to submit the relevant certificate (NSIC etc.) and financial limit to avail this exemption. Further, CPPP already has a provision of capturing UAM (Udyog Aadhar Memorandum) number issued by MSME of the vendors in order to identify themselves as MSME vendor. MSME vendors are to declare UAM number on CPPP, failing which such bidders will not be able to enjoy the benefits as per Public Procurement Policy of MSEs Order, 2012 for tender invited electronically through CPPP. Declaration of UAM number by the vendors on CPPP is mandatory. 2.4 EMD: Bidders need to deposit the EMD amount of Rs.3, 00,000/-(Rupees Three Lakh only) in the form of DD / Bank Guarantee in favour of Director, I.G.I.M.S., Patna in a sealed envelope on or before the Date of Submission of Bid in the Office of the Director, I.G.I.M.S., Patna - 800014 and its legible scanned copy must be uploaded in the Tendering Solution. I.G.I.M.S., Patna will not pay any interest on any EMD Amount to bidder. The EMD of the successful bidder shall be returned after the receipt of Performance Security Deposit and in case of unsuccessful bidders the same will be returned after award of the contract. The EMD of a Bidder will be forfeited, if a bidder withdraws bid after opening of Technical Bid / misrepresents facts or submit fabricated / forged / tampered / altered / manipulated documents. The FDR or BG submitted as EMD are subject to verification from the issuing bank before its acceptance. If at any time they said instrument is found to be fake or not as a valid banking instrument, the bidder submitting such instrument shall be black listed and shall be debarred from participating in future tenders of the Institute. The EMD BG should cover the liability period from last date of bid submission and should be valid for a minimum period of 180 days and claim date should be two months from expiry of BG validity period.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 6 of 85 2.5 Clarification of bidding documents: A prospective bidder requiring any clarification of the bidding documents shall contact the purchaser in writing at the purchasers e-mail address i.e.  HYPERLINK "mailto:storeofficer@igims.org" storeofficer@igims.org. The purchaser will respond in writing (e-mail) to any request for clarification, provided that such request is received within the due date. 2.6 Pre-Bid Conference: In view of increased need to minimize possibility of community spread of ongoing COVID 19 epidemics, physically pre-bid meeting will not be held. In case the bidders requires any clarification regarding the tender documents, they are requested to contact our office (e-mail:  HYPERLINK "mailto:storeofficer@igims.org" storeofficer@igims.org) on or before 21/ 09 / 2020. 2.7 Amendments in Bidding Documents: At any time till 7(seven) days before the deadline for submission of bids, the IGIMS, Patna may for any reason, whether at own initiative or in response to a clarification requested by a prospective bidder, modify the bidding document through amendment. All amendments will be uploaded on the website regularly. IGIMS, Patna shall not be responsible to notify the amendments to individual bidders. All amendments by the IGIMS, Patna till 7(seven) days before the deadline for submission of bids, shall be binding on the participatory bidders. 2.8 Withdrawal of Bid: The Bidder can withdraw its Bid before the closure date and time of receipt of the Bid. The system shall not allow any withdrawal after expiry of closure time of the Bid.  Director, I.G.I.M.S. - Patna. *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 7 of 85 Section-III TWO BID SYSTEM AND CONDITIONS 3.1 Technical Bid: All required documents are to be submitted/ uploaded online. However, the following documents in Original are to be sent to Director, IGIMS, Patna -800014, separately in a sealed envelope super scripted as : Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store / and Subject : Rate Contract for Supply of Common Drugs at IGIMS, PATNA. The sealed envelope should reach on or before last date & time for submission of Tender i.e., before the due date of submission of online bidding. EMD (Bid Security) Undertaking for acceptance of all Terms & Conditions (Annexure-I). Notarized affidavit on Indian Non-judicial stamp paper of Rs. 100/- as per Annexure-II. List of Drugs along with drugs code for which firm has quoted without mentioning price. Technical Literature / Catalogue & documents of the quoted items that is technically relevant and supportive to the bid. The statement of deviation (Parameter wise) from the Tender Technical Bid Specification-(Annexure-IV) The performance statement duly filled by the concerned firm/organization as per Annexure - V. The annual turnover statement (in the letterhead of the Charted Accountant should be attached) as per Annexure-VI. i. The company/manufacturer must submit the most recent certificate in support of the product which is manufactured as per most guidelines of a Good Manufacturing Practice (GMP) certified laboratory issued by the government or competent authority. Otherwise the bid will be rejected. Declaration for manufacturing items and production capacity as per GMP/WHO/COPP as per Annexure-VII. (Note : All the copies of uploaded documents duly signed & stamped by the Bidder as per the sections of Tender document, must be filed in a ring binder, properly indexed with page numbers). 3.2 Financial Bid: The Financial Bid to be submitted on line as per prescribed format in Section IX. The Financial Bid of bidders, who qualify in Technical Bid Evaluation, will be opened thereafter. 3.2.1 The Rates are to be quoted in the given format Section-IX. 3.2.2 All quoted rates should be inclusive of freight, packing, forwarding & insurance & Labour charges and also percentage of GST etc. 3.2.3 The rates should be quoted in Indian Rupees in figure as well as in words only. 3.2.4 If a firm quotes NIL charges/consideration, the bid shall be treated as unresponsive and will not be considered.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 8 of 85 3.2.5 L-1 will be decided on the lowest price excluding GST of each product for which the bidder is quoting. GST has to be mentioned clearly in percentage for each product. Item wise evaluation will be done for determining lowest quoted price for each of the Items. 3.2.6 The price in the Financial Bid to be quoted as per the formulation unit only as mentioned in the list of items. 3.2.7 The Tender Evaluation Committee may also verify the veracity of claims in respect of known performance of the item(s) offered, experience and reputation of the bidder in the field, the financial solvency etc. 3.2.8 An offer submitted in vague/ambiguous financial terms and the like, shall be termed as non-responsive and shall summarily be rejected. *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 9 of 85 Section-IV ELIGIBILITY CRITERIA 4.1 Bidder shall only be a manufacturer having valid own manufacturing license with product registration certificate issued by the Drugs Controller General of India. 4.2 The manufacturer shall have a valid manufacturing drug license or duly acknowledged renewal application with old license issued by the State Licensing Authority/Central Licensing Approving Authority (wherever applicable). The firm is required to submit the renewal License copy immediately on receipt and suspension/cancellation of License if any must be informed immediately. 4.3 In case of importer, it should have a valid import license and product registration certificate issued by the Drugs Controller General of India. 4.4 In case of manufacturer, it shall have valid GMP certificate as per Revised Schedule M of Drugs & Cosmetics Rule 1945/COPP (Certificate of Pharmaceutical Products) / WHO GMP certificate issued by the concerned licensing authority for drug items. 4.5 In case of imported item, WHO / GMP (of Manufacturer) / COPP (Certificate of Pharmaceutical Products) shall be submitted. Note: Valid certificate mean the certificates should be valid at least on the date of opening of technical bid. The firm is required to submit the renewal License copy immediately on receipt and suspension/cancellation of License if any must be informed immediately. 4.6 The Bidder should have experience (across at least 3 states of India) in supplying quoted item/Similar item as per tender specification to the State or Central Government or Government Hospitals / Corporate Hospitals / PSU Hospitals in India / UN agencies / Authorized agency of the State / Central Govt. / PSU as a manufacturer during the last 2(two)years. 4.7 The Bidders should have at least 02(Two) years market standing for the quoted item(s) as per tender specification (In Annexure-III / Market standing certificate issued by the licensing authority to establish the 2 years market standing of for the quoted item(s) as per tender specification). This would not applicable to new drugs; a certificate from the Drug Controller General (India) shall be required for all new drug formulations to this effect in From-46 for exemption. This would not be applicable for non-drug items. 4.8 Non-Conviction certificate issued by the licensing authority that the manufacturers/importer have not been convicted under the provision of D&C Act 1940 and Rules thereof by any court of law in contravention to the above Act & Rules. 4.9 Financial Standing Criteria: The Manufacturer shall have a minimum turnover of Rs.50 (Fifty) Crores or more in each year during last (3) three financial years in India. The proof of Turnover is to be furnished in the Annexure-VI certified by the Chartered accountant and supported by audited Financial statement. 4.10 The manufacturer should have only one authorized agency/authorized stockiest for all their quoted items in Patna (Bihar) and around only for the purpose of supply of items. No part authorization of items will be entertained at any stage of Contract. Any change of authorization must be intimated to IGIMS, Patna without any delay. The registered office of authorized agency/ stockiest /distributor/dealer should be existing within the radius of 50(Fifty) km distance from IGIMS, Patna.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 10 of 85 4.11 The drugs should have been evaluated and validated by at least by one international agencies like WHO,UNICEF and/or National level laboratories such as National Institute of Nutrition, Hyderabad; National Centre of Disease Control, Delhi; All India Institute of Medical Science, New Delhi; All India Institute of Hygiene & Public Health, Kolkata; Central Food Technological Research Institute, Mysore; Indian Council of Medical Research and Council of Scientific & Industrial Research Laboratories. The validation should include tests for the quality, packaging, ready to use testing (drop by drop), stability at various places, shelf life under sealed condition as well as open condition. The detail test report of all the test parameters must be furnished in the technical bid. 4.12 The participating bidder must have in house testing facilities and valid Good Laboratory Practice (GLP Certificate) as per schedule L1 of the Drugs and Cosmetic Rules issued by Central/State Drug Controller for the quoted common drugs (as applicable). 4.13 In case of newly introduced item(s), the participating Bidder will submit valid Certificate from Drug Controller General of India in support of the claim and valid Drug Licence from the concerned Licensing Authority. 4.14 In case of Proprietary item(s), participating Bidder will submit valid Certificate to this effect from State Drug Controller/Licensing Authority, else Bidders claim will not be considered. 4.15 For the item(s) which are being imported, the participating Bidder will submit valid Import License issued by appropriate authority in India. 4.16 For the item(s) quoted in the Tender enquiry, participating Bidder will have to submit Original Label of all quoted items and Literature/Brochure/Catalogue of all quoted items. 4.17 The bidder should have submitted in the bid a copy of Quality Management System (QMS) certificate of the quoted items. 4.18 The bidder should submit 05 nos. of end user certificate from any Govt./PSU Organization against execution of orders for tendered items. 4.19 A latest certificate of GST payment should be enclosed. Note for Bidders: Doctrine of Substantial Compliance: The Eligibility Criteria are for short listing of sources who are competent to perform this contract to ensure best value for money from expenditure of Public Money. This process is neither intended to bestow any entitlement upon nor to create any rights or privileges for the Bidders, by way of overly hair-splitting or viciously legalistic interpretations of these criteria, disregarding the very rationale of the Eligibility Criteria. Keeping this caveat in view, interpretation by Procuring Entity would be based on common usage of terminologies and phrases in public procurement in accordance with the Doctrine of Substantial Compliance and would be final. *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 11 of 85 Section-V TECHNICAL SPECIFICATION OF LIST OF ITEMS 5.1 General Specification item wise: SlCODEDescriptionStrengthFormulation UnitNo.12345Anthelmintic1GD001AlbendazoleTablet 400 mgOne Tablet2GD002AlbendazoleSyrup 200mg/10mlOne Bottle of 10 MLAnti Convulsant3GD003BetahistineTablet 16mgOne Tablet4GD004Caffeine citrateInjection 20 mg/mlOne Vial of 1 mlCaffeine citrateOral solution (20 mg of5GD005caffeine citrate/ ml)One Bottle of 3 ml6GD006CarbamazepineCR Tablet 200 mgOne Tablet7GD007CarbamazepineSyrup 100mg/5mlOne Bottle of 450 ml8GD008CarbamazepineSyrup200mg/5mlOne Bottle9GD009ClobazamTablet 10 mgOne Tablet10GD010ClobazamTablet 5 mgOne Tablet11GD011DiazepamInjection 5 mg/mlOne Vial of 10 ml12GD012DiazepamTablet 5 mgOne Tablet13GD013DiazepamSyrup 5mg/5mlOne Bottle of 500 ml14GD014EthosuximideCapsule 250 mgOne Capsule15GD015GabapentinTablet 100mgOne Tablet16GD016GabapentinTablet 300mgOne Tablet17GD017LacosamideInjection 10mg/mlOne Vial of 20 ml18GD018LacosamideTablet50 mgOne Tablet19GD019LacosamideTablet 100 mgOne Tablet20GD020LacosamideTablet 300 mgOne Tablet21GD021LamotrigineTablet50MGOne Tablet22GD022LamotrigineCapsule 100MGOne Capsule23GD023LevetiracetamTablet 500 mgOne Tablet24GD024LevetiracetamTablet 250 mgOne Tablet25GD025LevetiracetamSyrup 100mg/mlOne Bottle of 200 ml26GD026LevetiracetamInjection 1GMOne Vial27GD027LevetiracetamInjection 500 mgOne Vial of 5 ml28GD028LorazepamInjection 2 mg/mlOne Vial of 1 ml29GD029LorazepamTablet 2 mgOne Tablet30GD030Magnesium SulphateInjection 500 mg/mlOne Vial of 2ml31GD031OxcarbazepineTablet 100 mgOne Tablet32GD032OxcarbazepineTablet 200 mgOne Tablet33GD033PhenobarbitoneInjection 200 mg/mlOne Vial of 1 ml34GD034PhenobarbitoneOral liquid 20 mg/5 mlOne Bottle of 473ml35GD035PhenobarbitoneTablet 30 mgOne Tablet36GD036PhenothiazineInjection 12.5 MG/MLOne Vial37GD037PhenytoinTablet 50 mgOne Tablet38GD038PhenytoinTablet100 mgOne Tablet39GD039PhenytoinTablet300 mgOne Tablet40GD040PhenytoinInjection 50 mg/mlOne Vial of 2ml41GD041PhenytoinSyrup 30mg/5mlOne Bottle of 500 ml42GD042PregabalinTablet 75 mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 12 of 85SlCODEDescriptionStrengthFormulation UnitNo.1234543GD043PregabalinCapsule 200 mgOne Capsule44GD044Sodium valproateCR Tablet 500 mgOne Tablet45GD045Sodium valproateCR Tablet 300 mgOne Tablet46GD046Sodium valproateInjection 100 mg/mlOne Vial of 5 ml47GD047Sodium valproateOral liquid 200 mg/5ml,One Bottle of 100 ml48GD048Sumatriptan SuccinateTablet 50 mgOne Tablet49GD049TolterodineCapsule 2MGOne Capsule50GD050TolterodineCapsule4MGOne Capsule51GD051TopiramateTablet 25MGOne Tablet52GD052TopiramateTablet 50MGOne TabletTriclofos Oral SolutionOral Solution 500 Mg/5 ML53GD053One Bottle of 30 ml54GD054ZonisamideCapsule 25MGOne Capsule55GD055ZonisamideCapsule 50MGOne Capsule56GD056ZonisamideSuspensionOne Bottle57GD057ZonisamideCapsule100MGOne CapsuleAntiallergics58GD058AdrenalineInjection 1 mg/mlOne Ampoule of 1 ml59GD059CetirizineOral liquid 5 mg/5 mlOne Bottle of 30 ml60GD060CetirizineTablet 10 mg,One Tablet61GD061Chlorpheneramine maleateTablet 50mgOne Tablet62GD062Chlorpheneramine maleateTablet 25mgOne Tablet63GD063Chlorpheneramine maleateInjection 45.50mg/2mlOne Ampoule of 2ml64GD064ChlorpheniramineTablet 4 mgOne Tablet65GD065CyproheptadineSyrup 100 mlOne Bottle of 100 ml66GD066CyproheptadineTablet 4 mgOne Tablet67GD067FexofenadineTablet 120mgOne Tablet68GD068LevocetirizineSyrup 2.5mg/5mlOne Bottle of 60 ml69GD069LevocetirizineTablet 5mgOne Tablet70GD070LoratidineTablet10mgOne Tablet71GD071LoratidineOral Suspention 1mg/mlOne Bottle of 60 ml72GD072PheniramineInjection 22.75 mg/mlOne Ampoule of 2mlAnti-Asthmatics73GD073AmbroxolSyrup 15mg/5mlOne Bottle of 100 ml74GD074AminophyllineInjection 250mg/10mlOne Ampoule of 10 ml75GD075BromhexineSyrup 4mg/5mlOne Bottle of 100 mlBudesonideRespirator solution for use in76GD076nebulizer 0.5 mg/2mlOne Bottle of 2 mlBudesonide (A) + Formoterol (B)Inhalation (MDI/DPI) 400 mcg77GD077(A) + 6 mcg (B)Each container of 200 MDIBudesonide (A) + Formoterol (B)Inhalation (MDI/DPI) 200 mcg78GD078(A) + 6 mcg (B)Each container of 120 MDIIpratropiumRespirator solution for use in79GD079nebulizer 250 mcg/mlOne Bottle of 15 mlIpratropiumInhalation (MDI/DPI) 2080GD080mcg/doseEach container of 200 MDI81GD081Ipratropium + Levosalbutamolrespules 500 mg+ 1.25mgone respules of 2.5 ml  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 13 of 85SlCODEDescriptionStrengthFormulation UnitNo.1234582GD082MontelukastTablet10mgOne TabletSalbutamolRespirator solution for use in83GD083nebulizer 5mg/mlOne Bottle of 10 ML84GD084SalbutamolTablet 2 mgOne Tablet85GD085SalbutamolTablet 4 mg,One TabletSalbutamolInhalation (MDI/DPI) 10086GD086mcg/dose,Each container of 200 MDI87GD087SalbutamolOral liquid 2 mg/5 mlOne Bottle of 100 mlSalmetrol+FluticasoneMDI 250PUFFSEach container of MDI88GD088250PUFFS89GD089TerbutalineInjection 0.5mg/mlOne Ampoule of 1 ml90GD090TerbutalineTablet 2.5MGOne Tablet91GD091TerbutalineSyrup 100 mlOne Bottle of 100 mlTheophylline + EtofyllineInjection 50.6 mg +169.492GD092mg/2 mlOne Ampoule of 2ml93GD093TiotropiumInhalation (MDI) 9 mcg/doseEach container of 200 MDIAntibiotics94GD094AmikacinInjection 100 mgOne Vial of 2ml95GD095AmikacinInjection 500 mgOne Vial of 2ml96GD096AmoxicillinCapsule 250 mgOne Capsule97GD097AmoxicillinCapsule 500 mgOne CapsuleAmoxicillin (A) + Clavulanic acidOral liquid 200 mg (A) + 28.598GD098(B)mg (B)/5 mlOne Bottle of 30 mlAmoxicillin (A) + Clavulanic acid99GD099(B)Injection 300 mgOne Vial of single DoseAmoxicillin (A) + Clavulanic acid100GD100(B)Injection600 mgOne Vial of single DoseAmoxicillin (A) + Clavulanic acid101GD101(B)Injection 1200 mgOne Vial of single DoseAmoxicillin (A) + Clavulanic acidTablet 500 mg (A) + 125 mg102GD102(B)(B)One TabletAmoxicillin (A) + Clavulanic acidTablet 200 mg (A) + 125 mg103GD103(B)(B)One Tablet104GD104AmpicillinPowder for Injection 1 gOne Vial of single Dose105GD105AzithromycinPowder for Injection 500 mg,One Vial of single Dose106GD106AzithromycinTablet 250 mgOne Tablet107GD107AzithromycinTablet 500 mgOne Tablet108GD108AzithromycinSyrup 100mg/5mlOne Bottle of 15 ml109GD109AzithromycinE/D 1%Each container of 3 ML110GD110AztreonamInjection 1 gmOne Vial of single Dose111GD111AztreonamInjection 2 gmOne Vial of single DoseBenzyl penicillinPowder for Injection 10 lac112GD112unitsOne Vial of single Dose113GD113CefazolineInjection 1 gmOne Vial of single Dose114GD114Cefipime + TazobactumInjection 2.25gmOne Vial of single Dose115GD115CefiximeTablet 200 mgOne Tablet116GD116CefiximeOral liquid 50 mg/5 mlOne Bottle of 50 ML117GD117Cefoperazone + SulbactamInjection 1 g + 0.5 gOne Vial of single Dose118GD118CefotaximePowder for Injection 1 gOne Vial of single Dose119GD119CefotaximePowder for Injection 250mgOne Vial of single Dose Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 14 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345120GD120CeftazidimePowder for Injection 1 gOne Vial of single Dose121GD121CeftazidimePowder for Injection 500mgOne Vial of single Dose122GD122CeftazidimePowder for Injection 250mgOne Vial of single Dose123GD123CeftriaxonePowder for Injection 1 gOne Vial of single Dose124GD124CeftriaxonePowder for Injection 250mgOne Vial of single Dose125GD125CefuroximePowder forInjection 300 mgOne Vial of single Dose126GD126CefuroximePowder for Injection 750mg,One Vial of 15 ML127GD127CefuroximePowder for Injection 1.5 gmOne Vial of Single Dose Via128GD128CiprofloxacinEar Drop 0.03%,Each container of 5 ML129GD129CiprofloxacinTablet 500 mgOne Tablet130GD130CiprofloxacinTablet 250 mg,One Tablet131GD131CiprofloxacinInjection 200 mg/100 mlEach container of 100 ML132GD132CiprofloxacinOintment 0.05w/w,Each tube of 15GM133GD133ClarithromycinInjection 500mgOne Vial of single Dose134GD134ClarithromycinTablet 500 mgOne Tablet135GD135ClindamycinInjection 300 mgOne Vial of 2ml136GD136ClindamycinTablet 300 mgOne Tablet137GD137ClindamycinTablet 150 mgOne Tablet138GD138CloxacillinPowder for Injection 500 mgOne Vial of single Dose139GD139CloxacillinPowder for Injection 250 mgOne Vial of single Dose140GD140CloxacillinCapsule 500mgOne Capsule141GD141ColistinInjection 3 Million IUOne Vial of single Dose142GD142ColistinInjection 1 Million IUOne Vial of single Dose143GD143CotrimazoleTablet 400mgOne TabletCo-trimoxazole [SulphamethoxazolTablet 800 mg (A) + 160 mg+Trimethoprim (B)]144GD144(B)One TabletCo-trimoxazole [SulphamethoxazolOral liquid 200 mg (A) + 40+Trimethoprim (B)]145GD145mg (B)/5 mlOne Bottle of 100 ml146GD146DoxycyclineCapsule 100 mgOne Capsule147GD147DoxycyclineInjection 100 mgOne Vial of single Dose148GD148FaropenemTablet 500 mgOne Tablet149GD149GentamicinInjection 40 mg/mlOne Vial of 2ml150GD150Imipenem and CilastatinInjection 500mgOne Vial of single Dose151GD151LinezolidSyrup 100mg/5mlOne Bottle of 30 ml152GD152LinezolidInjection 600 mgOne Vial of 300 ml153GD153LinezolidInjection 200 mgOne Vial of 100 ml154GD154LinezolidInjection 2mg/mlOne Vial155GD155LinezolidTablet 600 mgOne Tablet156GD156MeropenemInjection 1 gOne Vial of single Dose157GD157MeropenemInjection 500 gOne Vial of single Dose158GD158MeropenemInjection 125MGOne Vial of single Dose Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 15 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345159GD159MetronidazoleTablet 400 mgOne Tablet160GD160MetronidazoleInjection 500 mg/100 mlOne Vial of 100 ml161GD161NitrofurantoinSyrup 25mg/5mlOne Bottle of 230 ml162GD162NitrofurantoinTablet 100 mgOne Tablet163GD163OfloxacinTablet 200 mgOne Tablet164GD164OfloxacinInjection 200 mgEach container of 100 ML165GD165OfloxacinSyrup 50mgOne Bottle of 60 ml166GD166OrnidazoleTablet 500mgOne Tablet167GD167Penicilline GInjection 250 mgOne Vial of single DosePiperacillin (A) + Tazobactam (B)Powder for Injection 4 g (A) +168GD168500 mg (B)One Vial of single DosePiperacillin (A) + Tazobactam (B)Powder for Injection 2 g (A) +169GD169250 mg (B)One Vial of single DosePiperacillin (A) + Tazobactam (B)Powder for Injection 1 g (A) +170GD170125 mg (B)One Vial of single Dose171GD171Polymyxin BInjection 5 kOne Vial of single Dose172GD172RoxythromycinTablet 150mgOne Tablet173GD173Streptomycin 750mgInjection 750mgOne Vial of single DoseSulfamethoxazole+TrimethoprimInjection (80mg+16mg)/ml in174GD1745 mlOne Vial of 30ml175GD175Sulfamethoxazole+TrimethoprimTablet 400 mg+80 mgOne Tablet176GD176Sulfamethoxazole+TrimethoprimTablet (800+160)One Tablet177GD177Sulfamethoxazole+TrimethoprimSusp. 800+160(60ml.)One Bottle178GD178TetracyclineTablet 250mgOne Tablet179GD179TigecyclineInjection 50 MGOne Vial of single Dose180GD180VancomycinPowder for Injection 500 mgOne Vial of single Dose181GD181VancomycinTablet 500 mgOne TabletAnticancer Drugs182GD1825-FluorouracilInjection 250 mg/5 mlOne Vial of 5 ml183GD1836-MercaptopurineTablet 50 mgOne Tablet184GD184AbirateroneTablet 500MGOne Tablet185GD185Abiraterone AcetateTablet 250 mgOne Tablet186GD186Actinomycin DPowder for Injection 0.5 mgOne Vial of single Dose187GD187All-trans retinoic acidCapsule 10 mgOne Capsule188GD188BendamustineInjection 100mgOne Vial of single Dose189GD189BicalutamideTablet 50 mgOne Tablet190GD190BleomycinPowder for Injection 15 unitsOne Vial of single Dose191GD191BortezomibPowder for Injection 3MGOne Vial of single Dose192GD192BortezomibPowder for Injection2.5MGOne Vial of single Dose193GD193BortezomibPowder for Injection 2mgOne Vial of single Dose194GD194Calcium folinateInjection 3 mg/mlOne Vial of 5 ml195GD195Calcium folinateTablet 15 mg,One Tablet196GD196CapecitabineTablet 500 mgOne Tablet197GD197CarboplatinInjection 10 mg/mlOne Vial of 5 ml198GD198CisplatinInjection 1mg/mlOne Vial of 50ml199GD199CyclophosphamideTablet 50 mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 16 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345200GD200CyclophosphamidePowder for Injection 200 mgOne Vial of single Dose201GD201CyclophosphamidePowder for Injection 1GMOne Vial of single Dose202GD202CyclophosphamidePowder for Injection 500 mgOne Vial of single Dose203GD203CytarabinInjection 100 mg/5mlOne Vial of single Dose204GD204DacarbazinePowder for Injection 500 mgOne Vial of single Dose205GD205DapoxetineTablet 50 MGOne Tablet206GD206DapoxetineTablet 30 mgOne Tablet207GD207DaunorubicinInjection 80MGOne Vial of single Dose208GD208DaunorubicinInjection 20MGOne Vial of single Dose209GD209DaunorubicinInjection 5 mg/mlOne Vial of 4 ml210GD210DecitabineInjection 50mgOne Vial of single Dose211GD211DocetaxelPowder for Injection 80 mgOne Vial of 2ml212GD212DocetaxelPowder for Injection 20 mg,One Vial of 0.5ml213GD213DoxorubicinInjection 2 mg/mlOne Vial of single DoseDoxorubicinOne Vial of Single Dose214GD214Injection 50MGLyophilized215GD215DoxorubicinInjection 20MG/10 mlOne Vial of 10 ml216GD216Enzulatamidesoft capsules 40MGOne soft capsule217GD217EpirubicinInjection 10MGOne Vial of single Dose218GD218EtoposideCapsule 50 mgOne Capsule219GD219EtoposideCapsule 100 mgOne Capsule220GD220EtoposideInjection 20 mg/mlOne Vial of 50ml221GD221GefitinibTablet 250 mgOne TabletGemcitabineOne Vial of Single Dose222GD222Powder for Injection 1 gLyophilized223GD223GemcitabinePowder for Injection 200 mgOne Vial of single DoseGranulocyte colony stimulatingInjection 300 g224GD224factor (G-CSF)One Vial of 1 mlGranulocyte colony stimulatingInjection 6 mg225GD225factor (G-CSF)One Vial of 1 ml226GD226IfosfamidePowder for Injection 1 gOne Vial of 20 ml227GD227ImatinibTablet 400 mgOne Tablet228GD228Intravesical bcgInjection 40 MGOne Vial of single DoseL-AsparaginasePowder for Injection 10000229GD229KUOne Vial of single Dose230GD230L-AsparaginasePowder for Injection 5000 KU.One Vial of single Dose231GD231LetrozoleTablet 20 mgOne TabletLeuprolideInjection 22.5 MGOne Vial of 2ml Single Dose232GD232Lyophilized233GD233MesnaInjection 100 mg/mlOne Vial of 2mlMethotrexateOne Vial of Single Dose234GD234Injection 1GM,Lyophilized235GD235MethotrexateInjection 50 MGOne Vial of 2ml236GD236MethotrexateInjection 15 MGOne Ampoule of 1 ml237GD237MethotrexateTablet10 mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 17 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345238GD238MethotrexateTablet 2.5 mgOne Tablet239GD239OctreotideInjection 100mcgOne Vial of 1 ml240GD240OxaliplatinInjection 5 mg/mlOne Vial of 20 ml241GD241PaclitaxelInjection 100 mg/16.7 mlOne Vial of single Dose242GD242PazopanibTablet 40MGOne Tablet243GD243PemetrexedInjection 800 mgOne Vial244GD244PemetrexedInjection 500mgOne Vial of single Dose245GD245RituximabInjection 500MGOne Vial of 50ml246GD246RituximabInjection 10 mg/mlOne Vial of 10 ml247GD247SunitinibCapsule 50MGOne Capsule248GD248TamoxifenTablet 20 mgOne Tablet249GD249TemozolomideTablet 100 mgOne Tablet250GD250ThalidomideCapsule 100 mgOne Capsule251GD251TrastuzumabInjection 440 mg/50 mlEach container of 50 ml252GD252TriptorelinInjection 11.25 MGOne Vial of single Dose253GD253VinblastineInjection 1 mg/mlOne Vial of 10 ml254GD254VincristineInjection 1 mg/mlOne Vial of 1 mlAnticoagulants255GD255AcenocoumarolTablet 2gmOne Tablet256GD256DabigatranTablet 150mgOne Tablet257GD257DabigatranTablet 110mgOne Tablet258GD258EnoxaparinInjection 60 mg (PFS)One Vial259GD259EnoxaparinInjection 40 mg/0.4 mlOne Vial of 0.4ml260GD260EnoxaparinInjection 20 mgOne Vial of 0.2ml261GD261Fondaparinux Sod.Injection 2.5mg/0.5mlOne Vial of 0.5ml262GD262HaemocoagulaseInjection 1 I.U/1mlOne Vial of 1 ml263GD263HeparinInjection 10000 IU/ml ,One Vial of 1 ml264GD264HeparinInjection 5000 IU/mlOne Vial of 5 ml265GD265Phytomenadione (Vit.K1)Injection 10 mg/mlOne Vial of 1 ml266GD266Phytomenadione (Vit.K1)Tablet 10mgOne Tablet267GD267ProtamineInjection 10 mg/mlOne Vial of 25 ml268GD268Tranexamic acidInjection 100 mg/mlOne Ampoule of 5ml269GD269Tranexamic acidTablet 500 mg,One Tablet270GD270WarfarinTablet 5 mgOne Tablet271GD271WarfarinTablet 2 mgOne TabletAntidepressants and Moodstabilizers272GD272AmitriptylineTablet 10 mg,One Tablet273GD273AmitriptylineTablet 25 mgOne Tablet274GD274ClomipramineCapsule 75 mgOne Capsule275GD275DothiepinTablet 25MGOne Tablet276GD276DuloxetineTablet 30mgOne Tablet277GD277DuloxetineTablet 10mgOne Tablet278GD278EscitalopramTablet 5 mgOne Tablet279GD279FluoxetineCapsule 20 mgOne Capsule280GD280SertralineTablet 50MGOne TabletAnti-Diabetic Medicines281GD281GlimepirideTablet 1 mgOne Tablet282GD282GlargineInjection 100 unit/mlOne Vial of 10 ml283GD283Insulin (Soluble)Injection 40 IU/mlOne Vial of 10 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 18 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345Insulin 30:70 Injection (Premix284GD284Regular: NPH)Injection 40 IU/mlOne Vial of 10 ml285GD285Intermediate Acting (NPH) InsulinInjection 40 IU/mlOne Vial of 10 ml286GD286MetforminTablet 500 mgOne Tablet287GD287PioglitazoneTablet 15 mgOne Tablet288GD288TeneligliptinTablet 20mgOne TabletAnti-diarrhoeal289GD289LactobacillusTablet / CapsulesOne Tablet290GD290LoperamideTablet 2mgOne Tablet291GD291Oral rehydration saltsAs licensed sachetone Sachet of 30gm292GD292Oral rehydration saltsliquid 200mlOne Container of 200ml293GD293RacecadotrilTablet 100 mgOne Tablet294GD294Zinc carbonate (elemental)Tablet 50 mgOne Tablet295GD295Zinc sulphateDispersible Tablet 20 mgOne TabletAntidotes296GD296Activated charcoalPower 200 GMEach container of 200 gm297GD297AtropineInjection 100mlOne Vial of 100 ml298GD298Calcium gluconateInjection 100 mg/mlOne Ampoule of 10 ml299GD299DesferrioxaminePowder for Injection 500 mgOne Vial of single Dose300GD300DiferasiroxTablet 250 mgOne TabletMethylthioninium chloride301GD301(Methylene blue)Injection 10 mg/mlOne Vial of 10 ml302GD302N-acetylcysteineInjection 200 mg/mlOne Vial of 30ml303GD303N-acetylcysteineSachet 200 mgone Sachet of 200 mg304GD304N-acetylcysteineNebuliser sol. 20%Each container of 30 ml305GD305N-acetylcysteineNebuliser sol. 10%Each container of 30 ml306GD306N-acetylcysteineInjection 20%One Vial of 5 ml307GD307N-acetylcysteineInjection 10%One Vial of 10 ml308GD308N-acetylcysteineTablet 600mgOne Tablet309GD309NaloxoneInjection 0.4 mg/mlOne Vial of 2ml310GD310PAM (Pralidoxime iodide)Injection 500 mgOne Ampoule of 20 ml311GD311PenicillamineCapsule 250 mgOne Capsule312GD312Pralidoxime chloride (2-PAM)Injection 25 mg/mlOne Vial313GD313Protamine sulfateInjection 50mg/5mlOne Vial of 5 ml314GD314Sodium ThiosulphateInjection 250mg/ml,50mlOne Vial of 50mlAnti-emetics315GD315DomperidoneInjection 40 MGOne Ampoule of 2ml316GD316DomperidoneTablet 10 mgOne Tablet317GD317DomperidoneSyrup 30mlOne Bottle of 30 ml318GD318MetoclopramideInjection 5 mg/mlOne Vial of 2ml319GD319MetoclopramideTablet 10 mgOne Tablet320GD320OndansetronInjection 8 mgOne Ampoule of 4ml321GD321OndansetronInjection 4 mgOne Ampoule of 2ml322GD322OndansetronTablet 4 mg,One Tablet323GD323OndansetronSyrup 2mg/5mlOne Bottle of 30 mlAntifungals324GD324Amphotericin-B ConventionalPowder for Injection 50 mgOne Vial of single Dose Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 19 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345325GD325Amphotericin-B Lipid/LiposomalPowder for Injection 50 mgOne Vial of single Dose326GD326CaspofunginInjection 50 mgOne Vial of single Dose327GD327ClotrimazolePessary 100 mgEach Pic.328GD328ClotrimazoleEar Drop,Each container of 5 ML329GD329ClotrimazoleMouth paint (1%) w/ wEach container of 25 ml330GD330ClotrimazoleTablet 100mgOne Tablet331GD331FluconazoleInjection 200 mg /100 mlEach container of 100 ML332GD332FluconazoleTablet 200 mgOne Tablet333GD333ItraconazoleCapsule 100mgOne Capsule334GD334ItraconazoleTablet 200MGOne Tablet335GD335ItraconazoleE/D 1%Each container of 5 ML336GD336VericonazoleCapsule 200 mgOne CapsuleAnti-Gout Agents337GD337AllopurinolTablet 100 mgOne Tablet338GD338FebuxostatTablet 40 mgOne TabletAnti-Leprotics339GD339ClofazimineCapsule 50 mgOne Capsule340GD340DapsoneTablet 50 mgOne TabletAnti-MalarialsArtemether (A) + Lumefantrine (B)Oral liquid 80 mg (A) + 480341GD341mg (B)/5 MlOne Bottle of 30 ml342GD342Artemether (A) + Lumefantrine (B)Tablet 40 mg (a) + 240 mg (b) ,One Tablet343GD343ArtesunatePowder for Injection 60 mgOne Vial of single Dose344GD344ChloroquineOral liquid 50 mg/5 ml,One Bottle of 60 ml345GD345ChloroquineTablet 150mgOne Tablet346GD346Hydroxychloroquine PhosphateTablet 200mgOne Tablet347GD347PrimaquineTablet 7.5 mgOne Tablet348GD348PrimaquineTablet 2.5 mg,One TabletAntimigraine Drugs349GD349FlunarizineTablet 5 mgOne Tablet350GD350PropanololTablet 20 mgOne TabletAnti-Parkinsonian DrugsLevodopa(A) + Carbidopa (B)CR Tablet 100 mg (A) + 25 mg351GD351(B)One Tablet352GD352RasagilineTablet 0.5mgOne Tablet353GD353RivastigmineTablet 1.5MGOne Tablet354GD354RizatriptanTablet 10 mgOne Tablet355GD355Ropinirole HCLTablet 0.25 mgOne Tablet356GD356TrihexyphenidylTablet 2 mgOne TabletAntipsychotics357GD357AmisulprideTablet 200mgOne Tablet358GD358AmisulprideTablet 400 mgOne Tablet359GD359CiticolineInjection 500mgOne Ampoule of 2ml360GD360CiticolineTablet. 500mgOne Tablet361GD361ClonidineInjection 500 Mcg/mlOne Vial of 10 ml362GD362ClonidineTablet 100 mcgOne Tablet363GD363ClozapineTablet 100 mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 20 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345364GD364DexmedetomidineInjection 50 Mcg/0.5mlOne Vial of 0.5ml365GD365DonepazilTablet.5mgOne Tablet366GD366DonepazilTablet 10mgOne Tablet367GD367HaloperidolInjection 5m/mlOne Vial of 1 ml368GD368HaloperidolTablet 5 mgOne Tablet369GD369OlanzapineTablet 5mgOne Tablet370GD370OlanzapineTablet 10mgOne Tablet371GD371ParaldehydeInjectionOne Vial of 1 mlPiracetamInjection 200mg 60ml vail372GD372One Vial of 60 ml373GD373PiracetamTablet 800mgOne Tablet374GD374PiracetamTablet 1200mgOne Tablet375GD375PiracetamSyrup 100mlOne Bottle of 100 ml376GD376PramipexoleTablet 0.25 mgOne Tablet377GD377QuetiapineTablet 50mgOne Tablet378GD378QuetiapineTablet 100mgOne Tablet379GD379QuetiapineTablet 300mgOne Tablet380GD380RisperidoneTablet 2 mgOne Tablet381GD381Zolpidem TartarateTablet 10 MgOne TabletANTISEPTIC382GD382Silver ColloidalTopical gel for burn woundsEach Jar of 60 ml383GD383Acriflavine antiseptic Powder25-gram packsEach container of 25 gm384GD384Bismuthpowder 200gmEach container of 200 gmChlorhexidineSolution 5% (Concentrate for385GD385dilution)One Bottle of 300 ml386GD386Chlorhexidine5 % LiquidOne Bottle of 500 ml387GD387Ethyl alcohol (Denatured)Solution 70%One Bottle of 500 ml388GD388HyaluronidaseInjection 15000IUOne Vial of 1 ml389GD389Hydrogen peroxideSolution 6%One Bottle of 500 ml390GD390Iodoformpowder 200gmEach container of 200 gm391GD391MetronidazoleOintment 1%Each tube of 45 gm392GD392MupirocinOintment 2%Each tube of 22 gm393GD393NeomycineCreame 0.5%Each tube of 15GM394GD394PiroxicamOintment 0.5%w/vEach tube 30 gm395GD395Silver sulphadiazineCreame 250 gmEach Jar of 250 gm396GD396Tincture BenzoinInjection 10mg/100 mlOne Vial of 100 ml397GD397Type II collagenTablet 500 mgOne TabletANTISERA-IMMUNOGLOBULINSAnti-D immunoglobulinEach container of 300 mcg of398GD398Injection-300 mcg of 1.3ml1.3ml399GD399Anti-rabies immunoglobulinInjection-300 iu of 2 mlEach container of 300 iu of 2 ml400GD400Anti-tetanus immunoglobulinInjection-250 iu of 2.5 mlEach container of 250 iu of 2.5 ml401GD401DipyridamoleTablet 25 mgOne Tablet402GD402Human Albumin 20%100 MlOne Bottle of 100 ml403GD403Immune Globulin (Human)10%30G/300 MlOne Bottle of 300 ml404GD404IVIGInjection 2.5 gmOne Vial of 100 ml405GD405Lyophilized polyvalentSingle DoseEach container of Single Dose406GD406Rabies vaccineSingle DoseEach container of Single Dose Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No09 / 2020 - 2021 / IGIMS / StorePage 21 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345407GD407Snake venom antiserumAnti Snake Venom (10ml)One Vial of 10 ml408GD408Tetanus toxoidInjection 0.5mlOne Vial of 0.5mlANTSPASMODIC409GD409DarifenacinTablet 7.5 mgOne Tablet410GD410DarifenacinTablet 15 MGOne Tablet411GD411DicyclomineSyrup 10MG/5MLOne Bottle412GD412DicyclomineTablet 20 mg,One Tablet413GD413DicyclomineInjection 10 mg/mlOne Ampoule of 2ml414GD414DrotaverineInjection 40 mgOne Ampoule of 2ml415GD415DrotaverineTablet40 mgOne Tablet416GD416Hyoscine butyl bromideInjection 20 mgOne Ampoule of 1 ml417GD417OxybutyninTablet 2.5 MGOne Tablet418GD418TamsulosinTablet 0.4 mgOne TabletANTITHYROID419GD419CarbimazoleTablet 5mgOne Tablet420GD420LevothyroxineTablet 25 mcgOne Tablet421GD421LevothyroxineTablet 50 mcgOne Tablet422GD422LevothyroxineTablet 12.5mg,One Tablet423GD423ThyroxineTablet 25MGOne Tablet424GD424ThyroxineTablet 50MGOne TabletANTITUBERCULAR425GD425EthambutolTablet 400 mgOne Tablet426GD426IsoniazidTablet 50 mgOne Tablet427GD427IsoniazidTablet 300 mgOne Tablet428GD428IsoniazidOral liquid 50 mg/5 mlOne Bottle of 200 ml429GD429LevofloxacinTablet 500 mgOne Tablet430GD430LevofloxacinTablet 750 mgOne Tablet431GD431LevofloxacinInjection 500mg/100 mlEach container of 100 ML432GD432LinezolidTablet 600 mgOne Tablet433GD433PyrazinamideTablet 500 mg,One Tablet434GD434PyrazinamideTablet 750 mgOne Tablet435GD435PyrazinamideSyrup 250 mg/5 mlOne Bottle of 120 ml436GD436PyrazinamideCapsule 300 mg,One Capsule437GD437PyrazinamideSyrupOne BottleAntiulcer Drugs438GD438LansoprazoleTablet 15mgOne Tablet439GD439OmeprazoleCapsule 20 mgOne Capsule440GD440PantoprazoleInjection 40 mgOne Vial of single Dose441GD441PantoprazoleTablet40 mgOne Tablet442GD442RanitidineInjection 25 mg/mlOne Vial of 2ml443GD443RanitidineTablet 150 mg,One TabletAntiviral Drugs444GD444AcyclovirTablet 400 mgOne Tablet445GD445AcyclovirPowder for Injection 250 mgOne Vial of single Dose446GD446AcyclovirPowder for Injection 500 mgOne Vial of single Dose447GD447AcyclovirOintment 5%Each tube of 30 gm448GD448AmantadineTablet 100mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 22 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345449GD449GanciclovirTablet 250mgOne Tablet450GD450GanciclovirOintment 0.15%Each tube of 5 gm451GD451Interferon betaInjection 30mcg/0.5mlOne Vial of 0.3 ml452GD452ValacyclovirTablet 1GMOne TabletCardiovascular Drugs453GD453AcetylsalicylicTablet 75 mgOne Tablet454GD454AdenosineInjection 6 mgOne Ampoule of 2ml455GD455AmbrissentanTablet 10mgOne Tablet456GD456AmiodaroneInjection 150 mg/3mlOne Ampoule of 3 ml457GD457AmiodaroneTablet 200mgOne Tablet458GD458AmlodipineTablet 5 mgOne Tablet459GD459AtorvastatinTablet 10 mg,One Tablet460GD460AtorvastatinTablet 20 mgOne Tablet461GD461BosentanTablet (62.5 mg)One Tablet462GD462BosentanTablet 125mgOne Tablet463GD463CarvediolTable 3.125mgOne Tablet464GD464ClopidogrelTablet 75 mgOne Tablet465GD465ClopidogrelTablet 150mgOne Tablet466GD466ClopidogrelTablet 100mg,One TabletClopidogrel (A) + Aspirin (B)Tablet (A)75mg + (B)75mg467GD467One Tablet468GD468DigoxinInjection 0.5 mg/mlOne Ampoule of 1 ml469GD469DigoxinTablet 0.25mgOne Tablet470GD470DigoxinTablet 62.5mgOne Tablet471GD471DiltiazemTablet 30 mgOne Tablet472GD472DiltiazemTablet 150mgOne Tablet473GD473DobutamineInjection 50 mg/mlOne Ampoule of 5ml474GD474DopamineInjection 40 mg/mlOne Ampoule of 5ml475GD475EnalaprilTable 5mgOne Tablet476GD476EphedrineInjection 30 mgOne Ampoule of 1ml477GD477EsmololInjection100mg/10mlOne Vial of 10 ml478GD478Glyceryl trinitrateInjection 1 mg/mlOne Vial of 10 ml479GD479Glyceryl trinitrateSublingual tablet 0.5 mg,One Tablet480GD480IsoprenalineInjection 2 mg/mlOne Ampoule of 1 ml481GD481Isosorbide DinitrateTablet 5 mgOne Tablet482GD482Isoxsuprine HclInjection 5mg/mlOne Ampoule of 2ml483GD483IvabradineTablet 5mgOne Tablet484GD484LabetalolInjection 5 mg/mlOne Vial of 4 ml485GD485LevosimendanPowder for Injection 12.5 mgOne Vial of single Dose486GD486Lidocaine Hcl 2%Injection 1000 mg/50mlOne Vial of 50ml487GD487LosartanTablet 25mgOne Tablet488GD488MacitentanTablet 10mgOne Tablet489GD489MethyldopaTablet 250 mg,One Tablet490GD490MetoprololInjection 5mg/5mlOne Vial of 5 ml491GD491MetoprololTablet 25 mgOne Tablet492GD492Milrinone LactateInjection. 10mg/10mlOne Vial of 10 ml493GD493NifedipineTablet 10mgOne Tablet494GD494Nifedipine sustained releaseTablet 30mgOne Tablet495GD495NimodipineTablet 30 mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 23 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345496GD496NoradrenalineInjection 2 mg/mlOne Ampoule of 2ml497GD497PrasugrelTablet 81 mg,One Tablet498GD498PrasugrelTablet 325 mgOne Tablet499GD499Prazosin sustained releaseTablet 2.5mgOne Tablet500GD500RamiprilTablet 1.25mgOne Tablet501GD501RamiprilTablet 2.5mgOne Tablet502GD502RiociguatTablet 0.5 mgOne Tablet503GD503RosuvastatinTablet 10mgOne TabletSildenafilInjection (10 mg/ 12.5ml)504GD504One Vial of 12.5 ml505GD505SildenafilTablet25 mgOne Tablet506GD506SildenafilTablet50 mgOne TabletSodium NitriteInjection 300mg/ml, 10ml507GD507One Vial of 10 ml508GD508Sodium NitroprussideInjection 25mg/mlOne Vial of 2ml509GD509TelmisartanTablet 40 mgOne Tablet510GD510TicagrelorTablet 60MG,One Tablet511GD511TicagrelorTablet 90mgOne Tablet512GD512Ursodeoxycholic AcidTablet 150mgOne Tablet513GD513Ursodeoxycholic AcidSyrup 125mg/100mlOne Bottle of 100 ml514GD514ValsartanTablet 40mgOne Tablet515GD515verapamilInjection 5mg/2mlOne Ampoule of 2ml516GD516verapamilTable 40mgOne Tablet517GD517verapamilTablet240mgOne TabletContraceptives and Gynecologicpreparations518GD518BetamethasoneInjection 4 mg/mlOne Ampoule of 1 ml519GD519Calcitonin salmonNasal Spray/3.7 mlOne Bottle of 30 doseper bottle520GD520Carboprost TromethamineInjection 250Mcg/mlOne Ampoule of 1 ml521GD521DinoprostoneGel 0.5 mgOne Tube of NET WT;-3.0GM522GD522EthinylestradiolTablet 0.05 mgOne Tablet523GD523EthinylestradiolTablet 0.01 mg ,One TabletEthinylestradiol (A)Tablet 0.03 mg (A) + 0.15 mg524GD524+Levonorgestrel (B)(B)One Tablet525GD525IUD containing CopperCuT-380A/375526GD526Medroxyprogesterone acetateTablet 10 mgOne Tablet527GD527MethylergometrineInjection 0.2 mg/mlOne Vial, 1ml528GD528MethylergometrineTablet 0.125 mg,One Tablet529GD529MifepristoneTablet 200 mgOne Tablet530GD530MisoprostolTablet 25 mcgOne Tablet531GD531MisoprostolTablet 100 mcgOne Tablet532GD532NifedipineTablet 10 mgOne Tablet533GD533NorethisteroneTablet 5 mgOne Tablet534GD534OxytocinInjection 5 IU/mlOne Ampoule of 1 ml535GD535OxytocinInjection 10 IU/mlOne Ampoule of 1 mlCorticosteroids536GD536DeflazacortTablet 60 MGOne Tablet537GD537DexamethasoneInjection 4 mg/mlOne Vial of 2ml538GD538DexamethasoneTablet2mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 24 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345539GD539DexamethasoneOral Suspention 0.5mg/5mlOne Bottle of 240 ml540GD540FludrocortisoneTablet100mcgOne Tablet541GD541HydrocortisoneInjection 100 mgOne Vial of single Dose542GD542HydrocortisoneTablet 5mgOne Tablet543GD543Hydrocortisone HemisuccinateInjection.200mgOne Vial of single Dose544GD544MethylprednisoloneInjection 1gmOne Vial of single Dose545GD545MethylprednisoloneInjection 500 mgOne Vial of single Dose546GD546MethylprednisoloneInjection 40 mg/mlOne Vial of single Dose547GD547MethylprednisoloneTablet 4MGOne Tablet548GD548MethylprednisoloneTablet 16MGOne Tablet549GD549PrednisoloneTablet 10 mgOne Tablet550GD550Prednisolone sodium phosphateE/D 0.5%Each container of 5 MLDermatological medicines551GD551BetamethasoneCream 0.1%One tube of 30 gm552GD552ClotrimazoleCream 1%One tube of 30 gmGentian VioletTopical preparation 0.25% to553GD5532%One tube554GD554GlycerinOral Liquid 500 MLOne Bottle of 500 ml555GD555MometasoneOintment 0.1%One tube of 30 gm556GD556PermethrinCream 5%One tube of 60 gm557GD557Salicylic acidOintment 6%One tubeSilicone geltopical gel for scar treatment558GD558One tube of 10 gm559GD559Silicone gel sheetfor scar treatmentOne Sheet560GD560Sodium fusidateOintment 2.0% w/wOne tube of 10 gmDiuretics & Anti Diuretics561GD562ChlorothiazideTablet 250mg,One Tablet562GD563EplerenoneTablet 25mgOne Tablet563GD564FurosemideInjection 10 mg/ mlOne Ampoule of 2ml564GD565FurosemideTablet 40 mgOne Tablet565GD567MannitolInjection 20%Each container of 100 ML566GD568MetolazoneTablet 2.5mgOne Tablet567GD569TolterodineTablet 2mgOne Tablet568GD570TorsemideInjection20mgOne Ampoule of 2ml569GD571TorsemideTablet 10mgOne Tablet570GD572VasopressinInjection 20 units/1mlOne Ampoule of 1 mlGeneral Anaesthetics571GD573AtracuriumInjection 25 mg in 2.5 mlOne Vial of 2.5 ml572GD574CisatracuriumInjection 2mg/mlOne Vial of 10 ml573GD575Desflurane240 ml liquidOne Bottle of 240 ml574GD576Desmopressin spray10 mcg/0.1mlOne Bottle of 5 ML575GD577EtomidateInjection 2mg/ mlOne Vial of 10 ml576GD578Glycopyrrolate+NeostigmineInjection 0.5mg+2.5mgOne Vial of 5 ml577GD579IsofluraneInhalation(30 ml)One Bottle of 30 ml578GD580IsofluraneInhalation(100 ml)One Bottle of 100 ml579GD581IsofluraneInhalation (250 ml)One Bottle of 250 ml580GD582KetamineInjection 100 mg/ml,One Vial of 5 ml581GD583KetamineInjection 250 mg/mlOne Vial of 10 ml582GD584Lignocaine viscous gargle 2%10 ml bottleOne Vial of 10 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: / 2020 - 2021 / IGIMS / StorePage 25 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345583GD585PropofolInjection 200 mg/20mlOne Vial of 20 ml584GD586RocroniumInjection 100 mg/10 mlOne Vial of 10 ml585GD587SevofluraneInhalation (50ml)One Container of 50 ml586GD588SuccinylcholineInjection 50mg/mlOne Vial of 10 ml587GD589ThiopentonePowder for Injection 0.5 gOne Vial of single Dose588GD590ThiopentonePowder for Injection 1 gOne Vial of single Dose589GD591Tincture benzoinLiquidOne Bottle of 500 mlVecuroniumPowder for Injection 10 mg590GD592(vial)One Vial of 10 mlVecuroniumPowder for Injection 4 mg591GD593(ampoules)One Ampoule of 1 mlHematologic agentsDarbepoetinInjection40 mcg/0.4ml s/c592GD594One Ampoule of 0.4 ml593GD595ErythropoietinInjection5000U s/c,One Ampoule of 0.5 ml594GD596ErythropoietinInjection6000U s/cOne Ampoule of 0.6 ml595GD597ErythropoietinTablet4000U s/c,One Ampoule of 0.4 ml596GD598Ferric carboxymaltoseInjection 1 gmOne Vial of 20 ml597GD599Ferric Carboxymaltose500mg, IVOne Vial of 10 mlFerrous salt (A) + Folic acid (B)Tablet 100 mg elemental iron598GD600(A)+ 500 mcg (B)One TabletFerrous salt (A) + Folic acid (B)Oral liqiud 20 mg elemental599GD601iron (A) + 100 mcg (B)/mlOne Bottle of 200 mlFerrous saltsTablet equivalent to 60 mg of600GD602elemental ironOne TabletFerrous saltsOral liquid equivalent to 25 mg601GD603of elemental iron/mlOne Bottle of 200 ml602GD604Folic acidTablet 5 mgOne Tablet603GD605Folic Acid+ CyanocobalminInjectionOne Vial of 10 ml604GD606HydroxocobalaminInjection 1 mg/1mlOne Ampoule of 1 ml605GD607HydroxyureaCapsule 500 mgOne Capsule606GD608IronDrop 25mg/1mlOne Bottle of 50 ML607GD609Iron sucroseInjection 20 mg/mlOne Ampoule of 5 ml608GD610MethylcobalaminInjection 500mcgOne Ampoule of 1ml609GD611MethylcobalaminTablet 1500mgOne Tablet610GD612MethylcobalaminTablet 500mcgOne Tablet611GD613Mycophenolate sodiumTablet 180mgOne Tablet612GD614Mycophenolate sodiumTablet 360 mgOne Tablet613GD615Mycophenolate sodiumTablet 540mgOne Tablet614GD616Mycophenolic acidTablet 250 mgOne Tablet615GD617SevelamerTablet 400mgOne TabletImmunosuppressants616GD618AzathioprineTablet 50 mgOne Tablet617GD619CyclosporineInjection 250mgOne Vial of 5 ml618GD620CyclosporineCapsule 50 mgOne Capsule619GD621CyclosporineE/D 0.05%3 ml container620GD622Hepatitis B ImmunoglobulinInjection 100 IU/0.5MLOne Vial of 0.5ml621GD623Mycophenolate MofetilTablet 250mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: / 2020 - 2021 / IGIMS / StorePage 26 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345622GD624Mycophenolate SodiumTablet 180mgOne Tablet623GD625Mycophenolate SodiumTablet 300mgOne Tablet624GD626Zoledronic AcidInjection 4mg/5 MLOne Vial of single DoseIntravenous Fluids andElectrolytes625GD627Amino Acid 10%Injection 500mlEach container of 500 ml626GD638Potassium chlorideInjection 150 mg/mlOne Vial of 10 ml627GD639Potassium chlorideOral liquid 500 mg/5 mlOne Bottle of 200 ml628GD640Potassium CitrateSyrup 500ml BottleOne Bottle of 500 ml629GD641Potassium PermanganateCrystal 200gmEach Piece of 200 gm630GD643Sodium bicarbonateInjection (as per IP)One Ampoule of 25 ML631GD644Sodium bicarbonateTablet 500mgOne TabletSurfactant (Bovine)Injection100 mg of632GD649phospholipid/ packOne Vial of 5 mlSurfactant (Bovine)Injection100 mg of633GD650phospholipid/ pack 4 mlOne Vial of 4 mlSurfactant (Bovine)Injection100 mg of634GD651phospholipid/ pack 5 mlOne VialInj.Elemental Chromium - 4mcg, Copper - 4 mg,SeleniumTrace Element- 20 mcg,Manganese - 1 mg,Zinc Sulfate - 1 mg/ ml)635GD652One Vial of 10 ml636GD653Water for InjectionInjection 10 mlOne Vial of 10 mlLaxatives637GD654BisacodylSuppository 10 mgEach Piece638GD655GlycerineSuppository 1 gmEach Piece639GD656GlycerineSuppository 2 gmEach Piece640GD657LactuloseOral liquid 10 g/15 mlOne Bottle of 15 ml641GD658LactuloseSyrup 200ml BottleOne Bottle of 200 mlLocal Anaesthetics642GD659AtropineInjection 0.6 mg/mlOne Ampoule of 1 ml643GD660BupivacaineInjection 0.5%,One Vial of 20 ml644GD661BupivacaineInjection 0.25%,One Vial of 50mlBupivacaineInjection 0.5% with7.5%645GD662glucoseOne Ampoule of 4ml646GD663(Prilocaine (A) + Lidocaine (B) )Cream 2.5% (A) + 2.5% (B)One tube of 30 gm647GD664GlycopyrrolateInjection 0.2 mg/mlOne Vial of 1ml648GD665LignocaineTopical forms 2% gelOne tube of 30 gm649GD666LignocaineInjection 2%One Vial of 30ml650GD667LignocaineSpray 10%Each container of 50 ml651GD668LignocaineViscous gargle 4%Each container of 50 MLLignocaine (A) + Adrenaline (B)Injection 2% (A) + 1:200000652GD669(5 mcg/ml) (B)One Vial of 30ml653GD670MidazolamInjection 1 mg/ml,One Ampoule of 5ml654GD671MidazolamInjection 5 mg/mlOne Vial of 1 ml655GD672MidazolamTablet 7.5mgOne Tablet656GD673MidazolamTablet 15mgOne Tablet657GD674RopivacaineInjection 0.5%,One Vial of 30ml658GD675RopivacaineInjection 0.75%One Vial of 20 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: / 2020 - 2021 / IGIMS / StorePage 27 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345Medicines for Sleep Disorders659GD676AlprazolamTablet0.25MgOne Tablet660GD677AlprazolamTablet0.5MgOne Tablet661GD678ClonazepamTablet 0.5 mgOne Tablet662GD679ClonazepamTablet 1 mgOne TabletMuscle Relaxants663GD680AlfuzosinTablet10mgOne Tablet664GD681BaclofenTablet 10mgOne Tablet665GD682BaclofenOral solution 5mg/5mlOne Bottle of 300 ml666GD683BethanecholTablet 25MGOne Tablet667GD684EperisoneTablet50 mgOne Tablet668GD685MirabegronTablet 25 mgOne Tablet669GD686MirabegronTablet 50 MGOne Tablet670GD687NeostigmineTablet 15 MGOne Tablet671GD688NeostigmineInjection 0.5 mg/mlOne Ampoule of 1 ml672GD689OxybutyninTablet 5mgOne Tablet673GD690PapaverineInjection 30mg/mlOne Vial of 2ml674GD691PyridostigmineTablet 60MGOne Tablet675GD692PyridostigmineTablet 180MG SROne Tablet676GD693SilodosinTablet 4mgOne Tablet677GD694SilodosinTablet 8mgOne Tablet678GD695SilodosinTablet 4mgOne Tablet679GD696SilodosinTablet8mgOne Tablet680GD697SolifenacinTablet 5mgOne Tablet681GD698TadalafilTablet 5mgOne Tablet682GD699TadalafilTablet 10mgOne Tablet683GD700TadalafilTablet 20mgOne Tablet684GD701ThiocolchicosideTablet8mgOne Tablet685GD702ThiocolchicosideTablet 16mgOne Tablet686GD703Tizanidine HCLTablet2MGOne Tablet687GD704Tizanidine HCLTablet 4MGOne Tablet688GD705TolperisoneTablet 50mgOne Tablet689GD706TolperisoneTablet 150mgOne Tablet690GD707TolperisoneTablet 100 mgOne TabletOpthalmic Preparations691GD7085% glucose in glycerineSolution 100mlOne Bottle of 100 ml692GD709AtropineDrops 1%Each container of 2 ml693GD710AtropineOintment 1%One tube of 3.5 gm694GD711BrimonidineE/D 0.2%Each container of 5 ML695GD713BromfenacE/D 0.09%Each container of 5mlCalcium chloride 0.048%W/V+Hydroxypropylmethylcellulose (HPMC) 2%W/V+Magnesium chloride 0.03Ointment%W/V+Potassium chloride 0.075%W/V+Sodium chloride 0.49696GD714%W/V+Sodium citrate 0.17 %W/VOne tube of 30gm697GD715CarboxymethylcelluloseE/D 10 MLEach container of 10 ml698GD716CarboxymethylcelluloseE/D 0.5%Each container of 10 ml699GD717CarboxymethylcelluloseEye GelOne tube of 15 ml700GD718ChloramphenicolOintment 1%One tube of 4 gm Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: / 2020 - 2021 / IGIMS / StorePage 28 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345701GD719Chloramphenicol + Polymyxin BOintmentOne tube of 5 gm702GD720CyclopentolateE/D 1%Each container of15 ml703GD721CyclopentolateE/D 0.5%Each container704GD722Difluprednate ophthalmic emulsionE/D 0.05%Each container of5 ml705GD723DorzolamideE/D 2%Each container of10 ml706GD724D-PanthenolOintment 5%One tube of 5gm707GD725Ephedrine nasal drop1%Each container of10 ml708GD726Ephedrine nasal drop0.50%Each container of10 ml709GD727FluorometholoneE/D 0.1%Each container of10 ml710GD728FlurbiprofenE/D 5mlEach container of5 ML711GD729Gatifloxacin + LoteprednolE/D (0.3%+0.5%)Each container of5 ML712GD730GatifloxacinE/D 0.5% As BaseEach container of5 ML713GD731GatifloxacinE/D 0.30%Each container of5 ML714GD732Gentian Violet paintSolution 50mlEach container of50 ml715GD733HomatropineDrops 2%Each container of5 ML716GD734Hydroxypropyl methylcelluloseInjectionOne Ampoule of 5ml717GD735IcthammolGlycerine (10%)Solution/emulsion 100mlEach container of 100ml718GD736LatanoprostE/D 0.005%Each container of2.5 ml719GD737LubricantE/D 1.0%W/VEach container of15 ml720GD738MethylcelluloseOintment 2%One tube of 10 gm721GD739MethylcelluloseE/D 0.5%Each container of10 ml722GD740Moxifloxacin + DexamethasoneE/D (0.5%+0.1%)Each container of5 ML723GD741Moxifloxacin + LoteprednolE/D (0.5%+0.5%)Each container of5 ML724GD742Moxifloxacin + PrednisoloneE/D (0.5%+1%)Each container of5 ML725GD743Moxifloxacin +KetorolacE/D (0.5%+0.4%)Each container of5 ML726GD744Moxifloxacin OphthalmicE/D 5mlEach container of5 ML727GD745Moxifloxacin OphthalmicOintment 0.5%One tube of 5 gm728GD746NatamycinE/D 5%Each container of5 MLNeomycin + Polymyxin BE/D 0.5% As Base729GD747+HydrocortisoneEach container of10 ml730GD748NepafenacE/D 0.3%Each container of3 ML731GD749OlopatadineE/D 0.1%Each container of5 ML732GD750OlopatadineE/D 0.2%Each container of3 ML733GD751OlopatadineE/D 0.1%Each container 10 ml734GD752Olopatadine + KetorolacE/D (0.1% +0.4%)Each container of5 ML735GD753PhenylephrineDrops 5%Each container of10 ml736GD754Phenylephrine HClInjection 10mgOne Vial of 1 ml737GD755PilocarpinE/D 2%Each container of15 ml738GD756Polyethylene glycolE/D 0.40%W/VEach container of10 ml739GD757Prednisolone AcetateE/D 1%Each container of5 ML740GD758ProparacaineE/D 0.50%Each container of15 ml741GD759RanibizumabInjection 10mg/mlOne Vial of single Dose742GD760RebamipideE/D 2%Each container of10 ml743GD761SerratiopeptidaseTablet 10mgOne Tablet744GD762Sodium chlorideE/D 5%Each container of15 ml745GD763Sodium chlorideOintment 6%One tube of 3 gm746GD764TacrolimusE/D 0.003%Each container of5 ml747GD765TacrolimusOintment 0.1%One tube of 10 gm748GD766Timolol maleate + BrimonidineE/D (0.5%+0.2%)Each container of5 ml749GD767Timolol maleate + PilocarpineE/D (0.5%+2%)Each container of5 ML Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: / 2020 - 2021 / IGIMS / StorePage 29 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345750GD768Timolol maleate + TravoprostE/D (0.5%+0.004%)Each containere of 2.5 ml751GD769Timolol maleate +DorzolamideE/D (0.5%+2%)Each container of10 ml752GD770Timolol maleate +LatanoprostE/D (0.5%+0.003%)Each container of3 ml753GD771Tobramycin + FluorometholoneE/D (0.3%+0.1%)Each container of5 ml754GD772TobramycinE/D 0.3%Each container of5 ML755GD773TobramycinInjection 80mg/2mlOne Vial of 2 ml756GD774Tobramycin + DexamethasoneE/D (0.3%+0.1%)Each container of5 ML757GD775TravoprostE/D 0.004%Each container of2.5 ml758GD776TropicamideDrops 1%Each container of15 mlTropicamide1 % & PhenylephrineDrops759GD7772.5%Each container of15 ml760GD778VoriconazoleE/D 1%Each container of30 mgNasal Drops761GD779FluconazoleEar DropEach container of5 ML762GD780Fluticasone FumarateNasal SprayEach container of120 MIDIntranasal DesmopressinNasal Spray 0.01%/Spray763GD781Each container of5 MLMidazolamSpray nasal 1.25 MG/0.1 ML764GD782Each container of25 TO 50 MID765GD783Saline NasalNasal SprayEach container of 20 ml766GD784Saline NasalDrop 0.65%Each container of10 ml767GD785Saline NasalNasal drops 0.9 %Each container of10 ML768GD786XylometazolineNasal drops 0.05 %Each container of 10 ml769GD787XylometazolineNasal drops 0.1 %Each container of10 mlNSAIDS/ Non-opioid analgesics770GD788AceclofenacTablet200 mgOne TabletBuprenorphine (synthetic mixedInjection 2mg/ml771GD789opioid)One Vial of 100 ml772GD790DiclofenacInjection 25 mg/mlOne Vial of 3 ml773GD791DiclofenacSuppositories 12.5 mgEach Piece774GD792DiclofenacSuppositories 25 mgEach Piece775GD793DiclofenacGel 1%.One tube of 30 gm776GD794DiclofenacTablet 50 mgOne Tablet777GD795EtodolacTablet400 mgOne Tablet778GD796EtoricoxibTablet60mgOne Tablet779GD797EtoricoxibTablet90mgOne Tablet780GD798IbuprofenTablet 200 mgOne Tablet781GD799IbuprofenOral liquid 100 mg/5 mlOne Bottle of 500 ml782GD800IndomethacinTablet75 mgOne Tablet783GD801KetoprofenTablet75mgOne Tablet784GD802Ketorolacinjection 30 mg/mlOne Ampoule of 1 ml785GD803KetorolacTablet10 mgOne Tablet786GD804KetorolacE/D 0.40%Each container of5 ml787GD805LornoxicamTablet8mgOne Tablet788GD806Mefenamic acidCapsule 500 mgOne Capsule789GD807Mefenamic acidTablet 250mgOne Tablet790GD808NaproxenTablet250 mgOne Tablet791GD809OxaceprolTablet200 mgOne Tablet792GD810ParacetamolTablet 500 mgOne Tablet793GD811ParacetamolTablet 650 mgOne Tablet794GD812ParacetamolOral liquid 250mg/mlOne Bottle of 60 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: / 2020 - 2021 / IGIMS / StorePage 30 of 85SlCODEDescriptionStrengthFormulation UnitNo.12345795GD813ParacetamolDrop 100mg/mlOne Bottle of 30 ml796GD814ParacetamolInjection 1 gm/100mlEach container of 100 ml797GD815ParacetamolInjection 150 mg/mlOne Vial of 2 ml798GD816ParacetamolSuppositories 50 mgEach Piece799GD817ParacetamolSuppositories 250 mgEach Piece800GD818PiroxicamCapsule. 20 MGOne CapsuleRadiocontrast agents801GD833Barium sulphateOral liquid 100% w/vOne Bottle of 500 ml802GD834Barium sulphateOral liquid 250% w/vOne Bottle of 500 mlDextranomer(A)+HyaluronicInjection (A)50mg/ml+(B)15MG/MLacid(B)803GD835,1MLEach Piece of 1 ml804GD836IohexolInjection 350 mg iodine/mlOne Vial of 90 ml805GD837Meglumine DiatrizoateInjection 60% w/vOne Vial of 50 ML806GD838Methylene blueInjection 10mg/ mlOne Vial of 10 ml807GD839UrografinInjection 76%, 50mlOne Vial of 50mlVitamins and Minerals808GD841CalcitriolTable 0.25 mcgOne Tablet809GD842Alendronate SodiumTablet 70 mgOne Tablet810GD844CalciumCapsule 500 mgOne Capsule811GD845Calcium carbonateTablet 500 mgOne Tablet812GD846CholecalciferolOral liquid 400 IU/mlOne Bottle of 15 ml813GD848Coenzyme Q10Capsule 300mgOne CapsuleMethylcobalamine+PyrodoxineInj.2ml/1500mcg+100mg+100814GD849Hydrochroide+nicotinamidemgOne Ampoule of 2ml815GD850Coral CalciumCapsule 1500mgOne Capsule816GD853PyridoxineTablet 10 mgOne Tablet817GD854PyridoxineTablet 50 mgOne Tablet818GD855PyridoxineInjection 50mgOne Ampoule of 1 ml819GD856UnivestineTablet. 500mgOne Tablet820GD857Vitamin A (Retinol Palmitate)Injection 50000 IU/mlOne Vial of 5 ml821GD858Vitamin A (Retinol Palmitate)Tablet(50000 IU)/ mlOne Tablet822GD859Vitamin A (Retinol Palmitate)Syrup 300000IU/5mlOne Bottle of 30 mlVitamin A (Retinol Palmitate)Oral liquid 100000 IU/ml823GD860One Bottle of 100 ml824GD863Vitamin CCapsule 35mgOne Capsule825GD864Vitamin DDrop 400IU/mlEach container of 10 ml826GD865Vitamin DDrop 800IU/mlEach container of 15 ml827GD866Vitamin ESyrup 50IU/mlOne Bottle of 25 ml *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 31 of 85 Section-VI GENERAL CONDITIONS OF CONTRACT 6.1 Validity of Tender: The validity of the Bid Tender Document shall be for 180(One hundred and eighty) days from the date of last date of submission of the bid. 6.2 Qualified Bidders are required to arrange a demonstration of the quoted products, if required by technical evaluation committee (TEC). Failure to arrange for a demonstration on the given date may lead to cancellation of the bid or depends upon recommendation of TEC. Cost of organizing such demonstration shall be borne by the bidder. 6.3 Tenders should be quoted only by the Original/actual manufacturer (OEM). The Bidder shall bear all costs associated with the preparation and submission of its Bid and IGIMS, Patna, hereinafter referred as Tender Inviting Authority, will in no case be responsible or liable for these costs, regardless of the conduct or outcome of the Bidding process. 6.4 The supply of Common Drugs/products/Articles should be of required quality/ standard as per specification, having useful life as specified in this tender and supply should be made in good condition to the Central Stores, IGIMS, Patna by the bidder at their own cost i.e., F.O.R. at IGIMS, Patna. Any spurious/ to be expired/ sub-standard item has to be replaced by the bidder without any fail at their own cost. If the supplier, having been notified, fails to respond to take action to replace the sub-standard items within 3 (three) days on a 24 x 7 x 365 basis, the purchaser may proceed to take such remedial action(s) as deemed fit by the purchaser, at the risk and expense of the supplier and without prejudice to other contractual rights and remedies, which the purchaser may have against the supplier.. 6.5 Fall Clause: If at any time during the execution of the contract, the Manufacturers reduces the sale price or sells or offers to sell such stores, as are covered under the contract, to any person/organization including the purchaser or any department of Central Government or any department of IGIMS, Patna / PSUs at a price lower than the price chargeable under the contract during the Current Financial Year, he shall forthwith notify IGIMS, Patna, The necessary difference amount about such reduction or sale or offer of sale to the purchaser and the price payable under the contract for the stores supplied after the date of coming into force of such reduction or sale or offer of sale shall stand correspondingly reduced and deposited to IGIMS, Patna by the Bidder or IGIMS, Patna will deduct from the pending bills/Performance Security Deposit to recover the loss to the Government. 6.6 The Director, IGIMS, Patna has full authority to take into account the performance of eligible Manufacturers and they should submit a latest performance certificate from any other Govt. Hospitals/Institutions/PSUs to testify the proper dealing & performance and Supply of Items. Any form of tampered document shall be out rightly rejected. 6.7 Purchase Order(s) will be placed from time to time during the currency of the contract in which exact quantities required on each occasion together with the date of delivery shall be specified. 6.7.1 No guarantee can be given as to the minimum quantity which will be drawn against this contract but the rate contract holder firm will have to supply quantity as may be ordered during the currency of the contract.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 32 of 85 6.7.2 Purchase Order(s) against the contract will be accepted as long as these reach the Rate Contract holder/firm on or before last date of the currency of the contract. Purchase Orders received during the closing days should be complied with in due course, in accordance with the contract, even though in some cases owing to contract having expired, supplies are to be executed after the expiry of the last date of contract. 6.8 Delivery of supplies/Stores: Delivery of stores shall be F.O.R to Central Store, IGIMS, Patna. The IGIMS, Patna is not liable for payments on account of Freight/Taxes/ allied expenditures, which are to be quoted inclusively by the suppliers. 6.8.1 The firm will be bound to supply the ordered items preferably within 30 days of issuance of purchase order and maximum by 45 days of issuance of purchase. Extension shall not be allowed in ordinary course, except in cases of any natural calamities, All India Transportation strike (with sufficient proof). Any other genuine case of request of extension may be considered/allowed (subject to approval from Competent Authority) provided that the request is received within 10-15 days of receipt/acceptance of Purchase Order. Thereafter, suitable action as deemed fit (Refer term No.-6.8.7), will be initiated. If the items are imported one, necessary documentary proof along with a request letter from the Manufacturer thereof may be submitted for consideration of 90 days Delivery Period for such items. 6.8.2 The successful Bidder along with the copy of the Invoice shall submit the copy of the Standard Quality Certificate of analysis from their own laboratory/NABL Accredited Laboratory/Government approved Laboratory as applicable with necessary protocols for every batch of items supplied to the Central Stores & Hospital Pharmacy, IGIMS, Patna at the time of supply. The successful bidder has to submit all copies of the Test Reports to Central Pharmacy, IGIMS, Patna for future reference within 7 days of delivery. 6.8.3 The supplier shall supply the materials along with copy of Invoice, Purchase Order, Test Report, Delivery Challan and other relevant documents at the Central Stores, IGIMS, Patna. Where more than one batch of Drug is supplied under one Invoice, the quantities of each batch supplied shall be clearly specified. The date of manufacture, the date of expiry of each shall be specified. The quantity supplied shall be in terms of the Units mentioned in the Tender Document/ PO. The suppliers are cautioned that the variation in the description of product in the Invoice/analysis report and actual supplies will be considered as improper invoicing and will be dealt accordingly. 6.8.4 If the supplier fails to deliver the goods on or before the stipulated date, then Liquidated damage (LD) charges at the rate of 0.5%per week or part there of exceeding 3 days from the stipulated date (Excluding the date of issue of purchase Order/acceptance letter and date of delivery) shall be levied subject to maximum of 10%of the total order value. Purchaser may also resort to termination of the Purchase Order & even contract at any time after expiry of the allowable period for supply of the materials. The competent authority of the institute may also cancel the supply. In such a case, bid security of the supplier shall stand forfeited. 6.8.5 Part/Partial supply will not be accepted. However, in special circumstances, part supply may be accepted as per the institutional requirement with prior written permission and total delivery is to be completed within stipulated delivery period. The Part billing is strictly prohibited.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 33 of 85 6.8.6 In case the quality of goods supplied are not in conformity with the standard given in tender and as per the samples supplied or the supplies are found defective at any stage these goods shall immediately will be taken back by the supplier and will be replaced with the tender quality goods, without any delay. The competent authority reserves all rights to reject the goods if the same are not found in accordance with the required description/specifications and liquidates damages shall be charged. 6.8.7 In case the bidder on whom the purchase order has been placed, fails to make supplies within the delivery schedule and the purchaser has to resort risk purchase, the purchaser (IGIMS, Patna) may recover from the bidder the difference between the cost calculated on the basis of risk purchase price and that calculated on the basis of rates quoted by bidder. The amount will be recovered from any of his subsequent/pending bills or Security Deposit & black listing of the firm may be initiated depending upon the circumstances of the default/merit of the case. 6.8.8 The quantity for supply will be as per the requirement of user departments and is subject to increase/decrease at the discretion of the competent authority of IGIMS, Patna. The payment would be made for actual supply made as per purchase order. 6.8.9 The selected Manufacturers shall also provide the name and mobile number of a key person, who can be contacted at any time, even beyond the office hours and on holidays. The person should be capable of taking orders and making arrangement for supply of the desired items even at short notice to IGIMS, Patna. The selected manufacturer should submit two working e-mail IDs for all official correspondence which will be registered in the vendor directory. Any changes in the Mail IDs must invariably be informed immediately to IGIMS, Patna. 6.9 Testing of Items: The IGIMS, Patna shall be at liberty to undertake regular and random testing of item(s) supplied by the Rate Contract Holder at regular interval to maintain and ensure the quality of item(s) supplied by any Govt. Approved Laboratory. The report of the Govt. Approved Laboratory shall be binding on the Rate contract Holder firm, If the R/C holder disagrees with the outcome of test result, may approach Appellate Authority for drugs i.e., CDSCO for a fresh test of the sample within three months from the date of communication of the disputed test report to the Rate contract holder firm. 6.10 If single item/Batch of item(s) is/are declared NSQ (Not of Standard Quality) under Central Drugs Standard Control Organization (CDSCO), then the supplier has to take back all the NSQ items immediately and replace the quantity. Recovery will be initiated wherever payment had already been made. Rate contract Holder will be liable to pay damages/compensation (if any) to individual/individuals arising due to consumption of such NSQ declared items and in case of any adverse reaction reported in the Hospital during administration of the item(s).If more than one item/batch of items belonging to a particular firm is declared NSQ within a year, then the firm will immediately be debarred from current and all future rate contracts of IGIMS, Patna for a period of three years. This will also lead to forfeiture of Performance Security of the concerned firm. 6.11 Payments: 100% payment shall be released after successful delivery of the ordered goods against the satisfactory inspection report/taking charge report by the User Dept. and only after the submission of the performance security duly confirmed by issuing bank, within to 30 to 45 days.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 34 of 85 6.11.1 Bills in triplicate for the items supplied by the selected firm(s), should be raised for payment. Payment shall be released after deducting TDS as per Income Tax Rules and any other deductions as per Government rules only after it is ensured that the items/quantity and quality of items supplied are to the entire satisfaction of this office and accepted. If any item is found to be sub-standard, or not of the desired quality at any point of time of the contract period, the same shall be replaced immediately, for which no extra payment shall be made by IGIMS, Patna. 6.11.2 The bills raised by the selected tendering Manufacturers should have all tax registration numbers printed on bill. The bill shall be signed by the authorized signatory of the firm across a revenue stamp. Validity of the tax registration during the currency of contract shall be the sole responsibility of the tendering eligible Manufacturers. The bill shall be raised indicating permissible taxes separately and the copies of proof of GST or other applicable taxes deposited to Tax Authorities by the firm for recent period, just before the submission of Bills must also be enclosed for reference of IGIMS, Patna authorities. 6.11.3 If the selected Manufacturers fail to deliver the Drugs or replace the defected/spurious/expired/ soon to expire items within the stipulated date & time, a penalty on weekly basis for delay @ 0.5% of total order value per week or part thereof exceeding 3 days (date of purchase order and date of delivery being excluded), subject to maximum of 10% of total order value as penalty and the actual cost paid to other sources by the Indira Gandhi Institute of Medical Sciences IGIMS, Patna, for the desired Drugs for Hospital, shall be deducted from the Manufacturers pending bills or Performance Security. 6.12 The tendering Manufacturers shall be bound by the details furnished by him/her to the Indira Gandhi Institute of Medical Sciences, Patna while submitting the tender or at subsequent stage. Upon selection of the tendering Manufacturers, if at any stage, the documents furnished by him/her is found to be false or the quality of the articles are found of poor quality/different specifications, it would be deemed to be a breach of terms of contract, the contract shall be cancelled, legal action as deemed fit will be taken and performance security shall stand forfeited. 6.13 The Lowest quoted rate by the selected tendering Manufacturers as approved by the Indira Gandhi Institute of Medical Sciences (IGIMS), Patna shall remain valid throughout the period of contract and the request to increase the rates for any or all items, during the currency of contract, shall not be entertained at any stage. 6.14 The selected firm(s) shall not be allowed to transfer, assign, pledge or sub-contract its rights and the contract will be valid from the date it is awarded/formalities completed. This office will, however, reserve the right to conduct performance review at any time during the contract period and deficiencies, if any, noticed shall be required to be rectified and compliance reported. This office reserves the right to suo-moto terminate the contract by giving one months notices at any point of time. 6.15 The Life period of any of the item supplied by the successful Bidder/Bidders will have the Minimum of two third of the expiry period remaining on the date of receipts of Items in IGIMS, Patna. The supplied items having less than two-third expiry period to IGIMS, Patna shall not be accepted. Loss or premature deterioration due to biological and/or other Factors during life span of Stores against the manufactures standard warranty/Expiry of such items shall be replaced by the Bidder on free of cost.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 35 of 85 6.16 The supply contract will be valid from the date when the Purchase Order Issued/formalities completed by IGIMS, Patna. This office will, however, reserve the right to conduct performance review at any time during the supply contract period and deficiencies, if any, noticed shall be required to be rectified and compliance be reported. This office reserves the right to Suo-moto terminate the supply contract by giving 30 days notices at any point of time. 6.17 Both on large and smallest units (Bottle/Strips/pack) of the Drugs, it is mandatory to Print/Sticker/stamp in indelible ink on label/packets/cartons GOVT. SUPPLY, NOT FOR SALE/FOR USE BY IGIMS, PATNA & No Price Should be quoted/printed on the Label. Cases, wherein quoting of price cannot dispensed with, it should be covered in indelible ink. 6.18 Inspection of supplies: - Inspection will be done by the duly constituted committee members nominated by Director, IGIMS, Patna and or his authorized representatives in IGIMS, Patna premises at designated place. 6.19 The IGIMS, Patna shall not be responsible for any financial loss or other damage or injury to any item or person deployed/supplied by the Supplier Agency in the course of their performing the duties to this office in connection with purchase order/purchase order for supplying of Stores/Goods/Items at IGIMS, Patna. 6.20 Packaging & marking of supplies: -The firm shall supply the stores with proper packing and marking for transit so as to be received at destination free from any loss or damage. 6.21 Disputes & Arbitration: -All disputes or differences arising during the execution of the contract shall be resolved by mutual discussion, failing which the matter will be referred to an Arbitrator who will be appointed by The Director, IGIMS, Patna for Arbitration for settlement of disputes in accordance with Arbitration & Conciliation Act 1996 or its subsequent amendment, whose decision shall be binding on the contracting parties. 6.22 Law governing the contract and Jurisdiction: -The contract shall be governed under Indian Contract Act 1872 and instructions thereon from the government of India. The Court of Patna shall alone have jurisdiction to decide any dispute arising out of or in respect of the contract. 6.23 Performance Security Deposit:-The successful bidder will be required to furnish a Performance Security Deposit of minimum of Rs.1,00,000/-(Rupees One Lakh only) OR an amount proportionate to the value of yearly consumption for number of items selected for award of contract be decided by IGIMS, Patna as Performance Security Deposit in favor of IGIMS, Patna by way of Irrevocable Performance Bank Guarantee (in favor of IGIMS, Patna) from Nationalized/Commercial Bank which is refundable. The performance security shall remain valid for a period of 14 months from the date of contract agreement. Security Deposit is liable to be forfeited if the bidder withdraws or impairs or derogates the bid in any respect. 6.24 Parallel Rate Contract/Purchase: The IGIMS, Patna reserves the right to place an order for supply of any items mentioned in the Rate Contract at any stage to any other firm(s) without any information to the Rate Contract holder. Purchaser reserves the right to conclude one or more than one rate contract for the same item.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 36 of 85 6.25 After due evaluation of the bid(s), Institute will award the contract to the responsive bidder who has quoted the lowest Price in each of the items. Item wise evaluation will be done for determining lowest quoted price in each of the Items. The Purchaser will have the option to negotiate the price with the bidders if situation warrants. 6.26 Conditional Bids will be treated as unresponsive and therefore shall be rejected. 6.27 The Institute reserves the right to accept in part or in full or reject any or more Tender/offer without assigning any reasons or cancel the tendering process and reject all Tender at any time prior to award of contract, without accepting any liability, whatsoever. 6.27.1 In the event of the claims in the on-line documents are materially missing or of substantial error or unqualified for want of required qualifications, the bid shall be rejected. However, minor/ trivial nature of deviations in the submission of documents may be ignored or may be allowed to be rectified by obtaining required clarification by the Tender Inviting Authority so as to ensure qualification of maximum number of competitive offers to the final round. 6.27.2 The Bidder shall be responsible for properly uploading the relevant documents in the Tender portal in the specific location and the Tender Inviting Authority shall not be held liable for errors or mistakes done while uploading the on-line Bid. 6.28 Force Majeure : If, at any time during the subsistence of this contract, the performance in whole or in part by either party of any obligation under this contract is prevented or delayed by reasons of any war or hostility, act of public enemy, civil commotion, sabotage, fire, floods, exception, epidemics, quarantine restrictions, strikes, lockout or act of God (hereinafter referred to as events) provided notice of happening of any such eventuality is given by party to other within 21 days from the date of occurrence thereof. Neither party shall by reason of such event be entitled to terminate this contact nor shall either party have any claim for damages against other in respect of such non-performance or delay in performance and deliveries have been so resumed or not shall be final and conclusive. Further, that if the performance in whole or in part of any obligation under this contract is prevented or delayed by reason of any such event for a period exceeding 60 days, IGIMS, Patna may, opt to terminate the contract. 6.29 Debarment from bidding: 6.29.1 A bidder shall be debarred if he has been convicted of an offence- under the Prevention of Corruption Act,1988 or the Indian Penal Code or any other law for the time being in force, for causing any loss of life or property or causing a threat to public health as part of execution of a public procurement contract. 6.29.2 A bidder debarred under sub-section 6.29.1 or any successor of the bidder shall not be eligible to participate in a procurement process of any procuring entity for a period not exceeding three years commencing from the date of debarment. Department of Commerce (DGS&D) will maintain such list which will also be displayed on the website of DGS&D as well as Central Public Procurement Portal. 6.29.3 A procuring entity may debar a bidder or any of its successors, from participating in any procurement process undertaken by it, for a period not exceeding two years, if it determines that the bidder has breached  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 37 of 85 the code of integrity. The Ministry/Department will maintain such list which will also be displayed on their website. 6.29.4 The bidder shall not be debarred unless such bidder has been given a reasonable opportunity to represent against such debarment. 6.30 Code of Integrity: 6.30.1 No official of the bidder shall act in contravention of the codes which includes prohibition of Making offer, solicitation or acceptance of bribe, reward or gift or any material benefit, either directly or indirectly, in exchange for an unfair advantage in the procurement process or to other wise influence the procurement process. Any omission, or misrepresentation that may mislead or attempt to mislead so that financial or other benefit may be obtained or an obligation avoided. Any collusion, bid rigging or anti-competitive behaviour that may impair the transparency, fairness and the progress of the procurement process. Improper use of information provided by the procuring entity to the bidder with intent to gain unfair advantage in the procurement process or for personal gain. Any financial or business transactions between the bidder and any official of the procuring entity related to tender or execution process of contract; which can affect the decision of the procuring entity directly or indirectly. Any coercion or any threat to impair or harm, directly or indirectly, any party or its property to influence the procurement process. Obstruction of any investigation or auditing of a procurement process. Making false declaration or providing false information for participation in a tender process or to secure a contract. Disclosure of conflict of interest. Disclosure by the bidder of any previous transgressions made in respect of the provisions of sub-clause with any entity in any country during the last three years or of being debarred by any other procuring entity. 6.30.2 The purchaser will reject a proposal for award if it determines that the bidder recommended for award has directly or through an agent, engaged in corrupt, Fraudulent, collusive or coercive practices in competing for the contract in question. 6.31 The Director, IGIMS, Patna, Bihar, India has the full and exclusive right to accept or reject, increase or decrease order quantity, any or all the tenders without assigning any reasons thereof and also to cancel the supply at any time without assigning any reason.  Director, I.G.I.M.S. Patna. *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 38 of 85 Section-VII INSTRUCTION TO BIDDERS FOR ONLINE REGISTRATION AND SUBMISSION OF BIDS 7.1 General: The Special Instructions (for Tendering) supplement Instruction to Bidders, as given in this Tender Document. Submission of Online Bids is mandatory for this Tender. Tendering is a new methodology for conducting Public Procurement in a transparent and secured manner. Suppliers / Vendors will be the biggest beneficiaries of this new system of procurement. 7.2 Instructions: Tender Bidding Methodology: Two Stage Bidding Broad outline of activities from prospective Bidders: Procure a Class III Digital Signature Certificate (DSC). Register on the Procurement portal at www.eproc.bihar.gov.in. Create Users on the above portal. View Notice Inviting Tender (NIT) on the above portal. Download Official Copy of Tender Documents from the above portal. Seek Clarification to Tender Documents on the above portal. View response to queries of bidders, posted as addendum, by IGIMS, Patna. Bid-Submission on the above portal. Attend Public Online Tender Opening Event (TOE) on the above portal - Opening of Technical Part. Post-TOE Clarification on the above portal (Optional) Respond to IGIMS, Patnas Post-TOE queries. Attend Public Online Tender Opening Event (TOE) on the above portal - Opening of Financial Part (Only for Technical Responsive Bidders). Digital Certificates : For integrity of data and authenticity / non-repudiation of electronic records, and to be compliant with IT Act 2000, it is necessary for each user to have a Digital Certificate (DC), also referred to as Digital Signature Certificate (DSC), of Class III, issued by a Certifying Authority (CA) licensed by Controller of Certifying Authorities (CCA) [refer  HYPERLINK "http://www.cca.gov.in]./" http://www.cca.gov.in]. Registration: To use the Electronic Tender portal  HYPERLINK "http://www.eproc.bihar.gov.in, " www.eproc.bihar.gov.in, vendors need to register on the portal. Registration of each organization is to be done by one of its senior persons vis--vis Authorised Signatory who will be the main person coordinating for the Tendering activities. In the above portal terminology, this person will be referred to as the Super User (SU) of that organization. For further details, please visit the website/portal, and follow further instructions as given on the site. Note: After successful submission of Registration details and Registration Fee, please contact to the Helpdesk of the portal to get your registration accepted/activated  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09/ 2020 - 2021 / IGIMS / Store Page 39 of 85 The Bidder must ensure that after following above, the status of bid submission must become Submitted. Please take due care while scanning the documents so that the size of documents to be uploaded remains minimum. If required, documents may be scanned at lower resolutions say at 150 dpi. However, it shall be sole responsibility of bidder that the uploaded documents remain legible. It is advised that all the documents to be submitted are kept scanned or converted to PDF format in a separate folder on your computer before starting online submission. The Financial part may be downloaded and rates may be filled appropriately. This file may also be saved in a folder on your computer. Please dont change the file names & total size of documents (Preferably below 5 MB per document) may be checked. 7.3 Bid submission: The entire bid-submission would be online on the Tender wizard portal i.e.  HYPERLINK "https://www.eproc.bihar.gov.in " https://www.eproc.bihar.gov.in Broad outline of submissions are as follows: Submission of Bid Parts (Technical & Financial). Submission of information pertaining to Bid Security/ EMD. Submission of signed copy of Tender Documents/Addendums. The TECHNICAL PART shall consist of Electronic Form of Technical Main Bid and Bid Annexure. Scanned/Electronic copies of the various documents to be submitted under the Eligibility Conditions, offline submissions, instructions to bidders and documents required to establish compliance to Technical Specifications and Other Terms & Conditions of the tender are to be uploaded. The FINANCIAL PART shall consist of Electronic Form of Financial Main Bid and Financial Bid Annexure, if any. Scanned copy of duly filled price schedule as Annexure are to be uploaded. Processing Fee: Firm have to pay processing fee , when participating in the Tender. 7.4 Offline Submissions: The bidder is requested to submit the following documents offline to The Director, IGIMS, Patna 800014 on or before the date & time of submission of bids specified in covering letter of this tender document, in a Sealed Envelope. The envelope shall bear (name of the tender), the tender number and the words DO NOT OPEN BEFORE (due date & time). EMD-Bid Security in Original, in shape of DD/BG only in favour of Director, I.G.I.M.S., Patna, valid for a period 180 days. Documents as Per NIT. Director, I.G.I.M.S. - Patna. *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09/ 2020 - 2021 / IGIMS / Store Page 42 of 85 Section-VIII CHECKLIST OF IMPORTANT DOCUMENTS The Scanned copies of the following Mandatory documents to be uploaded on Tendering Portal in the following format: S/NDetails / ParticularsDocument requiredUploadedPage(Yes/No)No1Details of Bidders as per Annexure-IXMention in Letter Head2Name, Address, Email IDs & designation of theMention in Letter Headauthorized person for signing the bid documents.3Name, Address, Email ID, Phone & Fax No. ofMention in Letter Headoffice/Go-down/Authorized supplier at Patnaor within 50 Kms. radius of IGIMS, Patna.4PAN No.Attested copy of PAN Card5GST Registration No.Attested copy of GSTRegistration Certificate6Annual Turn Over for last Three financial years.As per Annexure-VI in the letterHead of CA along with copies ofauthenticated Balance Sheet&P&L Account for the last threefinancial years.7Details of the Earnest Money Deposit (EMD)DD / BG Rs.3,00,000 (Rupees Three Lakh only)8Firms registered with NSIC are exempted fromAttested copy of NSICsubmission of EMD (subject to the financial limitsRegistration Certificateindicated in the NSIC certificate).9Whether the firm is a registered firm under MSEs orAttested copy of MSE / SSISSI. MSME bidders are to mention UAM (UdyogRegistration Certificate.Aadhar Memorandum) number issued by MSME.Document showing UAMWhether declaration of UAM number by the bidder onCPPP has been made or not.10Undertaking for acceptance of all Terms & ConditionsAnnexure I typed on Letterin original (Annex. -I).head11Notarized affidavit as per (Annex. II) on IndianNotarised AffidavitNon-Judicial Stamp Paper of Rs.10/-12Market Standing Certificate form as per (Annex. III)Attested copy of Certificate13Valid GLP (Good Laborartory Practice) CertificateAttested copy of Certificateissued by Central/State Drug Controller/FDA14Whether the products/items quoted is as perAnnexure IV typed on letterspecification, if not the statement of deviationhead along with Copy of the(Parameter wise) from the tender technicalrelevant documents.specification must be enclosed. - (Annex. -IV )15Performance statement Form as per Annex. - VAnnexure V typed on letter(05 Nos. user Certificate along with PO copies)head along with Attested Copyof the relevant documents Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09/ 2020 - 2021 / IGIMS / Store Page 43 of 85  S/NDetails / ParticularsDocument requiredUploadedPage(Yes/No)No16The Procurement of goods and services under thisAttested copy of Certificatetender will be regulated as per the applicable provisionof Public Procurement (Preference to Make in India),order 2017 of MoC & I (DIPP), Govt. Of India,therefore bidders who are claiming to be regulatedunder the said order are to submit documentaryevidence in support of their claim.17Details of Licence as per Annexure-XCopy of the documents &Attested copy of Certificate18Manufacturing Licence CertificateAttested copy of Certificate19Valid GMP/COPP/ Certificate (Annexure-VII)Attested copy of Certificate20Evaluation and validation by International/nationalAttested copy of Certificateagencies as per Clause 4.1121QMS CertificateAttested copy of Certificate 22Original Label of all quoted items and TechnicalCopy of the documentsLiterature/Catalogue & documents23Newly introduced item Certified by theAttested copy of Certificateconcerned Licensing Authority.(if applicable)24Any other information, if necessary Signature of the bidder with seal. Place: Date: *****  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 44 of 85 Section-IX Financial Bid Note: The price in the Financial Bid to be quoted per piece / foil / vial /capsule / tablet/bottle/ container/ tube etc. (as the case may be) and not the Pack Price. The price to be quoted is inclusive of packing & forwarding, transit insurance, loading & unloading, labour charges and all other incidental charges up to delivery at Central Store, IGIMS, Patna. GST if applicable will be charged extra showing rate percentage separately against each item. MRP (Maximum Retail Price) as per the manufacturer. Certificate: I/We have gone through the Terms & Conditions as stipulated in the Tender enquiry document and confirm to accept and abide by the same. No other charges would be payable by the Institute That I/We shall supply the items of requisite quality and quantity as per PO placed. That I/We undertake that the information given in this tender are true and correct in all respects Signature of the bidder with seal. Place: Date:  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 45 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213Anthelmintic1GD001AlbendazoleTablet 400 mgOne Tablet2GD002AlbendazoleSyrup 200mg/10mlOne Bottle of 10 MLAnti Convulsant3GD003BetahistineTablet 16mgOne Tablet4GD004Caffeine citrateInjection 20 mg/mlOne Vial of 1 mlOral solution (20 mg of caffeineCaffeine citratecitrate/ ml)5GD005One Bottle of 3 ml6GD006CarbamazepineCR Tablet 200 mgOne Tablet7GD007CarbamazepineSyrup 100mg/5mlOne Bottle of 450 ml8GD008CarbamazepineSyrup 200mg/5mlOne Bottle9GD009ClobazamTablet 10 mgOne Tablet10GD010ClobazamTablet 5 mgOne Tablet11GD011DiazepamInjection 5 mg/mlOne Vial of 10 ml12GD012DiazepamTablet 5 mgOne Tablet13GD013DiazepamSyrup 5mg/5mlOne Bottle of 500 ml14GD014EthosuximideCapsule 250 mgOne Capsule15GD015GabapentinTablet 100mgOne Tablet16GD016GabapentinTablet 300mgOne Tablet17GD017LacosamideInjection 10mg/mlOne Vial of 20 ml18GD018LacosamideTablet50 mgOne Tablet19GD019LacosamideTablet 100 mgOne Tablet20GD020LacosamideTablet 300 mgOne Tablet21GD021LamotrigineTablet 50MGOne Tablet22GD022LamotrigineCapsule 100MGOne Capsule23GD023LevetiracetamTablet 500 mgOne Tablet24GD024LevetiracetamTablet 250 mgOne Tablet25GD025LevetiracetamSyrup 100mg/mlOne Bottle of 200 ml26GD026LevetiracetamInjection 1GMOne Vial27GD027LevetiracetamInjection 500 mgOne Vial of 5 ml28GD028LorazepamInjection 2 mg/mlOne Vial of 1 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09/ 2020 - 2021 / IGIMS / StorePage 46 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)1234567891011121329GD029LorazepamTablet 2 mgOne Tablet30GD030Magnesium SulphateInjection 500 mg/mlOne Vial of 2ml31GD031OxcarbazepineTablet 100 mgOne Tablet32GD032OxcarbazepineTablet 200 mgOne Tablet33GD033PhenobarbitoneInjection 200 mg/mlOne Vial of 1 ml34GD034PhenobarbitoneOral liquid 20 mg/5 mlOne Bottle of 473ml35GD035PhenobarbitoneTablet 30 mgOne Tablet36GD036PhenothiazineInjection 12.5 MG/MLOne Vial37GD037PhenytoinTablet 50 mgOne Tablet38GD038PhenytoinTablet100 mgOne Tablet39GD039PhenytoinTablet300 mgOne Tablet40GD040PhenytoinInjection 50 mg/mlOne Vial of 2ml41GD041PhenytoinSyrup 30mg/5mlOne Bottle of 500 ml42GD042PregabalinTablet 75 mgOne Tablet43GD043PregabalinCapsule 200 mgOne Capsule44GD044Sodium valproateCR Tablet 500 mgOne Tablet45GD045Sodium valproateCR Tablet 300 mgOne Tablet46GD046Sodium valproateInjection 100 mg/mlOne Vial of 5 ml47GD047Sodium valproateOral liquid 200 mg/5ml,One Bottle of 100 ml48GD048Sumatriptan SuccinateTablet 50 mgOne Tablet49GD049TolterodineCapsule 2MGOne Capsule50GD050TolterodineCapsule4MGOne Capsule51GD051TopiramateTablet25MGOne Tablet52GD052TopiramateTablet 50MGOne TabletOral Solution 500 Mg/5 MLTriclofos Oral Solution53GD053One Bottle of 30 ml54GD054ZonisamideCapsule 25MGOne Capsule55GD055ZonisamideCapsule 50MGOne Capsule56GD056ZonisamideSuspensionOne Bottle57GD057ZonisamideCapsule100MGOne CapsuleAntiallergics Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 47 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)1234567891011121358GD058AdrenalineInjection 1 mg/mlOne Ampoule of 1 ml59GD059CetirizineOral liquid 5 mg/5 mlOne Bottle of 30 ml60GD060CetirizineTablet 10 mg,One Tablet61GD061Chlorpheneramine maleateTablet 50mgOne Tablet62GD062Chlorpheneramine maleateTablet 25mgOne Tablet63GD063Chlorpheneramine maleateInjection 45.50mg/2mlOne Ampoule of 2ml64GD064ChlorpheniramineTablet 4 mgOne Tablet65GD065CyproheptadineSyrup 100 mlOne Bottle of 100 ml66GD066CyproheptadineTablet 4 mgOne Tablet67GD067FexofenadineTablet 120mgOne Tablet68GD068LevocetirizineSyrup 2.5mg/5mlOne Bottle of 60 ml69GD069LevocetirizineTablet 5mgOne Tablet70GD070LoratidineTablet10mgOne Tablet71GD071LoratidineOral Suspention 1mg/mlOne Bottle of 60 ml72GD072PheniramineInjection 22.75 mg/mlOne Ampoule of 2mlAnti-Asthmatics73GD073AmbroxolSyrup 15mg/5mlOne Bottle of 100 ml74GD074AminophyllineInjection 250mg/10mlOne Ampoule of 10 ml75GD075BromhexineSyrup 4mg/5mlOne Bottle of 100 mlBudesonideRespirator solution for use in76GD076nebulizer 0.5 mg/2mlOne Bottle of 2 mlBudesonide (A) + Formoterol (B)Inhalation (MDI/DPI) 400 mcgEach container of 20077GD077(A) + 6 mcg (B)MDIBudesonide (A) + Formoterol (B)Inhalation (MDI/DPI) 200 mcgEach container of 12078GD078(A) + 6 mcg (B)MDIIpratropiumRespirator solution for use in79GD079nebulizer 250 mcg/mlOne Bottle of 15 mlIpratropiumInhalation (MDI/DPI) 20Each container of 20080GD080mcg/doseMDI81GD081Ipratropium+Levosalbutamolrespules 500 mg+ 1.25mgone respules of 2.5 ml82GD082MontelukastTablet10mgOne TabletSalbutamolRespirator solution for use in83GD083nebulizer 5mg/mlOne Bottle of 10 ML Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 48 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)1234567891011121384GD084SalbutamolTablet 2 mgOne Tablet85GD085SalbutamolTablet 4 mg,One TabletSalbutamolInhalation (MDI/DPI) 100Each container of 20086GD086mcg/dose,MDI87GD087SalbutamolOral liquid 2 mg/5 mlOne Bottle of 100 mlSalmetrol+FluticasoneMDI 250PUFFSEach container of MDI88GD088250PUFFS89GD089TerbutalineInjection 0.5mg/mlOne Ampoule of 1 ml90GD090TerbutalineTablet 2.5MGOne Tablet91GD091TerbutalineSyrup 100 mlOne Bottle of 100 mlTheophylline + EtofyllineInjection 50.6 mg +169.4 mg/292GD092mlOne Ampoule of 2mlTiotropiumEach container of 20093GD093Inhalation (MDI) 9 mcg/doseMDIAntibiotics94GD094AmikacinInjection 100 mgOne Vial of 2ml95GD095AmikacinInjection 500 mgOne Vial of 2ml96GD096AmoxicillinCapsule 250 mgOne Capsule97GD097AmoxicillinCapsule 500 mgOne CapsuleAmoxicillin (A) + Clavulanic acidOral liquid 200 mg (A) + 28.5 mg(B)98GD098(B)/5 mlOne Bottle of 30 mlAmoxicillin (A) + Clavulanic acid99GD099(B)Injection 300 mgOne Vial of single DoseAmoxicillin (A) + Clavulanic acid100GD100(B)Injection600 mgOne Vial of single DoseAmoxicillin (A) + Clavulanic acid101GD101(B)Injection 1200 mgOne Vial of single DoseAmoxicillin (A) + Clavulanic acid102GD102(B)Tablet 500 mg (A) + 125 mg (B)One TabletAmoxicillin (A) + Clavulanic acid103GD103(B)Tablet 200 mg (A) + 125 mg (B)One Tablet104GD104AmpicillinPowder for Injection 1 gOne Vial of single Dose105GD105AzithromycinPowder for Injection 500 mg,One Vial of single Dose106GD106AzithromycinTablet 250 mgOne Tablet107GD107AzithromycinTablet 500 mgOne Tablet108GD108AzithromycinSyrup 100mg/5mlOne Bottle of 15 ml109GD109AzithromycinE/D 1%Each container of 3 ML Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 49 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213110GD110AztreonamInjection 1 gmOne Vial of single Dose111GD111AztreonamInjection 2 gmOne Vial of single DoseBenzyl penicillin112GD112Powder for Injection 10 lac unitsOne Vial of single Dose113GD113CefazolineInjection 1 gmOne Vial of single Dose114GD114Cefipime + TazobactumInjection 2.25gmOne Vial of single Dose115GD115CefiximeTablet 200 mgOne Tablet116GD116CefiximeOral liquid 50 mg/5 mlOne Bottle of 50 ML117GD117Cefoperazone + SulbactamInjection 1 g + 0.5 gOne Vial of single Dose118GD118CefotaximePowder for Injection 1 gOne Vial of single Dose119GD119CefotaximePowder forInjection 250mgOne Vial of single Dose120GD120CeftazidimePowder for Injection 1 gOne Vial of single Dose121GD121CeftazidimePowder forInjection 500mgOne Vial of single Dose122GD122CeftazidimePowder for Injection 250mgOne Vial of single Dose123GD123CeftriaxonePowder for Injection 1 gOne Vial of single Dose124GD124CeftriaxonePowder for Injection 250mgOne Vial of single Dose125GD125CefuroximePowder forInjection 300 mgOne Vial of single Dose126GD126CefuroximePowder for Injection750mg,One Vial of 15 MLCefuroximeOne Vial of Single Dose127GD127Powder for Injection1.5 gmVia128GD128CiprofloxacinEar Drop 0.03%,Each container of 5 ML129GD129CiprofloxacinTablet 500 mgOne Tablet130GD130CiprofloxacinTablet 250 mg,One Tablet131GD131CiprofloxacinInjection 200 mg/100 mlEach container of 100 ML132GD132CiprofloxacinOintment 0.05w/w,Each tube of 15GM133GD133ClarithromycinInjection 500mgOne Vial of single Dose134GD134ClarithromycinTablet 500 mgOne Tablet135GD135ClindamycinInjection 300 mgOne Vial of 2ml136GD136ClindamycinTablet 300 mgOne Tablet137GD137ClindamycinTablet 150 mgOne Tablet138GD138CloxacillinPowder for Injection 500 mgOne Vial of single Dose139GD139CloxacillinPowder for Injection 250 mgOne Vial of single Dose140GD140CloxacillinCapsule 500mgOne Capsule Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 50 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213141GD141ColistinInjection 3 Million IUOne Vial of single Dose142GD142ColistinInjection 1 Million IUOne Vial of single Dose143GD143CotrimazoleTablet 400mgOne TabletCo-trimoxazole[Sulphamethoxazol144GD144+Trimethoprim (B)]Tablet 800 mg (A) + 160 mg (B)One TabletCo-trimoxazole[SulphamethoxazolOral liquid 200 mg (A) + 40 mg+Trimethoprim (B)]145GD145(B)/5 mlOne Bottle of 100 ml146GD146DoxycyclineCapsule 100 mgOne Capsule147GD147DoxycyclineInjection 100 mgOne Vial of single Dose148GD148FaropenemTablet 500 mgOne Tablet149GD149GentamicinInjection 40 mg/mlOne Vial of 2ml150GD150Imipenem and CilastatinInjection 500mgOne Vial of single Dose151GD151LinezolidSyrup 100mg/5mlOne Bottle of 30 ml152GD152LinezolidInjection 600 mgOne Vial of 300 ml153GD153LinezolidInjection 200 mgOne Vial of 100 ml154GD154LinezolidInjection 2mg/mlOne Vial155GD155LinezolidTablet 600 mgOne Tablet156GD156MeropenemInjection 1 gOne Vial of single Dose157GD157MeropenemInjection 500 gOne Vial of single Dose158GD158MeropenemInjection 125 MGOne Vial of single Dose159GD159MetronidazoleTablet 400 mgOne Tablet160GD160MetronidazoleInjection 500 mg/100 mlOne Vial of 100 ml161GD161NitrofurantoinSyrup 25mg/5mlOne Bottle of 230 ml162GD162NitrofurantoinTablet 100 mgOne Tablet163GD163OfloxacinTablet 200 mgOne Tablet164GD164OfloxacinInjection 200 mgEach container of 100 ML165GD165OfloxacinSyrup 50mgOne Bottle of 60 ml166GD166OrnidazoleTablet 500mgOne Tablet167GD167Penicilline GInjection 250 mgOne Vial of single DosePiperacillin (A) + Tazobactam (B)Powder for Injection 4 g (A) + 500168GD168mg (B)One Vial of single Dose Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 51 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213Piperacillin (A) + Tazobactam (B)Powder for Injection 2 g (A) + 250169GD169mg (B)One Vial of single DosePiperacillin (A) + Tazobactam (B)Powder for Injection 1 g (A) + 125170GD170mg (B)One Vial of single Dose171GD171Polymyxin BInjection 5 kOne Vial of single Dose172GD172RoxythromycinTablet 150mgOne Tablet173GD173Streptomycin 750mgInjection 750mgOne Vial of single DoseInjection (80mg+16mg)/ml in 5Sulfamethoxazole+Trimethoprimml174GD174One Vial of 30ml175GD175Sulfamethoxazole+TrimethoprimTablet 400 mg+80 mgOne Tablet176GD176Sulfamethoxazole+TrimethoprimTablet (800+160)One Tablet177GD177Sulfamethoxazole+TrimethoprimSusp. 800+160(60ml.)One Bottle178GD178TetracyclineTablet 250mgOne Tablet179GD179TigecyclineInjection 50 MGOne Vial of single DoseVancomycin180GD180Powder for Injection 500 mgOne Vial of single Dose181GD181VancomycinTablet 500 mgOne TabletAnticancer Drugs182GD1825-FluorouracilInjection 250 mg/5 mlOne Vial of 5 ml183GD1836-MercaptopurineTablet 50 mgOne Tablet184GD184AbirateroneTablet 500MGOne Tablet185GD185Abiraterone AcetateTablet 250 mgOne TabletActinomycin D186GD186Powder for Injection 0.5 mgOne Vial of single Dose187GD187All-trans retinoic acidCapsule 10 mgOne Capsule188GD188BendamustineInjection 100mgOne Vial of single Dose189GD189BicalutamideTablet 50 mgOne Tablet190GD190BleomycinPowder for Injection 15 unitsOne Vial of single Dose191GD191BortezomibPowder for Injection 3MGOne Vial of single Dose192GD192BortezomibPowder for Injection2.5MGOne Vial of single Dose193GD193BortezomibPowder for Injection 2mgOne Vial of single Dose194GD194Calcium folinateInjection 3 mg/mlOne Vial of 5 ml195GD195Calcium folinateTablet 15 mg,One Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 52 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213196GD196CapecitabineTablet 500 mgOne Tablet197GD197CarboplatinInjection 10 mg/mlOne Vial of 5 ml198GD198CisplatinInjection 1mg/mlOne Vial of 50ml199GD199CyclophosphamideTablet 50 mgOne Tablet200GD200CyclophosphamidePowder for Injection 200 mgOne Vial of single Dose201GD201CyclophosphamidePowder for Injection 1GMOne Vial of single Dose202GD202CyclophosphamidePowder for Injection 500 mgOne Vial of single Dose203GD203CytarabinInjection 100 mg/5mlOne Vial of single DoseDacarbazine204GD204Powder for Injection 500 mgOne Vial of single Dose205GD205DapoxetineTablet 50 MGOne Tablet206GD206DapoxetineTablet 30 mgOne Tablet207GD207DaunorubicinInjection 80MGOne Vial of single Dose208GD208DaunorubicinInjection 20MGOne Vial of single Dose209GD209DaunorubicinInjection 5 mg/mlOne Vial of 4 ml210GD210DecitabineInjection 50mgOne Vial of single DoseDocetaxel211GD211Powder for Injection 80 mgOne Vial of 2ml212GD212DocetaxelPowder for Injection 20 mg,One Vial of 0.5ml213GD213DoxorubicinInjection 2 mg/mlOne Vial of single DoseDoxorubicinOne Vial of Single Dose214GD214Injection 50MGLyophilized215GD215DoxorubicinInjection 20MG/10 mlOne Vial of 10 ml216GD216Enzulatamidesoft capsules 40MGOne soft capsules217GD217EpirubicinInjection 10MGOne Vial of single Dose218GD218EtoposideCapsule 50 mgOne Capsule219GD219EtoposideCapsule 100 mgOne Capsule220GD220EtoposideInjection 20 mg/mlOne Vial of 50ml221GD221GefitinibTablet 250 mgOne TabletGemcitabineOne Vial of Single Dose222GD222Powder for Injection 1 gLyophilized223GD223GemcitabinePowder for Injection 200 mgOne Vial of single Dose Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 53 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213Granulocyte colony stimulatingInjection 300 g224GD224factor (G-CSF)One Vial of 1 mlGranulocyte colony stimulatingInjection 6 mg225GD225factor (G-CSF)One Vial of 1 ml226GD226IfosfamidePowder for Injection 1 gOne Vial of 20 ml227GD227ImatinibTablet 400 mgOne Tablet228GD228Intravesical bcgInjection 40 MGOne Vial of single Dose229GD229L-AsparaginasePowder for Injection 10000 KUOne Vial of single Dose230GD230L-AsparaginasePowder for Injection 5000 KU.One Vial of single Dose231GD231LetrozoleTablet 20 mgOne TabletLeuprolideInjection 22.5 MGOne Vial of 2ml Single232GD232Dose Lyophilized233GD233MesnaInjection 100 mg/mlOne Vial of 2mlMethotrexateOne Vial of Single Dose234GD234Injection 1GM,Lyophilized235GD235MethotrexateInjection 50 MGOne Vial of 2ml236GD236MethotrexateInjection 15 MGOne Ampoule of 1 ml237GD237MethotrexateTablet10 mgOne Tablet238GD238MethotrexateTablet 2.5 mgOne Tablet239GD239OctreotideInjection 100mcgOne Vial of 1 ml240GD240OxaliplatinInjection 5 mg/mlOne Vial of 20 ml241GD241PaclitaxelInjection 100 mg/16.7 mlOne Vial of single Dose242GD242PazopanibTablet 40MGOne Tablet243GD243PemetrexedInjection 800 mgOne Vial244GD244PemetrexedInjection 500mgOne Vial of single Dose245GD245RituximabInjection 500MGOne Vial of 50ml246GD246RituximabInjection 10 mg/mlOne Vial of 10 ml247GD247SunitinibCapsule 50MGOne Capsule248GD248TamoxifenTablet 20 mgOne Tablet249GD249TemozolomideTablet 100 mgOne Tablet250GD250ThalidomideCapsule 100 mgOne Capsule251GD251TrastuzumabInjection 440 mg/50 mlEach container of 50 ml252GD252TriptorelinInjection 11.25 MGOne Vial of single Dose253GD253VinblastineInjection 1 mg/mlOne Vial of 10 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 54 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213254GD254VincristineInjection 1 mg/mlOne Vial of 1 mlAnticoagulants255GD255AcenocoumarolTablet 2gmOne Tablet256GD256DabigatranTablet 150mgOne Tablet257GD257DabigatranTablet 110mgOne Tablet258GD258EnoxaparinInjection 60 mg (PFS)One Vial259GD259EnoxaparinInjection 40 mg/0.4 mlOne Vial of 0.4ml260GD260EnoxaparinInjection 20 mgOne Vial of 0.2ml261GD261Fondaparinux Sod.Injection 2.5mg/0.5mlOne Vial of 0.5ml262GD262HaemocoagulaseInjection 1 I.U/1mlOne Vial of 1 ml263GD263HeparinInjection 10000 IU/ml ,One Vial of 1 ml264GD264HeparinInjection 5000 IU/mlOne Vial of 5 ml265GD265Phytomenadione (Vit.K1)Injection 10 mg/mlOne Vial of 1 ml266GD266Phytomenadione (Vit.K1)Tablet 10mgOne Tablet267GD267ProtamineInjection 10 mg/mlOne Vial of 25 ml268GD268Tranexamic acidInjection 100 mg/mlOne Ampoule of 5ml269GD269Tranexamic acidTablet 500 mg,One Tablet270GD270WarfarinTablet 5 mgOne Tablet271GD271WarfarinTablet 2 mgOne TabletAntidepressants and MoodStabilizers272GD272AmitriptylineTablet 10 mg,One Tablet273GD273AmitriptylineTablet 25 mgOne Tablet274GD274ClomipramineCapsule 75 mgOne Capsule275GD275DothiepinTablet 25MGOne Tablet276GD276DuloxetineTablet 30mgOne Tablet277GD277DuloxetineTablet 10mgOne Tablet278GD278EscitalopramTablet 5 mgOne Tablet279GD279FluoxetineCapsule 20 mgOne Capsule280GD280SertralineTablet 50MGOne TabletAnti-Diabetic Medicines281GD281GlimepirideTablet 1 mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 55 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213282GD282GlargineInjection 100 unit/mlOne Vial of 10 ml283GD283Insulin (Soluble)Injection 40 IU/mlOne Vial of 10 mlInsulin 30:70 Injection (Premix284GD284Regular: NPH)Injection 40 IU/mlOne Vial of 10 mlIntermediate Acting (NPH)285GD285InsulinInjection 40 IU/mlOne Vial of 10 ml286GD286MetforminTablet 500 mgOne Tablet287GD287PioglitazoneTablet 15 mgOne Tablet288GD288TeneligliptinTablet 20mgOne TabletAnti-diarrhoeal289GD289LactobacillusTablet / CapsulesOne Tablet290GD290LoperamideTablet 2mgOne Tablet09291GD291Oral rehydration saltsAs licensed sachetone Sachet of 30gm292GD292Oral rehydration saltsliquid 200mlOne Container of 200ml293GD293RacecadotrilTablet 100 mgOne Tablet294GD294Zinc carbonate (elemental)Tablet 50 mgOne Tablet295GD295Zinc sulphateDispersible Tablet 20 mgOne TabletAntidotes296GD296Activated charcoalPower 200 GMEach container of 200 gm297GD297AtropineInjection 100mlOne Vial of 100 ml298GD298Calcium gluconateInjection 100 mg/mlOne Ampoule of 10 ml299GD299DesferrioxaminePowder for Injection 500 mgOne Vial of single Dose300GD300DiferasiroxTablet 250 mgOne TabletMethylthioninium301GD301chloride(Methylene blue)Injection 10 mg/mlOne Vial of 10 ml302GD302N-acetylcysteineInjection 200 mg/mlOne Vial of 30ml303GD303N-acetylcysteineSachet 200 mgone Sachet of 200 mg304GD304N-acetylcysteineNebuliser sol. 20%Each container of 30 ml305GD305N-acetylcysteineNebuliser sol. 10%Each container of 30 ml306GD306N-acetylcysteineInjection 20%One Vial of 5 ml307GD307N-acetylcysteineInjection 10%One Vial of 10 ml308GD308N-acetylcysteineTablet 600mgOne Tablet309GD309NaloxoneInjection 0.4 mg/mlOne Vial of 2ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 56 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213310GD310PAM(Pralidoxime iodide )Injection 500 mgOne Ampoule of 20 ml311GD311PenicillamineCapsule 250 mgOne Capsule312GD312Pralidoxime chloride (2-PAM)Injection 25 mg/mlOne Vial313GD313Protamine sulfateInjection 50mg/5mlOne Vial of 5 mlGD314Sodium ThiosulphateInjection 250mg/ml,50ml314One Vial of 50mlAnti-emetics315GD315DomperidoneInjection 40 MGOne Ampoule of 2ml316GD316DomperidoneTablet 10 mgOne Tablet317GD317DomperidoneSyrup 30mlOne Bottle of 30 ml318GD318MetoclopramideInjection 5 mg/mlOne Vial of 2ml319GD319MetoclopramideTablet 10 mgOne Tablet320GD320OndansetronInjection 8 mgOne Ampoule of 4ml321GD321OndansetronInjection 4 mgOne Ampoule of 2ml322GD322OndansetronTablet 4 mg,One Tablet323GD323OndansetronSyrup 2mg/5mlOne Bottle of 30 mlAntifungals324GD324Amphotericin-B ConventionalPowder for Injection 50 mgOne Vial of single Dose325GD325Amphotericin-B Lipid/LiposomalPowder for Injection 50 mgOne Vial of single Dose326GD326CaspofunginInjection 50 mgOne Vial of single Dose327GD327ClotrimazolePessary 100 mgEach Pic.328GD328ClotrimazoleEar Drop,Each container of 5 ML329GD329ClotrimazoleMouth paint (1%) w/ wEach container of 25 ml330GD330ClotrimazoleTablet 100mgOne Tablet331GD331FluconazoleInjection 200 mg /100 mlEach container of 100 ML332GD332FluconazoleTablet 200 mgOne Tablet333GD333ItraconazoleCapsule 100mgOne Capsule334GD334ItraconazoleTablet 200MGOne Tablet335GD335ItraconazoleE/D 1%Each container of 5 ML336GD336VericonazoleCapsule 200 mgOne CapsuleAnti-Gout Agents337GD337AllopurinolTablet 100 mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 57 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213338GD338FebuxostatTablet 40 mgOne TabletAnti-Leprotics339GD339ClofazimineCapsule 50 mgOne Capsule340GD340DapsoneTablet 50 mgOne TabletAnti-MalarialsArtemether (A) + LumefantrineOral liquid 80 mg (A) + 480 mg341GD341(B)(B)/5 MlOne Bottle of 30 mlArtemether (A) + Lumefantrine342GD342(B)Tablet 40 mg (a) + 240 mg (b) ,One Tablet343GD343ArtesunatePowder for Injection 60 mgOne Vial of single Dose344GD344ChloroquineOral liquid 50 mg/5 ml,One Bottle of 60 ml345GD345ChloroquineTablet 150mgOne Tablet346GD346Hydroxychloroquine PhosphateTablet 200mgOne Tablet347GD347PrimaquineTablet 7.5 mgOne Tablet348GD348PrimaquineTablet 2.5 mg,One TabletAntimigraine Drugs349GD349FlunarizineTablet 5 mgOne Tablet350GD350PropanololTablet 20 mgOne TabletAnti-Parkinsonian DrugsLevodopa(A) + Carbidopa (B)CR Tablet 100 mg (A) + 25 mg351GD351(B)One Tablet352GD352RasagilineTablet 0.5mgOne Tablet353GD353RivastigmineTablet 1.5MGOne Tablet354GD354RizatriptanTablet 10 mgOne Tablet355GD355Ropinirole HCLTablet 0.25 mgOne Tablet356GD356TrihexyphenidylTablet 2 mgOne TabletAntipsychotics357GD357AmisulprideTablet 200mgOne Tablet358GD358AmisulprideTablet 400 mgOne Tablet359GD359CiticolineInjection 500mgOne Ampoule of 2ml360GD360CiticolineTablet. 500mgOne Tablet361GD361ClonidineInjection 500 Mcg/mlOne Vial of 10 ml362GD362ClonidineTablet 100 mcgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 58 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213363GD363ClozapineTablet 100 mgOne Tablet364GD364DexmedetomidineInjection 50 Mcg/0.5mlOne Vial of 0.5ml365GD365DonepazilTablet.5mgOne Tablet366GD366DonepazilTablet 10mgOne Tablet367GD367HaloperidolInjection 5m/mlOne Vial of 1 ml368GD368HaloperidolTablet 5 mgOne Tablet369GD369OlanzapineTablet 5mgOne Tablet370GD370OlanzapineTablet 10mgOne Tablet371GD371ParaldehydeInjectionOne Vial of 1 mlInjection 200mg 60ml vailPiracetam372GD372One Vial of 60 ml373GD373PiracetamTablet 800mgOne Tablet374GD374PiracetamTablet 1200mgOne Tablet375GD375PiracetamSyrup 100mlOne Bottle of 100 ml376GD376PramipexoleTablet 0.25 mgOne Tablet377GD377QuetiapineTablet 50mgOne Tablet378GD378QuetiapineTablet 100mgOne Tablet379GD379QuetiapineTablet 300mgOne Tablet380GD380RisperidoneTablet 2 mgOne Tablet381GD381Zolpidem TartarateTablet 10 MgOne TabletANTISEPTIC382GD382Silver ColloidalTopical gel for burn woundsEach Jar of 60 ml383GD383Acriflavine antiseptic Powder25 gram packsEach container of 25 gm384GD384Bismuthpowder 200gmEach container of 200 gmChlorhexidineSolution 5% (Concentrate for385GD385dilution)One Bottle of 300 ml386GD386Chlorhexidine5 % LiquidOne Bottle of 500 ml387GD387Ethyl alcohol (Denatured)Solution 70%One Bottle of 500 ml388GD388HyaluronidaseInjection 15000IUOne Vial of 1 ml389GD389Hydrogen peroxideSolution 6%One Bottle of 500 ml390GD390Iodoformpowder 200gmEach container of 200 gm391GD391MetronidazoleOintment 1%Each tube of 45 gm Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 59 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213392GD392MupirocinOintment 2%Each tube of 22 gm393GD393NeomycineCreame 0.5%Each tube of 15GM394GD394PiroxicamOintment 0.5%w/vEach tube 30 gm395GD395Silver sulphadiazineCreame 250 gmEach Jar of 250 gm396GD396Tincture BenzoinInjection 10mg/100 mlOne Vial of 100 ml397GD397Type II collagenTablet 500 mgOne TabletANTISERA-IMMUNOGLOBULINSAnti-D immunoglobulinEach container of 300 mcg398GD398Injection-300 mcg of 1.3mlof 1.3mlAnti-rabies immunoglobulinEach container of 300 iu399GD399Injection-300 iu of 2 mlof 2 mlAnti-tetanus immunoglobulinEach container of 250 iu400GD400Injection-250 iu of 2.5 mlof 2.5 ml401GD401DipyridamoleTablet 25 mgOne Tablet402GD402Human Albumin 20%100 MlOne Bottle of 100 ml403GD403Immune Globulin (Human)10%30G/300 MlOne Bottle of 300 ml404GD404IVIGInjection 2.5 gmOne Vial of 100 mlLyophilized polyvalentEach container of Single405GD405Single DoseDoseRabies vaccineEach container of Single406GD406Single DoseDoseSnake venom antiserum407GD407Anti Snake Venom (10ml)One Vial of 10 ml408GD408Tetanus toxoidInjection 0.5mlOne Vial of 0.5mlANTSPASMODIC409GD409DarifenacinTablet 7.5 mgOne Tablet410GD410DarifenacinTablet 15 MGOne Tablet411GD411DicyclomineSyrup 10MG/5MLOne Bottle412GD412DicyclomineTablet 20 mg,One Tablet413GD413DicyclomineInjection 10 mg/mlOne Ampoule of 2ml414GD414DrotaverineInjection 40 mgOne Ampoule of 2ml415GD415DrotaverineTablet40 mgOne Tablet416GD416Hyoscine butyl bromideInjection 20 mgOne Ampoule of 1 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 60 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213417GD417OxybutyninTablet 2.5 MGOne Tablet418GD418TamsulosinTablet 0.4 mgOne TabletANTITHYROID419GD419CarbimazoleTablet 5mgOne Tablet420GD420LevothyroxineTablet 25 mcgOne Tablet421GD421LevothyroxineTablet 50 mcgOne Tablet422GD422LevothyroxineTablet 12.5mg,One Tablet423GD423ThyroxineTablet 25MGOne Tablet424GD424ThyroxineTablet 50MGOne TabletANTITUBERCULAR425GD425EthambutolTablet 400 mgOne Tablet426GD426IsoniazidTablet 50 mgOne Tablet427GD427IsoniazidTablet 300 mgOne Tablet428GD428IsoniazidOral liquid 50 mg/5 mlOne Bottle of 200 ml429GD429LevofloxacinTablet 500 mgOne Tablet430GD430LevofloxacinTablet 750 mgOne Tablet431GD431LevofloxacinInjection 500mg/100 mlEach container of 100 ML432GD432LinezolidTablet 600 mgOne Tablet433GD433PyrazinamideTablet 500 mg,One Tablet434GD434PyrazinamideTablet 750 mgOne Tablet435GD435PyrazinamideSyrup 250 mg/5 mlOne Bottle of 120 ml436GD436PyrazinamideCapsule 300 mg,One Capsule437GD437PyrazinamideSyrupOne BottleAntiulcer Drugs438GD438LansoprazoleTablet 15mgOne Tablet439GD439OmeprazoleCapsule 20 mgOne Capsule440GD440PantoprazoleInjection 40 mgOne Vial of single Dose441GD441PantoprazoleTablet40 mgOne Tablet442GD442RanitidineInjection 25 mg/mlOne Vial of 2ml443GD443RanitidineTablet 150 mg,One TabletAntiviral Drugs Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 61 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213444GD444AcyclovirTablet 400 mgOne TabletAcyclovir445GD445Powder for Injection 250 mgOne Vial of single DoseAcyclovir446GD446Powder for Injection 500 mgOne Vial of single Dose447GD447AcyclovirOintment 5%Each tube of 30 gm448GD448AmantadineTablet 100mgOne Tablet449GD449GanciclovirTablet 250mgOne Tablet450GD450GanciclovirOintment 0.15%Each tube of 5 gm451GD451Interferon betaInjection 30mcg/0.5mlOne Vial of 0.3 ml452GD452ValacyclovirTablet 1GMOne TabletCardiovascular Drugs453GD453AcetylsalicylicTablet 75 mgOne Tablet454GD454AdenosineInjection 6 mgOne Ampoule of 2ml455GD455AmbrissentanTablet 10mgOne Tablet456GD456AmiodaroneInjection 150 mg/3mlOne Ampoule of 3 ml457GD457AmiodaroneTablet 200mgOne Tablet458GD458AmlodipineTablet 5 mgOne Tablet459GD459AtorvastatinTablet 10 mg,One Tablet460GD460AtorvastatinTablet 20 mgOne Tablet461GD461BosentanTablet (62.5 mg)One Tablet462GD462BosentanTablet 125mgOne Tablet463GD463CarvediolTable 3.125mgOne Tablet464GD464ClopidogrelTablet 75 mgOne Tablet465GD465ClopidogrelTablet 150mgOne Tablet466GD466ClopidogrelTablet 100mg,One TabletTablet(A)75mg + (B)75mgClopidogrel (A) + Aspirin (B)467GD467One Tablet468GD468DigoxinInjection 0.5 mg/mlOne Ampoule of 1 ml469GD469DigoxinTablet 0.25mgOne Tablet470GD470DigoxinTablet 62.5mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 62 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213471GD471DiltiazemTablet 30 mgOne Tablet472GD472DiltiazemTablet 150mgOne Tablet473GD473DobutamineInjection 50 mg/mlOne Ampoule of 5ml474GD474DopamineInjection 40 mg/mlOne Ampoule of 5ml475GD475EnalaprilTable 5mgOne Tablet476GD476EphedrineInjection 30 mgOne Ampoule of 1ml477GD477EsmololInjection100mg/10mlOne Vial of 10 ml478GD478Glyceryl trinitrateInjection 1 mg/mlOne Vial of 10 ml479GD479Glyceryl trinitrateSublingual tablet 0.5 mg,One Tablet480GD480IsoprenalineInjection 2 mg/mlOne Ampoule of 1 ml481GD481Isosorbide DinitrateTablet5 mgOne Tablet482GD482Isoxsuprine HclInjection 5mg/mlOne Ampoule of 2ml483GD483IvabradineTablet 5mgOne Tablet484GD484LabetalolInjection 5 mg/mlOne Vial of 4 mlLevosimendan485GD485Powder for Injection 12.5 mgOne Vial of single Dose486GD486Lidocaine Hcl 2%Injection 1000 mg/50mlOne Vial of 50ml487GD487LosartanTablet 25mgOne Tablet488GD488MacitentanTablet 10mgOne Tablet489GD489MethyldopaTablet 250 mg,One Tablet490GD490MetoprololInjection 5mg/5mlOne Vial of 5 ml491GD491MetoprololTablet 25 mgOne Tablet492GD492Milrinone LactateInjection. 10mg/10mlOne Vial of 10 ml493GD493NifedipineTablet 10mgOne Tablet494GD494Nifedipine sustained releaseTablet 30mgOne Tablet495GD495NimodipineTablet30 mgOne Tablet496GD496NoradrenalineInjection 2 mg/mlOne Ampoule of 2ml497GD497PrasugrelTablet 81 mg,One Tablet498GD498PrasugrelTablet 325 mgOne Tablet499GD499Prazosin sustained releaseTablet 2.5mgOne Tablet500GD500RamiprilTablet 1.25mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 63 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213501GD501RamiprilTablet 2.5mgOne Tablet502GD502RiociguatTablet 0.5 mgOne Tablet503GD503RosuvastatinTablet 10mgOne TabletInjection (10 mg/ 12.5ml)Sildenafil504GD504One Vial of 12.5 ml505GD505SildenafilTablet25 mgOne Tablet506GD506SildenafilTablet50 mgOne TabletInjection 300mg/ml, 10mlSodium Nitrite507GD507One Vial of 10 ml508GD508Sodium NitroprussideInjection 25mg/mlOne Vial of 2ml509GD509TelmisartanTablet 40 mgOne Tablet510GD510TicagrelorTablet 60MG,One Tablet511GD511TicagrelorTablet 90mgOne Tablet512GD512Ursodeoxycholic AcidTablet 150mgOne Tablet513GD513Ursodeoxycholic AcidSyrup 125mg/100mlOne Bottle of 100 ml514GD514ValsartanTablet 40mgOne Tablet515GD515VerapamilInjection 5mg/2mlOne Ampoule of 2ml516GD516VerapamilTable 40mgOne Tablet517GD517VerapamilTablet240mgOne TabletContraceptives andGynecologic preparations518GD518BetamethasoneInjection 4 mg/mlOne Ampoule of 1 mlCalcitonin salmonNasal Spray/3.7 mlOne Bottle of 30 doseper519GD519bottle520GD520Carboprost TromethamineInjection 250Mcg/mlOne Ampoule of 1 mlDinoprostoneOne Tube of NET521GD521Gel 0.5 mgWT;-3.0GM522GD522EthinylestradiolTablet 0.05 mgOne Tablet523GD523EthinylestradiolTablet 0.01 mg ,One TabletEthinylestradiol (A)524GD524+Levonorgestrel (B)Tablet 0.03 mg (A) + 0.15 mg (B)One Tablet525GD525IUD containing CopperCuT-380A/375526GD526Medroxyprogesterone acetateTablet 10 mgOne Tablet527GD527MethylergometrineInjection 0.2 mg/mlOne Vial, 1ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 64 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213528GD528MethylergometrineTablet 0.125 mg,One Tablet529GD529MifepristoneTablet 200 mgOne Tablet530GD530MisoprostolTablet 25 mcgOne Tablet531GD531MisoprostolTablet 100 mcgOne Tablet532GD532NifedipineTablet 10 mgOne Tablet533GD533NorethisteroneTablet 5 mgOne TabletOxytocin534GD534Injection 5 IU/mlOne Ampoule of 1 ml535GD535OxytocinInjection 10 IU/mlOne Ampoule of 1 mlCorticosteroids536GD536DeflazacortTablet 60 MGOne Tablet537GD537DexamethasoneInjection 4 mg/mlOne Vial of 2ml538GD538DexamethasoneTablet2mgOne TabletDexamethasone539GD539Oral Suspention 0.5mg/5mlOne Bottle of 240 ml540GD540FludrocortisoneTablet100mcgOne Tablet541GD541HydrocortisoneInjection 100 mgOne Vial of single Dose542GD542HydrocortisoneTablet 5mgOne Tablet543GD543Hydrocortisone HemisuccinateInjection.200mgOne Vial of single Dose544GD544MethylprednisoloneInjection 1gmOne Vial of single Dose545GD545MethylprednisoloneInjection 500 mgOne Vial of single Dose546GD546MethylprednisoloneInjection 40 mg/mlOne Vial of single Dose547GD547MethylprednisoloneTablet 4MGOne Tablet548GD548MethylprednisoloneTablet 16MGOne Tablet549GD549PrednisoloneTablet 10 mgOne Tablet550GD550Prednisolone sodium phosphateE/D 0.5%Each container of 5 MLDermatological medicines551GD551BetamethasoneCream 0.1%One tube of 30 gm552GD552ClotrimazoleCream 1%One tube of 30 gmGentian Violet553GD553Topical preparation 0.25% to 2%One tube Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 65 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213554GD554GlycerinOral Liquid 500 MLOne Bottle of 500 ml555GD555MometasoneOintment 0.1%One tube of 30 gm556GD556PermethrinCream 5%One tube of 60 gm557GD557Salicylic acidOintment 6%One tubetopical gel for scar treatmentSilicone gel558GD558One tube of 10 gm559GD559Silicone gel sheetfor scar treatmentOne Sheet560GD560Sodium fusidateOintment 2.0% w/wOne tube of 10 gmDiuretics & Anti Diuretics561GD562ChlorothiazideTablet 250mg,One Tablet562GD563EplerenoneTablet 25mgOne Tablet563GD564FurosemideInjection 10 mg/ mlOne Ampoule of 2ml564GD565FurosemideTablet 40 mgOne Tablet565GD567MannitolInjection 20%Each container of 100 ML566GD568MetolazoneTablet 2.5mgOne Tablet567GD569TolterodineTablet 2mgOne Tablet568GD570TorsemideInjection20mgOne Ampoule of 2ml569GD571TorsemideTablet 10mgOne Tablet570GD572VasopressinInjection 20 units/1mlOne Ampoule of 1 mlGeneral AnaestheticsAtracurium571GD573Injection 25 mg in 2.5 mlOne Vial of 2.5 ml572GD574CisatracuriumInjection 2mg/mlOne Vial of 10 ml573GD575Desflurane240 ml liquidOne Bottle of 240 ml574GD576Desmopressin spray10 mcg/0.1mlOne Bottle of 5 ML575GD577EtomidateInjection 2mg/ mlOne Vial of 10 ml576GD578Glycopyrrolate+NeostigmineInjection 0.5mg+2.5mgOne Vial of 5 ml577GD579IsofluraneInhalation(30 ml)One Bottle of 30 ml578GD580IsofluraneInhalation(100 ml)One Bottle of 100 ml579GD581IsofluraneInhalation (250 ml)One Bottle of 250 ml580GD582KetamineInjection 100 mg/ml,One Vial of 5 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 66 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213581GD583KetamineInjection 250 mg/mlOne Vial of 10 ml582GD584Lignocaine viscous gargle 2%10 ml bottleOne Vial of 10 ml583GD585PropofolInjection 200 mg/20mlOne Vial of 20 ml584GD586RocroniumInjection 100 mg/10 mlOne Vial of 10 ml585GD587SevofluraneInhalation (50ml)One Container of 50 ml586GD588SuccinylcholineInjection 50mg/mlOne Vial of 10 mlThiopentone587GD589Powder for Injection 0.5 gOne Vial of single Dose588GD590ThiopentonePowder for Injection 1 gOne Vial of single Dose589GD591Tincture benzoinLiquidOne Bottle of 500 mlVecuronium590GD592Powder for Injection 10 mg (vial)One Vial of 10 mlVecuroniumPowder for Injection 4 mg591GD593(ampoules)One Ampoule of 1 mlHematologic agentsInjection40 mcg/0.4ml s/cDarbepoetin592GD594One Ampoule of 0.4 ml593GD595ErythropoietinInjection5000U s/c,One Ampoule of 0.5 ml594GD596ErythropoietinInjection6000U s/cOne Ampoule of 0.6 ml595GD597ErythropoietinTablet4000U s/c,One Ampoule of 0.4 ml596GD598Ferric carboxymaltoseInjection 1 gmOne Vial of 20 ml597GD599Ferric Carboxymaltose500mg, IVOne Vial of 10 mlFerrous salt (A) + Folic acid (B)Tablet 100 mg elemental iron598GD600(A)+ 500 mcg (B)One TabletFerrous salt (A) + Folic acid (B)Oral liqiud 20 mg elemental iron599GD601(A) + 100 mcg (B)/mlOne Bottle of 200 mlFerrous saltsTablet equivalent to 60 mg of600GD602elemental ironOne TabletFerrous saltsOral liquid equivalent to 25 mg of601GD603elemental iron/mlOne Bottle of 200 ml602GD604Folic acidTablet 5 mgOne Tablet603GD605Folic Acid+ CyanocobalminInjectionOne Vial of 10 ml604GD606HydroxocobalaminInjection 1 mg/1mlOne Ampoule of 1 ml605GD607HydroxyureaCapsule 500 mgOne Capsule606GD608IronDrop 25mg/1mlOne Bottle of 50 ML Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09/ 2020 - 2021 / IGIMS / StorePage 67 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213607GD609Iron sucroseInjection 20 mg/mlOne Ampoule of 5 ml608GD610MethylcobalaminInjection 500mcgOne Ampoule of 1ml609GD611MethylcobalaminTablet 1500mgOne Tablet610GD612MethylcobalaminTablet 500mcgOne Tablet611GD613Mycophenolate sodiumTablet 180mgOne Tablet612GD614Mycophenolate sodiumTablet 360 mgOne Tablet613GD615Mycophenolate sodiumTablet 540mgOne Tablet614GD616Mycophenolic acidTablet 250 mgOne Tablet615GD617SevelamerTablet 400mgOne TabletImmunosuppressants616GD618AzathioprineTablet 50 mgOne Tablet617GD619CyclosporineInjection 250mgOne Vial of 5 ml618GD620CyclosporineCapsule 50 mgOne Capsule619GD621CyclosporineE/D 0.05%3 ml container620GD622Hepatitis B ImmunoglobulinInjection 100 IU/0.5MLOne Vial of 0.5ml621GD623Mycophenolate MofetilTablet 250mgOne Tablet622GD624Mycophenolate SodiumTablet 180mgOne Tablet623GD625Mycophenolate SodiumTablet 300mgOne Tablet624GD626Zoledronic AcidInjection 4mg/5 MLOne Vial of single DoseIntravenous Fluids andElectrolytes625GD627Amino Acid 10%Injection 500mlEach container of 500 ml626GD638Potassium chlorideInjection 150 mg/mlOne Vial of 10 ml627GD639Potassium chlorideOral liquid 500 mg/5 mlOne Bottle of 200 ml628GD640Potassium CitrateSyrup 500ml BottleOne Bottle of 500 ml629GD641Potassium PermanganateCrystal 200gmEach Piece of 200 gm630GD643Sodium bicarbonateInjection (as per IP)One Ampoule of 25 ML631GD644Sodium bicarbonateTablet 500mgOne TabletInjection100 mg of phospholipid/Surfactant (Bovine)pack632GD649One Vial of 5 mlInjection100 mg of phospholipid/Surfactant (Bovine)pack 4 ml633GD650One Vial of 4 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 68 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213Injection100 mg of phospholipid/Surfactant (Bovine)pack 5 ml634GD651One VialInj.Elemental Chromium - 4 mcg,Trace ElementCopper - 4 mg,Selenium - 20mcg,Manganese - 1 mg, Zinc635GD652Sulfate - 1 mg/ ml)One Vial of 10 ml636GD653Water for InjectionInjection 10 mlOne Vial of 10 mlLaxatives637GD654BisacodylSuppository 10 mgEach Piece638GD655GlycerineSuppository 1 gmEach Piece639GD656GlycerineSuppository 2 gmEach Piece640GD657LactuloseOral liquid 10 g/15 mlOne Bottle of 15 ml641GD658LactuloseSyrup 200ml BottleOne Bottle of 200 mlLocal Anaesthetics642GD659AtropineInjection 0.6 mg/mlOne Ampoule of 1 ml643GD660BupivacaineInjection 0.5%,One Vial of 20 ml644GD661BupivacaineInjection 0.25%,One Vial of 50ml645GD662BupivacaineInjection 0.5% with7.5% glucoseOne Ampoule of 4ml646GD663(Prilocaine (A) + Lidocaine (B) )Cream 2.5% (A) + 2.5% (B)One tube of 30 gm647GD664GlycopyrrolateInjection 0.2 mg/mlOne Vial of 1ml648GD665LignocaineTopical forms 2% gelOne tube of 30 gm649GD666LignocaineInjection 2%One Vial of 30ml650GD667LignocaineSpray 10%Each container of 50 ml651GD668LignocaineViscous gargle 4%Each container of 50 MLLignocaine (A) + Adrenaline (B)Injection 2% (A) + 1:200000 (5652GD669mcg/ml) (B)One Vial of 30ml653GD670MidazolamInjection 1 mg/ml,One Ampoule of 5ml654GD671MidazolamInjection 5 mg/mlOne Vial of 1 ml655GD672MidazolamTablet 7.5mgOne Tablet656GD673MidazolamTablet 15mgOne Tablet657GD674RopivacaineInjection 0.5%,One Vial of 30ml658GD675RopivacaineInjection 0.75%One Vial of 20 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 69 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213Medicines for Sleep Disorders659GD676AlprazolamTablet0.25MgOne Tablet660GD677AlprazolamTablet0.5MgOne Tablet661GD678ClonazepamTablet 0.5 mgOne Tablet662GD679ClonazepamTablet 1 mgOne TabletMuscle Relaxants663GD680AlfuzosinTablet10mgOne Tablet664GD681BaclofenTablet 10mgOne Tablet665GD682BaclofenOral solution 5mg/5mlOne Bottle of 300 ml666GD683BethanecholTablet 25MGOne Tablet667GD684EperisoneTablet50 mgOne Tablet668GD685MirabegronTablet 25 mgOne Tablet669GD686MirabegronTablet 50 MGOne Tablet670GD687NeostigmineTablet 15 MGOne Tablet671GD688NeostigmineInjection 0.5 mg/mlOne Ampoule of 1 ml672GD689OxybutyninTablet 5mgOne Tablet673GD690PapaverineInjection 30mg/mlOne Vial of 2ml674GD691PyridostigmineTablet 60MGOne Tablet675GD692PyridostigmineTablet 180MG SROne Tablet676GD693SilodosinTablet 4mgOne Tablet677GD694SilodosinTablet 8mgOne Tablet678GD695SilodosinTablet 4mgOne Tablet679GD696SilodosinTablet8mgOne Tablet680GD697SolifenacinTablet 5mgOne Tablet681GD698TadalafilTablet 5mgOne Tablet682GD699TadalafilTablet 10mgOne Tablet683GD700TadalafilTablet 20mgOne Tablet684GD701ThiocolchicosideTablet8mgOne Tablet685GD702ThiocolchicosideTablet 16mgOne Tablet686GD703Tizanidine HCLTablet2MGOne Tablet687GD704Tizanidine HCLTablet 4MGOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 70 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213688GD705TolperisoneTablet 50mgOne Tablet689GD706TolperisoneTablet 150mgOne Tablet690GD707TolperisoneTablet 100 mgOne TabletOpthalmic Preparations691GD7085% glucose in glycerineSolution 100mlOne Bottle of 100 ml692GD709AtropineDrops 1%Each container of 2 ml693GD710AtropineOintment 1%One tube of 3.5 gm694GD711BrimonidineE/D 0.2%Each container of 5 ML695GD713BromfenacE/D 0.09%Each container of 5mlCalcium chloride 0.048%W/V+Hydroxypropylmethylcellulose (HPMC) 2%W/V+Magnesium chloride 0.03Ointment%W/V+Potassium chloride 0.075%W/V+Sodium chloride 0.49%W/V+Sodium citrate 0.17696GD714%W/VOne tube of 30gm697GD715CarboxymethylcelluloseE/D 10 MLEach container of 10 ml698GD716CarboxymethylcelluloseE/D 0.5%Each container of 10 ml699GD717CarboxymethylcelluloseEye GelOne tube of 15 ml700GD718ChloramphenicolOintment 1%One tube of 4 gm701GD719Chloramphenicol + Polymyxin BOintmentOne tube of 5 gm702GD720CyclopentolateE/D 1%Each container of 15 ml703GD721CyclopentolateE/D 0.5%Each containerDifluprednate ophthalmicE/D 0.05%704GD722EmulsionEach container of 5 ml705GD723DorzolamideE/D 2%Each container of 10 ml706GD724D-PanthenolOintment 5%One tube of 5gm707GD725Ephedrine nasal drop1%Each container of 10 ml708GD726Ephedrine nasal drop0.50%Each container of 10 ml709GD727FluorometholoneE/D 0.1%Each container of 10 ml710GD728FlurbiprofenE/D 5mlEach container of 5 ML711GD729Gatifloxacin + LoteprednolE/D (0.3%+0.5%)Each container of 5 ML712GD730GatifloxacinE/D 0.5% As BaseEach container of 5 ML713GD731GatifloxacinE/D 0.30%Each container of 5 ML Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 71 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213714GD732Gentian Violet paintSolution 50mlEach container of 50 ml715GD733HomatropineDrops 2%Each container of 5 ML716GD734Hydroxypropyl methylcelluloseInjectionOne Ampoule of 5mlSolution/emulsion 100mlIcthammolGlycerine (10%)717GD735Each container of 100ml718GD736LatanoprostE/D 0.005%Each container of 2.5 ml719GD737LubricantE/D 1.0%W/VEach container of 15 ml720GD738MethylcelluloseOintment 2%One tube of 10 gm721GD739MethylcelluloseE/D 0.5%Each container of 10 ml722GD740Moxifloxacin + DexamethasoneE/D (0.5%+0.1%)Each container of 5 ML723GD741Moxifloxacin + LoteprednolE/D (0.5%+0.5%)Each container of 5 ML724GD742Moxifloxacin + PrednisoloneE/D (0.5%+1%)Each container of 5 ML725GD743Moxifloxacin +KetorolacE/D (0.5%+0.4%)Each container of 5 ML726GD744Moxifloxacin OphthalmicE/D 5mlEach container of 5 ML727GD745Moxifloxacin OphthalmicOintment 0.5%One tube of 5 gm728GD746NatamycinE/D 5%Each container of 5 MLNeomycin + Polymyxin BE/D 0.5% As Base729GD747+HydrocortisoneEach container of 10 ml730GD748NepafenacE/D 0.3%Each container of 3 ML731GD749OlopatadineE/D 0.1%Each container of 5 ML732GD750OlopatadineE/D 0.2%Each container of 3 ML733GD751OlopatadineE/D 0.1%Each container 10 ml734GD752Olopatadine + KetorolacE/D (0.1% +0.4%)Each container of 5 ML735GD753PhenylephrineDrops 5%Each container of 10 ml736GD754Phenylephrine HClInjection 10mgOne Vial of 1 ml737GD755PilocarpinE/D 2%Each container of 15 ml738GD756Polyethylene glycolE/D 0.40%W/VEach container of 10 ml739GD757Prednisolone AcetateE/D 1%Each container of 5 ML740GD758ProparacaineE/D 0.50%Each container of 15 ml741GD759RanibizumabInjection 10mg/mlOne Vial of single Dose742GD760RebamipideE/D 2%Each container of 10 ml743GD761SerratiopeptidaseTablet 10mgOne Tablet Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 72 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213744GD762Sodium chlorideE/D 5%Each container of 15 ml745GD763Sodium chlorideOintment 6%One tube of 3 gm746GD764TacrolimusE/D 0.003%Each container of 5 ml747GD765TacrolimusOintment 0.1%One tube of 10 gm748GD766Timolol maleate + BrimonidineE/D (0.5%+0.2%)Each container of 5 ml749GD767Timolol maleate + PilocarpineE/D (0.5%+2%)Each container of 5 ML750GD768Timolol maleate + TravoprostE/D (0.5%+0.004%)Each containere of 2.5 ml751GD769Timolol maleate +DorzolamideE/D (0.5%+2%)Each container of 10 ml752GD770Timolol maleate +LatanoprostE/D (0.5%+0.003%)Each container of 3 ml753GD771Tobramycin + FluorometholoneE/D (0.3%+0.1%)Each container of 5 ml754GD772TobramycinE/D 0.3%Each container of 5 ML755GD773TobramycinInjection 80mg/2mlOne Vial of 2 ml756GD774Tobramycin + DexamethasoneE/D (0.3%+0.1%)Each container of 5 ML757GD775TravoprostE/D 0.004%Each container of 2.5 ml758GD776TropicamideDrops 1%Each container of 15 mlTropicamide1 % &Drops759GD777Phenylephrine 2.5%Each container of 15 ml760GD778VoriconazoleE/D 1%Each container of 30 mgNasal Drops761GD779FluconazoleEar DropEach container of 5 MLFluticasone FumarateNasal SprayEach container of 120762GD780MID763GD781Intranasal DesmopressinNasal Spray 0.01%/SprayEach container of 5 MLMidazolamSpray nasal 1.25 MG/0.1 MLEach container of 25 TO764GD78250 MID765GD783Saline NasalNasal SprayEach container of 20 ml766GD784Saline NasalDrop 0.65%Each container of 10 ml767GD785Saline NasalNasal drops 0.9 %Each container of 10 ML768GD786XylometazolineNasal drops 0.05 %Each container of 10 ml769GD787XylometazolineNasal drops 0.1 %Each container of 10 mlNSAIDS/ Non-opioid analgesics770GD788AceclofenacTablet 200 mgOne TabletBuprenorphine (synthetic mixedInjection 2mg/ml771GD789opioid)One Vial of 100 ml772GD790DiclofenacInjection 25 mg/mlOne Vial of 3 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 73 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213773GD791DiclofenacSuppositories 12.5 mgEach Piece774GD792DiclofenacSuppositories 25 mgEach Piece775GD793DiclofenacGel 1%.One tube of 30 gm776GD794DiclofenacTablet 50 mgOne Tablet777GD795EtodolacTablet400 mgOne Tablet778GD796EtoricoxibTablet60mgOne Tablet779GD797EtoricoxibTablet90mgOne Tablet780GD798IbuprofenTablet 200 mgOne Tablet781GD799IbuprofenOral liquid 100 mg/5 mlOne Bottle of 500 ml782GD800IndomethacinTablet75 mgOne Tablet783GD801KetoprofenTablet75mgOne Tablet784GD802Ketorolacinjection 30 mg/mlOne Ampoule of 1 ml785GD803KetorolacTablet10 mgOne Tablet786GD804KetorolacE/D 0.40%Each container of 5 ml787GD805LornoxicamTablet8mgOne Tablet788GD806Mefenamic acidCapsule 500 mgOne Capsule789GD807Mefenamic acidTablet 250mgOne Tablet790GD808NaproxenTablet250 mgOne Tablet791GD809OxaceprolTablet200 mgOne Tablet792GD810ParacetamolTablet 500 mgOne Tablet793GD811ParacetamolTablet 650 mgOne Tablet794GD812ParacetamolOral liquid 250mg/mlOne Bottle of 60 ml795GD813ParacetamolDrop 100mg/mlOne Bottle of 30 ml796GD814ParacetamolInjection 1 gm/100mlEach container of 100 ml797GD815ParacetamolInjection 150 mg/mlOne Vial of 2 ml798GD816ParacetamolSuppositories 50 mgEach Piece799GD817ParacetamolSuppositories 250 mgEach Piece800GD818PiroxicamCapsule. 20 MGOne CapsuleRadiocontrast agents801GD833Barium sulphateOral liquid 100% w/vOne Bottle of 500 ml802GD834Barium sulphateOral liquid 250% w/vOne Bottle of 500 ml Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 74 of 85MRPUnit Price(up to 3GSTTotalSlinclusiveGSTCODEDescriptionStrengthBrand NameFormulation UnitPack Sizedecimal)AmountAmountTotal amount in WordsNo.of GST in%(Unit asin Rs.in Rs.Rs.per Col.-6)12345678910111213Dextranomer(A)+HyaluronicInjection (A)803GD835acid(B)50mg/ml+(B)15MG/ML ,1MLEach Piece of 1 ml804GD836IohexolInjection 350 mg iodine/mlOne Vial of 90 ml805GD837Meglumine DiatrizoateInjection 60% w/vOne Vial of 50 ML806GD838Methylene blueInjection 10mg/ mlOne Vial of 10 ml807GD839UrografinInjection 76%, 50mlOne Vial of 50mlVitamins and Minerals808GD841CalcitriolTable 0.25 mcgOne Tablet809GD842Alendronate SodiumTablet 70 mgOne Tablet810GD844CalciumCapsule 500 mgOne Capsule811GD845Calcium carbonateTablet 500 mgOne Tablet812GD846CholecalciferolOral liquid 400 IU/mlOne Bottle of 15 ml813GD848Coenzyme Q10Capsule 300mgOne CapsuleMethylcobalamine+Pyrodoxine814GD849Hydrochroide+nicotinamideInj.2ml/1500mcg+100mg+100mgOne Ampoule of 2ml815GD850Coral CalciumCapsule 1500mgOne Capsule816GD853PyridoxineTablet 10 mgOne Tablet817GD854PyridoxineTablet 50 mgOne Tablet818GD855PyridoxineInjection 50mgOne Ampoule of 1 ml819GD856UnivestineTablet. 500mgOne Tablet820GD857Vitamin A (Retinol Palmitate)Injection 50000 IU/mlOne Vial of 5 ml821GD858Vitamin A (Retinol Palmitate)Tablet(50000 IU)/ mlOne Tablet822GD859Vitamin A (Retinol Palmitate)Syrup 300000IU/5mlOne Bottle of 30 mlOral liquid 100000 IU/mlVitamin A (Retinol Palmitate)823GD860One Bottle of 100 ml824GD863Vitamin CCapsule 35mgOne Capsule825GD864Vitamin DDrop 400IU/mlEach container of 10 ml826GD865Vitamin DDrop 800IU/mlEach container of 15 ml827GD866Vitamin ESyrup 50IU/mlOne Bottle of 25 ml ***** Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 75 of 85 Section-X FORMATS FOR BIDDERS (TECHNICAL BID) Annexure-I Name of the Tender: Tender for Supply of Common Drugs to IGIMS, Patna on Rate Contract Basis for a period of two years from the date of Agreement extendable for one more year on mutually agreed Terms and Conditions. UNDERTAKING FOR COMPLIANCE OF ALL TERMS&CONDITIONS MENTIONED IN THIS TENDER DOCUMENT To, The Director, IGIMS, Patna, Sir/Madam, The undersigned certify that I/we have gone through the entire tender documents including terms and conditions mentioned in the tender document and undertake to comply with them. I have no objection for any of the content of the tender document and I undertake not to submit any complaint/representation against the tender document after submission date and time of the tender. The rates quoted by me/us are valid and binding on me/us for acceptance till the validity of tender. I/We undersigned hereby bind myself/ourselves Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) to supply the approved awarded items in the approved prices to IGIMS, Patna. The articles shall be of the best quality and of the kind as per the requirement of the institution. The decision of The Director, IGIMS, Patna, India (herein after called the said officer) as regard to the quality and kind of article shall be final and binding on me/us. I/we undertake to arrange for a demonstration of the Items, if required. Failure to arrange for a demonstration on the given date may lead to cancellation of the bid. Cost of such demonstration shall be borne by me/us. Performance security of Rs.3,00,000/- (proportionately be decided by IGIMS, PATNA) shall be deposited by me/us in the form of DD / Irrevocable Bank Guarantee in favour of Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) on award of the contract from a Nationalized/Commercial Bank and shall remain in the custody of the Director, IGIMS, Patna till the validity of the Contract period plus two month (i.e. for 14 months, extendable if required). If it is deemed necessary to change any article on being found of inferior quality, it shall be replaced by me/us free of cost in time to prevent inconvenience. I/We hereby undertake to supply the items during the validity of tender as per directions given in purchase order within stipulated period positively. If I/We fail to execute the contract after receipt of NOA within stipulated time or fail to supply the stores in stipulated period the IGIMS, Patna has full power to compound or forfeit the Bid Security/ Performance Security deposit. I/We declare that no legal/financial irregularities are pending against the proprietor Partner of the tendering firm or manufacturer. I/we undertake to supply the ordered items within stipulated period and if fail to supply during the stipulated period the necessary action can be taken by The Director, IGIMS, Patna, India. I/We undertake that if the rates of any items are lowered due to any reason, I will charge the lower rates. I/We undertake that the items supplied are as per Make /Catalogue/technical literature description. I/we do hereby confirm that the prices/rates quoted are fixed and are at par with the prices quoted by me/us to any other Govt. of India/Govt. Hospitals/Medical Institutions/PSUs. I/we also offer to supply the items at the prices and rates not exceeding those mentioned in the Financial Bid. I pledge and solemnly affirm that the information submitted in tender documents is true to the best of my knowledge and belief. I further pledge and solemnly affirm that nothing has been concealed by me and if anything adverse comes to the notice of purchaser during the validity of tender period, the Director, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) will have full authority to take appropriate action as he/she may deem fit. Signature and seal of the Manufacturer/Bidder  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09/ 2020 - 2021 / IGIMS / Store Page 76 of 85 ANNEXUREII Name of the Tender: Tender for Supply of Common Drugs to IGIMS, PATNA on Rate Contract Basis for a period of two years from the date of Agreement extendable for one more year on mutually agreed Terms and Conditions. UNDERTAKING (To be executed on 10/-Non-judicial Stamp Paper duly attested by Public Notary) I& & & & & & & & & & & & & & & & & & & & . S/o, D/o, W/o& & & & & & & ....& & & ............. Resident of.............................................................................................................................................. ................................................................................................................................................................ do solemnly pledge and affirm that, 1I am the Proprietor/Partner/Director/authorized signatory of M/s....................................................... No police case and/or case by CBI/FEMA/Income Tax/Sales Tax authorities are pending against the Proprietor/Partner/Director of the firm/company (Agency) and also against the firm/company. (Indicate any convictions if any against the above persons or Firm/Company). The Proprietor/Partner/Director of the firm/company (Agency) and also the firm/company has never been blacklisted/ debarred from any contract by any Government authority/organization. I/We have not quoted the price higher than previously supplied to any Government Institute/Organization/ PSU/reputed Private Organization or rate of Rate contract with Govt. procurement Agency in recent past. Name & Signature Seal of the participating Bidder Company Affirmation/Verification Notary Public  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 77 of 85 Annexure-III Name of the Tender: Tender for Supply of Common Drugs to IGIMS, Patna on Rate Contract Basis for a period of two years from the date of Agreement extendable for one more year on mutually agreed Terms and Conditions. MARKET STANDING FORMAT (To be submitted in PartI Technical Bid) (IN LETTER HEAD OF THE LICENSING AUTHORITY) PRODUCT MANUFACTURING CERTIFICATE MARKET STANDING (DRUG ITEMS) Tender Ref. No: THIS IS TO CERTIFY THAT THE FOLLOWING PRODUCTS ARE BEING MANUFACTURED AND MARKETED BY M/S________________________________________________________________________ ADDRESS__________________________________________________________________________________ _________________________________________________AS PER THE DETAILS MENTIONED BELOW: Name ofName of the OfficialManufacturing andManufacturingS/NItem CodeStrengthmarketing sincethe DrugCompendia (IP/BP/USP/EP)License Number(Month/year)123(ATTACH SEPARATE SHEETS IF THE QUOTED ITEMS ARE MORE IN NUMBERS) Signature and seal of the Manufacturer/Bidder NAME: DESIGNATION OF LICENSING AUTHORITY: SEAL DATE: NOTE: THE BIDDERS MAY FURNISH THE MARKET STANDING CERTIFICATE AS PER THE FORMAT OF THE CONCERNED DRUG LICENSING AUTHORITY, IF IT IS NOT POSSIBLE TO PROVIDE THE MARKET STANDING IN THE ABOVE FORMAT.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 78 of 85 Annexure-IV Name of the Tender: Tender for Supply of Common Drugs to IGIMS, Patna on Rate Contract Basis for a period of two years from the date of Agreement extendable for one more year on mutually agreed Terms and Conditions. Deviation Statement Form The following are the particulars of deviations from the requirements of the tender Specifications.  Sr.NoItem CodeDescriptionSpecification asDeviationsRemarksper Tender(including Justification) Place: Date: Signature and seal of the Manufacturer/Bidder Note: Where there is no deviation, the statement should be returned duly signed with an endorsement indicating No deviations  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 79 of 85 AnnexureV Name of the Tender: Tender for Supply of Common Drugs to IGIMS, Patna on Rate Contract Basis for a period of two years from the date of Agreement extendable for one more year on mutually agreed Terms and Conditions. Performance Statement Form Name of the Firm............................................... Order placed byValueHave the itemsSl No(Full addressOrder No. & dateBeen suppliedof orderof Purchaser)satisfactorily (Yes/No) Signature Seal of the Firm/organization Place: Date: Note: Documents to be attached in support of the above.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 80 of 85 Annexure-VI Name of the Tender: Tender for Supply of Common Drugs to IGIMS, Patna on Rate Contract Basis for a period of two years from the date of Agreement extendable for one more year on mutually agreed Terms and Conditions. ANNUAL TURN OVER STATEMENT (In the letterhead of the Chartered Accountant) The Annual Turnover for the last three financial years of M/S__________________________________________ who is a manufacturer and bidder for I.V. Fluids as per audited Financial Statements are given below and certified that the statement is true and correct to the best of our knowledge and belief.  Sl.No. Financial Year Turnover in Crores (Rs) both in figures & words 2016-2017 2017-2018 2018-2019 Date: Place: Signature of Auditor/Chartered Account: (Name in Capital): Seal Membership No: N.B: This turnover statement should also be supported by copies of audited annual statement of the last three financial years/Annual Report and the turnover figures mentioned above should be highlighted there.  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 81 of 85 ANNEXURE-VII Name of the Tender: Tender for Supply of Common Drugs to IGIMS, Patna on Rate Contract Basis for a period of two years from the date of Agreement extendable for one more year on mutually agreed Terms and Conditions. DECLARATION FOR MANUFACTURING ITEMS AND PRODUCTION CAPACITY AS PER GMP/WHO GMP/COPP (FOR DRUG ITEMS) (To be submitted in PartI Technical Bid) 01. Name and Address of the Firm: 02. Name of Proprietor/Partner/Director: Name, Designation and address of Person responsible to the company under Section 34 of D and C Act 1940: GMP Certificate as per Revised Schedule M/COPP/WHO GMP: Testing Facilities (List of Equipment to be furnished Separately in the format to meet the bench mark vide Annexure/own facility/name of approved institutions carrying out testing of drugs on behalf of the firm Chemical Method:Yes/NoInstrumental:Yes/No(Type of Instrument Provided as indicated in Annexure)Biological:Yes/NoMicro Biological:Yes/NoAnimal Testing:Yes/No (C)Production Capacity (Section Wise) in detail based on the quoted items. Signature and Seal of Proprietor/Partner/Director To be attested by the Notary/Gazetted Officer/Licensing Authority  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 82 of 85 ANNEXURE-VIII Model Bank Guarantee Format for Bid Security (EMD) (To be executed on Non-Judicial Stamp paper of Rs. ) Guarantee No.. Amount of Guarantee Rs.. Guarantee cover from Dated : To Dated: . Last Date for Lodgment of claim: .. Whereas M/s ............................................................................. (herein after called the Bidder) has submitted their offer/ bid for the supply of I.V. Fluids (herein after called the tender) against the purchasers tender enquiry No............ KNOW ALL MEN by these presents that we..............................................................(Bank), a body corporate constituted under the Banking Companies (Acquisition & Transfer of Undertakings) Act, 1970 having its Registered Office/ Head Office at .................................................. are bound unto Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) (herein after called the Purchaser) in the sum of Rs.3,00,000/-(Rupees Three Lac only) for which payment will and truly to be made to the said purchaser. THE CONDITION OF THIS OBLIGATION ARE: If the Bidder withdraws or amends, impairs or derogates from the tender in any respect within the period of validity of this tender. If the Bidder having been notified of the acceptance of his tender by the purchaser during the period of its validity: - If the Bidder fails to furnish the performance security for the due performance of the contract. Fails or refuses to accept/execute the contract. We undertake to pay the purchaser up to the above amount upon receipt of its first written demand, without the purchaser having to substantiate its demand, provided that in its demand the purchaser will note that the amount claimed by it is due to it owing to the occurrence of one or both of two conditions, specifying the occurred condition or conditions. This guarantee shall be valid until the _____/_____/ 2020. We the ......................................................(Bank).........................................(Branch) undertake not to revoke the guarantee during its currency except with the previous consent of the Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) in writing. We the ......................................................(Bank).........................................(Branch). further agree that a mere demand by Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar), is sufficient for us........................................Branch at Patna to pay the amount covered by the Bank Guarantee without reference to the Agency and protest by said Agency cannot be a valid ground for us.............................................. Branch to decline payment to Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar). (Signature of the authorized officer of the Bank) Name and designation of the officer with seal Common Seal of the Bank is affixed this................day of................20........... Seal with name & address of the Banks and address of the Branch  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / Store Page 83 of 85 ANNEXURE-IX (To be submitted on bidders Letter head in Technical Bid) Details of BidderGENERAL INFORMATION ABOUT THE BIDDERName of the BidderRegistered addressOfthe FirmStateDistrictTelephone No.E-mail IDWebsiteTwo Contact Persons DetailsNameDesignationTelephone No.Mobile No.NameDesignationTelephone No.Mobile No.Communication addressAddressStateDistrictTelephone No.EmailWebsiteTwo Contact Persons Details for Authorized stockiest/dealer only for the purpose of supplyNameDesignationTelephone No.Mobile No.NameDesignationTelephone No.Mobile No.Type of the Firm (please tick ')Private Ltd.Public Ltd.ProprietorshipPartnershipSocietyOthers, SpecifyRegistration No. & Date of RegNature of BusinessManufacturerDirect ImporterName designation and address of the person(s) responsible to the Company as per Sec.34 of D & C Act 1940NameDesignationWhether the Owner/Proprietor/Chairman/CEO/Director/Managing Partner has beenconvicted of an offence for supplying NSQ/ Spurious/Adulterated/Misbranded items by anyYes/Nocompetent court of law within the last 3 years from the date of floating of the tender. Other relevant Information to be furnished in a separate sheet:- If the bidder is blacklisted/banned/de-recognized for supplying drugs/items within the last 3 years from the date of floating of the tender by authorities. Bank Details of the Bidder: The bidders have to furnish the Bank Details as mentioned below for return of EMD /Payment for supply if any (if selected) a. Name of the Bank : b. Full address of the Branch concerned : c. Account no. of the bidder : d. IFS Code of the Bank :  Signature and seal of the Firm/organization Place: Date:  Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: 09 / 2020 - 2021 / IGIMS / StorePage 84 of 85DETAILS OF LICENSESANNEXURE-XFor Indigenous Items (Minimum one row entry required) DETAILS OF LICENSES FOR QUOTED ITEMS S.No.ItemDrug LicenceGMPGLPNo ConvictionProprietaryNew ItemCode.CertificateCertificateSiteNumberValidPageValidPageValidPageDate ofPageNumberDate ofNumberDate ofup toNo.Up toNo.Up toNo.IssueNo.issueissue For Imported Items (Minimum one row entry required)  DETAILS OF LICENSES FOR QUOTED ITEMS ItemProprietaryNew ItemS.No.Code.Import License Form-10COPPForm-20B/21BForm-41No ConvictionCertificateCertificateDateDateDateValidPageCountryValidPageValidPageValidPageofPageofofNumberuptoNo.of OriginUptoNo.Numberup toNo.Numberup toNo.IssueNo.NumberissueNumberissue Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) Tender Notice No.: / 2020 - 2021 / IGIMS / Store Page 85 of 85 Annexure -XI Form of Performance Guarantee / Bank Guarantee bond In consideration of the Director of Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna - 800 014 (Bihar) (Hereinafter called IGIMS, PATNA) having offered to accept the terms and conditions of the proposed agreement between IGIMS, PATNA and ..................... (hereinafter called the said Vendor(s)) for the supply, installation & Commissioning of (Hereinafter called the said agreement) having agreed to Production of an irrevocable Bank Guarantee for Rs. . (Rupees only) as a bid Security/performance guarantee from the vendor(s) for compliance of his obligations in accordance with the terms And conditions in the said agreement with reference to tender No...................... We. (hereinafter referred to as the Bank) hereby undertake to pay to the IGIMS, PATNA an amount not exceeding Rs. .. (Rupees. Only) on demand by the IGIMS, PATNA. 2. We, .(indicate the name of the Bank) do hereby undertake to pay the amounts due and payable Under this guarantee without any demure, merely on a demand from the IGIMS, PATNA stating that the amount claimed as required to meet the recoveries due or likely to be due from the said vendor(s). Any such demand made on the bank shall be conclusive as regards the amount due and payable by the bank under this Guarantee. However, our liability under this guarantee shall be restricted to an amount not exceeding Rs. (Rupees .only) 3. We, the said bank further undertake to pay the IGIMS, PATNA any money so demanded notwithstanding any dispute or disputes raised by the vendor(s) in any suit or proceeding pending before any court or Tribunal relating thereto, our liability under this present being absolute and unequivocal. The payment so made by us under this bond shall be a valid discharge of our liability for payment there under and the vendor(s) shall have no claim against us for making such payment. 4. We, . (Indicate the name of the Bank) further agree that the guarantee herein contained shall remain in full force and effect during the period that would be taken for the performance of the said agreement and that it shall continue to be enforceable till all the dues of the IGIMS, PATNA under or by virtue of the said agreement have been fully paid and its claims satisfied or discharged or till Director IGIMS, PATNA on behalf of the Government certified that the terms and conditions of the said agreement have been fully and properly carried out by the said Vendor(s) and accordingly discharges this guarantee. 5. We, . (Indicate the name of the Bank) further agree with the IGIMS, PATNA that the Institute shall have the fullest liberty without our consent and without affecting in any manner our obligation hereunder to vary any of the terms and conditions of the said agreement or to extend time of performance by the said Vendor(s) from time to time or to postpone for any time or from time to time any of the powers exercisable by the Government against the said vendor(s) and to forbear or enforce any of the terms and conditions relating to the said agreement and we shall not be relieved from our liability by reason of any such variation, or extension being granted to the said Vendor(s) or for any forbearance, act of omission on the part of the IGIMS, PATNA or any indulgence by the IGIMS, PATNA to the said Vendor(s) or by any such matter or thing whatsoever which under the law relating to sureties would, but for this provision, have effect of so relieving us. 6. This guarantee will not be discharged due to !OPRSWXYZ\sͿyjXG3&h| hh>mS5>*CJ OJPJQJaJ h5>*CJ OJPJQJaJ #hm`h>mS5CJOJPJQJaJhm`hm`B*CJaJph$hUB*CJaJph$8jh| hh>mS56B*CJOJPJQJUaJph h| hh>mSCJOJPJQJaJhTCJOJPJQJjhTUmHnHuh>mSCJOJPJQJh>mSB*CJph$h^B*CJph$h9B*CJph$jh>mSUPQRTUVWXZ[\$d]a$gdE~Dd $d]a$dv $da$gdl $d8a$gdTdddgd^d8d "ld^l  i j k l q y | } ~ μμέμΏ΃vic]GCh*jhCJOJPJQJUmHnHu hCJ hCJh5CJOJPJQJhE~D5CJOJPJQJh>mSCJOJPJQJh%(5CJOJPJQJaJhE5CJOJPJQJaJhl4t5CJOJPJQJaJ#hE~DhE~D5CJOJPJQJaJ#hE~Dh>mS5CJOJPJQJaJhE~D5CJOJPJQJaJ h| hh>mSCJ OJPJQJaJ k l m n o p q r s t u v w x y z { | }  gd$a$gdgd $d]a$ $da$gdE~D$d]a$gdE~D   8 9 F G Q R y z     e ǺǤǺǤǺǤǺǤؗygU"hm`5B*CJOJPJQJphz"hT5B*CJOJPJQJphz"jhT5CJOJPJQJUh>mSCJOJPJQJh>mS5CJOJPJQJ*hh0J5CJOJQJ\^JaJhhOJQJ^J!jhhOJQJU^J&hh5CJOJQJ\^JaJ&hh5CJOJQJ\^JaJ I    f g h pd$If^p (d$If^( d$Ifd$d^a$gdT$d^a$gdT$d]a$gd$a$gd $ a$gd e f g h | ~  ɿɵߜߏߏ߃wgWK?hUCJOJPJQJhUCJOJPJQJhE~DhU5CJOJPJQJhE~DhU5CJOJPJQJhUCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mS5CJOJPJQJh>mSB*CJRHaph$h>mSB*CJph$h.B*CJph$hm`B*CJph$h>mSCJOJPJQJh>mSCJOJPJQJ(hTh>mS5B*CJOJPJQJphz d$Ifqkd$$IfF & &    4apytE~D F===== d$Ifkd$$Ifֈ P %& D&4ap<ytE~D %kd$$Ify֞ P %& D &4apFytE~D d$If @d$If^@ d$If^ d$If dd$If^d ^UUUUU d$Ifkdߒ$$Iftr P %& D&4ap2ytE~D ^QB$d$Ifa$gdE~D xd$If^xkd$$Ifr P %& D&4ap2ytE~D   d$IfYkd$$Ifo0 % "&4apytE~D    ! $ vi\E5$od$If^oa$$xd$If]^xa$gdE~D d$If^ xd$If^xkd$$If\ P % D&4ap(ytE~D  ! $ & , 6 7 R X Z ` j k   * 0 2 8 B C ¨訚xhE~DCJOJPJQJhE~DCJ OJPJQJhE~DOJPJQJhE~DCJOJPJQJRHahE~DCJOJPJQJh>mSCJOJPJQJRHah>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJRHch.CJOJPJQJh>mSCJOJPJQJ/$ % & ' ( ) * + UB$d$If]a$gdE~Dkd$$Ifor P %& D&4ap2ytE~D d$If+ , . ; R ^QD-$xd$If]^xa$gdE~D d$If^ xd$If^xkd$$Ifr P %& D&4ap2ytE~DR X Y Z [ \ Ekd$$Ifor P %& D&4ap2ytE~D d$If$od$If^oa$\ ] ^ _ ` b B5 xd$If^xkd$$Ifr P %& D&4ap2ytE~D d$If$d$If]a$gdE~Db p d$If$od$If^oa$$xd$If]^xa$gdE~D d$If^ ^UUBUU$d$If]a$gdE~D d$Ifkd$$Ifor P %& D&4ap2ytE~D ^QD-$xd$If]^xa$gdE~D d$If^ xd$If^xkd$$Ifr P %& D&4ap2ytE~D Ekd$$Ifor P %& D&4ap2ytE~D d$If$od$If^oa$ B5 xd$If^xkd$$Ifr P %& D&4ap2ytE~D d$If$d$If]a$gdE~D d$If$od$If^oa$$xd$If]^xa$gdE~D d$If^ ^UUBUU$d$If]a$gdE~D d$Ifkd$$Ifor P %& D&4ap2ytE~D * ^QD-$xd$If]^xa$gdE~D d$If^ xd$If^xkd$$Ifr P %& D&4ap2ytE~D* 0 1 2 3 4 Ekd$$Ifor P %& D&4ap2ytE~D d$If$od$If^oa$4 5 6 7 8 : B5 xd$If^xkd$$Ifr P %& D&4ap2ytE~D d$If$d$If]a$gdE~D: H d$If$od$If^oa$$xd$If]^xa$gdE~D d$If^ \SS<SS$xd$If]^xa$gdE~D d$Ifkd$$If4r P %&` `D``&4ap2ytE~D \SS@SS$d$If]a$gdE~D d$Ifkd֣$$If4r P %&   D  &4ap2ytE~D \OB+$xd$If]^xa$gdE~D d$If^ xd$If^xkd$$If4r P %& D &4ap2ytE~D Ekd$$Ifsr P %& D&4ap2ytE~D d$If$od$If^oa$ #$;ACEcflntx¸ܬn\J"h,$5B*CJOJPJQJphz"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjhTCJOJPJQJUhR[OJPJQJ"h>mS5B*CJOJPJQJphh>mSCJ OJPJQJh>mSOJPJQJh>mSCJOJPJQJRHah.CJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ B5 xd$If^xkd$$Ifr P %& D&4ap2ytE~D d$If$d$If]a$gdE~D  d$If$od$If^oa$$xd$If]^xa$gdE~D d$If^^UUBUU$d$If]a$gdE~D d$Ifkd$$Ifor P %& D&4ap2ytE~D';^QD-$xd$If]^xa$gdE~D d$If^ xd$If^xkd $$Ifr P %& D&4ap2ytE~D;ABCDECkd $$If4r P %&` `D`&4ap2ytE~D d$If$od$If^oa$Ecdefgh<kd#$$If4r P %&   D` &4ap2ytE~D d$If$xd$If]^xa$gdE~DhijklmntuSF d$If^kd>$$If4r P %& D &4ap2ytE~D d$Ifuvwxyz=88dkdJ$$If$ֈ P %& D  &4ap<ytE~D d$Ifz{|}~d8234>?OPgh$Xdx]Xa$gd0 xd^xgd0dgd0dgd0$(d](a$gd0dd "d^gdTd^$d^a$gdTdd8$%24>?OPSTgȾȾzlzYE'hO)h05>*B*OJQJ^Jph$hO)h05B*OJQJ^Jphh0B*OJQJ^Jph!h^h0B*OJQJ^Jph!h05>*B*OJQJ^Jphh0OJQJh05CJOJPJQJh05CJOJPJQJh0OJPJQJh05>*CJOJPJQJh>mSB*CJph$h>mSOJPJQJh.B*CJph$hm`B*CJph$h?@AxkdR$$Ifl\lLV%FF FhF  t$6Balyt0$$7$8$H$If^a$gd0$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[$dx]a$gd0?@BCDefijlqxy{|}ܷܓpܷhh^Rjh00J5Uh;@h00J5jh0U$hpyh05B*OJQJ^Jphh05B*OJQJ^JphhA5B*OJQJ^Jph'hO)h05>*B*OJQJ^Jph$hO)h05B*OJQJ^Jphh0B*OJQJ^Jphh0!h^h0B*OJQJ^Jph$h^h05B*OJQJ^Jph@ADEfgijx$$7$8$H$Ifa$gdA$$7$8$H$If`a$gd[$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[xyz}~E}}llccWW $$Ifa$gd[ $Ifgd[$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[skd$$Ifl\lLV% h  t$6alyt0 DEFHIJ`npstu ¯œxjxWMEEjh0Uh0OJQJ^J$h^h05B*OJQJ^JphhO)h05OJQJ^J$hO)h05B*OJQJ^Jphh0h^h0OJQJ^J$hpyh05B*OJQJ^Jph$hch05B*OJQJ^JphhA5B*OJQJ^Jphh0B*OJQJ^Jph!h^h0B*OJQJ^Jphh^h05OJQJ^JEFGJKpqst}}ll}}lWW$$7$8$H$If`a$gd[$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[skd$$Ifl\lLV% h  t$6alyt0 +156abxyz²܀|n[[[S|SIh;@h00J5jh0U$hO)h05B*OJQJ^Jphh0B*OJQJ^Jphh0!h^h0B*OJQJ^Jphh^h05OJQJ^J$hpyh05B*OJQJ^Jphh05B*OJQJ^JphhA5B*OJQJ^Jphh0OJQJ^Jh^h0OJQJ^Jjh00J5Uh^h00J5{}}l}S$$7$8$H$If^`a$gd0$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[skd-$$Ifl\lLV% h  t$6alyt0z{}<?DEFGVWXYefijqxyʺtf[f[f[f[fچth05OJQJ^JhO)h05OJQJ^Jh0B*OJQJ^Jphh0!h^h0B*OJQJ^Jphh05B*OJQJ^Jph$hpyh05B*OJQJ^JphhA5B*OJQJ^Jphh+5B*OJQJ^Jph$h^h05B*OJQJ^Jph$hO)h05B*OJQJ^Jph#fgijzziizzii$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[vkdȰ$$Ifl\lLV%FF FhF  t$6Balyt0 WXZ[}}ll}}Z$7$8$H$If`gd[$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[skdi$$Ifl\lLV% h  t$6alyt0=>TUVWZ^_ÿõۖÿÌ|iVHh0B*OJQJ^Jph%h^h0B*CJOJQJaJph$hpyh05B*OJQJ^JphhA5B*OJQJ^Jphh^h00J5$h^h05B*OJQJ^Jphjh00J5Uh;@h00J5h0jh0Uh05B*OJQJ^Jph$hO)h05B*OJQJ^Jph!h^h0B*OJQJ^Jph[faSSB$$7$8$H$Ifa$gd[ $7$8$H$Ifgd[gd0skd$$Ifl\lLV% h  t$6alyt07d$7$8$H$If^7gd[ $7$8$H$Ifgd0Jnkd$$Ifl\lLV% h  t$6alyt[$$7$8$H$If`a$gd[$7$8$H$If`gd[ $7$8$H$Ifgd[$$7$8$H$Ifa$gd[#'4?BCIJZ]^GHJLɻɻɻɻɻɯyrbJ/h~]h0>*CJOJQJaJmH nH sH tH h>1h05OJQJ\^J h/n8h0h!h05CJOJQJaJh>1h05CJOJQJaJjh00J5Uh^h00J5h0jh0Uh0B*OJQJ^Jph!h^h0B*OJQJ^Jph$h^h05B*OJQJ^Jph$hO)h05B*OJQJ^Jph5G $$Ifa$gd[ 7$8$H$gd0 GH%kd0$$Ifl֞,:NJ#'F7FSFFTFFn t0*BBayt0HJL,-DQR $$Ifa$gd[$=r$7$8$H$If^=`ra$gd[$X$If]^Xa$gd0$r$If]r^a$gd[$""$7$8$H$If]"^"a$gd[ LCRSZ[\ ˾˷{q{q{g{VF9h05OJQJ\^JhbMh05OJQJ\^J!hbMh05>*OJQJ\^Jh,$OJPJQJh.B*CJph$h,$B*CJph$"h05B*CJOJPJQJphz)jh0OJQJU\^JmHnHuh0OJQJ\^J h/n8h0h05CJOJQJaJh l h05CJOJQJaJ&h l h05CJOJQJ\^JaJh l h05CJOJQJaJRSX%$<7$8$H$]<a$gd0kdM$$Ifl֞,:NJ#'F7FSFFTFFn t0*BBayt0XYZ\ tuTU$Z7$8$H$^Z`a$gd0 $7$8$H$a$gd0$Zr7$8$H$^Z`ra$gd0 $0^0a$gd0 P#4d^4gd,$$Hd^Ha$gd0$<7$8$H$]<a$gd0 3tu"*./Z[qrUVRSTUZ]^ޭyobh/n8h.OJQJ^Jh0OJQJ^Jh05OJQJ\^Jh/n8h05OJQJ\^Jh/n8h0OJQJ^Jjh00JUh/n8h00Jh/n8h0OJQJ\^Jjh00JU\h;@h00J\h0jh0Uh0OJQJ\^Jh>1h0OJQJ\^J"^g ! " 7 9 Y Z g i ۹}kaWaMh>mSB*CJph$h.B*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"h05B*CJOJPJQJphzh0CJOJPJQJh0B*CJph$h>mSOJPJQJhOJPJQJhR[OJPJQJ/jjhWhW5OJQJU^JmHnHuh/n8h05OJQJ^Jh/n8h0OJQJ^Jh.OJQJ^JU P#4d^4d8gd0$a$gd0$ U"^`a$gd0$a$gdW 7$8$H$^gd0 d$Ifgd[ $Ifgd[ P#4d^4   ! " g h "d^dgd,$d8$ P#4d^4a$gd0 P#4d^4 P#Zd^Zgd0Ff d$Ifgd[h i t u ;"<"F$G$r's'((w$ QdI]^`Qa$d$hdf]^h`a$d$hde]^h`a$d$hdd]^h`a$d $d]a$$d]a$gdL%od i s t u 9";"<"Q"""F$G$K$T$U$V$$$%%&&r's'v'w'z'''''''''( ( ( ( ( (((ƺƭƭƭƠ|pp|p|p|p|h.CJOJPJQJhl4tCJOJPJQJhL%oCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mS5CJOJPJQJh>mSCJOJPJQJh>mSOJPJQJhW5>*CJOJPJQJ"hL%oh>mS5>*CJOJPJQJh>mS5>*CJOJPJQJ,(((((((l(x(z({(|(}(~((((((((((((((((((((((((((((((((H*I*s*t*|*}*~******ܱܥܛh0LCJOJPJQJh>mSOJPJQJhQ6oCJOJPJQJh>mS5CJOJPJQJhL%ohQ6oCJOJPJQJhL%oh>mSCJOJPJQJh>mSCJOJPJQJhl4tCJOJPJQJh.CJOJPJQJ8((***,,,,,,,--a-b-c-/$>d:]^`>a$gd0 d:]gdL%o "d^Hd^H$Hd^Ha$gdR[dd8dd$de]^a$********$+(++,,,,,--3-5-S-T-a-b-c-g-ީޗ{q{gZMhQ6o5CJOJPJQJhL%o5CJOJPJQJh>mSB*CJph$h.B*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjhR[CJOJPJQJUh>mS6CJOJPJQJhL%oCJOJPJQJhl4tCJOJPJQJh>mSOJPJQJh.CJOJPJQJh>mSCJOJPJQJg-j-w----.=.>.G.H.s.t......//~l\L\:"hsMB*CJOJPJQJ\phh1B*CJOJPJQJphh>mSB*CJOJPJQJph"h0>*B*CJOJPJQJph hllQh00JCJOJPJQJ(jh0B*CJOJPJQJUphh0B*CJOJPJQJphh0CJOJPJQJhL%oCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJhQ6o5CJOJPJQJh05CJOJPJQJ//// /"/#/7/n///D0L0M0x0y00yhVAA-'hsMh00J5CJOJQJ^JaJ)jhsMh0CJOJQJU^JaJ#hsMh05CJOJQJ^JaJ hsMh+CJOJQJ^JaJh^CJOJQJ^JaJ hsMh0CJOJQJ^JaJ'hsMh+5CJOJPJQJ^JaJ'hsMh05CJOJPJQJ^JaJ'hsMh>mS5CJOJPJQJ^JaJh>mS5CJOJPJQJh>mSOJPJQJ(hsMh>mSB*CJOJPJQJ\ph///00022e3f333z$_K]_^`Ka$gd*{d^d dd$ Qd[]^`Qa$d$QdT]^`Qa$gd0$ud87$8$H$^u`a$gd.d d8 00000000000000 1 1 1!1%121q1r122z22«֏vjv[v[NBNBBhl4tCJOJPJQJh>mS5CJOJPJQJh>mS5>*CJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSCJOJPJQJh>mSOJPJQJ#hsMh05CJOJQJ^JaJ,hsMh05B*CJOJQJ^JaJph&h15B*CJOJQJ^JaJph hsMh0CJOJQJ^JaJ0jhsMh00J5CJOJQJU^JaJ2222222 3e3f33334444444444455(5ޘގބtbPFhm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjhL%oCJOJPJQJUhR[OJPJQJhL%oOJPJQJh+OJPJQJh/n8h*{5OJQJ^Jh*{OJPJQJ,jhWhWOJPJQJUmHnHuh>mS5CJOJPJQJh>mSOJPJQJhCeCJOJPJQJh>mSCJOJPJQJ33444444444444444444444d $d]a$d d8 $]a$gd*{$ U"]^`a$gd*{44444444455V5W5X5d5e555{7$ wdZ]^`wa$dd $d]a$d "d^Hd^H$Hd^Ha$gdR[dd8(5*5H5I5V5X5d5e555555555555666)6*616h6|6~6ᮡwweVeGhsM5>*CJOJPJQJhCe5>*CJOJPJQJ"hCehCe5>*CJOJPJQJhl4t5>*CJOJPJQJh>mS5>*CJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mS5CJOJPJQJh>mS5CJOJPJQJh>mS5>*CJOJPJQJh>mSB*CJph$h>mSOJPJQJhm`B*CJph$hsMB*CJph$~6666666697:7y7{7|77777 88+8-8888888888889979²¢’†|oococccWW҆hWCJOJPJQJh=dCJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh=dhQ6o5CJOJPJQJh=dhCe5CJOJPJQJh=dhl4t5CJOJPJQJh=dh>mS5CJOJPJQJh>mS5CJOJPJQJh>mS5>*CJOJPJQJ"hCehCe5>*CJOJPJQJ"{7|77777,8-88899zg$d^`a$gdW$ & F d^]^`a$gdW$d}^`a$gdW$d^`a$gdW$d^`a$gdW$d^`a$gdW$ & Fd^`a$gdWd 7989g9i99999999):*:,:<:=:>:@:A:X;Z;[;c;;;;;0<1<<<<<<<<O=P=U=V=====>>÷誠à誠sss۠۠h>mS5CJOJPJQJh>mS56>*CJOJPJQJh>mS56>*CJOJPJQJh>mSOJPJQJh>mS5CJOJPJQJh=dCJOJPJQJh>mSCJOJPJQJhWCJOJPJQJh>mS5CJOJPJQJh>mSCJOJPJQJhQ6oCJOJPJQJ-9h9i999=:>:Z;[;|eR$d^`a$gdW$dW]^`a$gdW$d^`a$gdW$ & FdQ]^`a$gdW$d|^`a$gdW$ & Fd^`a$gdW$d^`a$gdW$ & Fd^]^`a$gdW[;;;<<O=P===>>s>pd dgdW rd^]^`rgdW d}gdW ldgdW dgdW Kd<]^`KgdWdd^]^`d$ & F pdR]^`a$gdW >">#>s>t>y>z>>>>>>>D?F?Z?\?z?{????????@@@ AAAAAAArBsByBBȸ覔vihL%oh>mSB*CJph$h>mSB*CJph$hsMB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjhL%oCJOJPJQJUhR[OJPJQJhL%oOJPJQJh>mSCJOJPJQJh>mSOJPJQJh>mS5CJOJPJQJ's>t>>>>>>>>>>E?F?????d "d^gdL%oHd^H$Hd^Ha$gdL%odd8d kd[]^`kgdW d{gdW?@@ A AAArBsByBzB{B~ymhhd $d]a$d$ v{d^]^`{a$gdW vdgdW$ v{d[]^`{a$gdW vd{gdW vdgdW vdgdW$ v{dc]^`{a$gdW {B|B}B~BBBBBBBBBBBBBBBBBBBBBBBBBBBd8BBBBBBBBBBBBBBBBBBBBBBBBBC$Hd^Ha$gdR[d8gdR[d8BBBCCCC7C8CECGCRCSChCiClCmCDDDDEEEE#F$F'F(FFFFFFFGG"G#Gzmzmzmzazazazmh=dCJOJPJQJh>mS5CJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mS5>*CJOJPJQJh>mSB*CJph$hsMB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJ"jhR[5CJOJPJQJU&CCECFCGCRCSChCiCDDEE#Fw$ l{d^]^`{a$d$ l{dd]^`{a$d$ cde]^`ca$dqd $d]a$dd8 "d^Hd^H #F$FGGHHJJ&L'LMMSNn$ l{db]^`{a$$ l{dc]^`{a$d$ l{de]^`{a$dd$ l{dd]^`{a$d$ l{da]^`{a$d #G@GAGBGCGXGYGZG[G_G`GGGHHHHoIpIqIrIIIIIIIIIIIIIIIIIIIIIJJJJJ@JAJJJJJ^KdKKK&L'L*L+LMMMŸŸŸŸh.CJOJPJQJh>mS5>*CJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJh>mS6CJOJPJQJh0LCJOJPJQJh=dCJOJPJQJh>mSCJOJPJQJ>MM5MTMUM}M~MSNTNXNYNNNNNOOOOOO1P9P=P?PCPDPEPPPPݶݪݪr`Vhm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzhR[OJPJQJjhR[CJOJPJQJUhQ6oCJOJPJQJhl4tCJOJPJQJhsMCJOJPJQJh0LCJOJPJQJh>mS5>*CJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJSNTN?P@PAPBPCPEPPPPPPSST$ l{dc]^`{a$d$ l{df]^`{a$d "d^Hd^Hdd8d$ l{de]^`{a$dPPPPPPPPSSSSTTTTUUUUVVVV%W&W*W+WWWWWYXZX^X_X`XXXXXXX&Y(Y8Y:Y;YmS6CJOJPJQJh>mS6CJOJPJQJh>mS5>*CJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSB*CJph$h>mSOJPJQJhm`B*CJph$hsMB*CJph$5TTUUVV%W&WWWYXZXXn$ l{dT]^`{a$d$ l{d[]^`{a$d$ l{d^]^`{a$d$ l{d[]^`{a$d$ l{dc]^`{a$d XX&Y'Y(Y:Y;Y[[\\\\\\\\\ \ \ \dwd`d^`d$dZ]^`a$dddd8 ldd[[[\ \ \ \\\^\r\t\\\\\\\\\\\\\\]] ] ]IJssfYGG"h>mS5B*CJOJPJQJphh>mS5CJOJPJQJh>mS5CJOJPJQJh>mS5>*CJOJPJQJh>mSB*CJph$hCfB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzhR[OJPJQJjhR[CJOJPJQJUh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJ \]\^\\\\\\\\\\\]]]] ] ] ] $d$Ifa$ d$Ifd ddd $d]a$dd8 "d^Hd^H ]]]]]$]%]&]7]8]9]:]>]?]@]A]B]C]D]E]F]G] $d$Ifa$Ff% d$If^$d$If]a$ d$If \d$If^\ ]]]$]&]7]9]:]>]a]b]d]f]h]j]l]o]q]s]u]x]]]]]]]]]]]]]]]]]]]] ^^!^+^-^/^5^6^B^C^O^P^^^`^f^g^x^y^^^^ֶ⪘"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJ&h>mS5B*CJOJPJQJRHaphh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJph$IfFf d$If^^^^^^^^^^^^_(_*_,_2_3_A_B_S_T_b_d_j_k_y_z____________________ ` `````)`*`9`;`A`B`K`L`^`_`u`w`}`~``````ĴĴĴĴh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJG^^^^^ ___________________ _!_"_#_FfM"Ff d$If#_$_%_&_'_(_*_+_,_2_3_A_B_S_T___`_b_c_d_j_k_y_z____Ff+ xd$If^xFf/' d$If_______________________`Ff4 <d$If^< d$If xd$If^xFf<0`` ` ` `````)`*`5`6`9`:`;`A`B`K`L`^`_`q`r`u`v`FfAFfC= d$If xd$If^xFf9v`w`}`~````````````````````````FfI xd$If^xFfE d$If``````````````aaaaaa*a+a8a9aHaJaPaQa\a]ajakaza|aaaaaaaaaaaaaaaaaaaaa bbbb%b&b1b2b@bAbMbPbRbXbYbebfbrbsbbbbbbbbbbbbbbh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJU``aaaaaaaaa*a+a8a9aDaEaHaIaJaPaQa\a]ajaFftR xd$If^xFf7N d;$If d$Ifjakavawaza{a|aaaaaaaaaaaaaaaaaaaaFf+_FfZ xd$If^xFfV d$Ifaaaaaaaa bbbbbbb%b&b1b2b@bAbLbMbPbQbRbXbFfgFfhc d$If xd$If^xXbYbebfbmbrbsb~bbbbbbbbbbbbbbbbbFfop xd$If^xFfl dd;$If^d d;$If d$Ifbbbbbbbbbbbbbccccc c#c$c%c+c,c:c;cJcFfx xd$If^xFft d$Ifbbbbbbbbcccc#c%c+c,c:c;cJcKcdcfclcmc{c|ccccccccccccccccccccdddd'd(d4d5dDdFdLdMd`dadudvdddddddddddddddddddddddee#eh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJUJcKc`cacdcecfclcmc{c|ccccccccccccccccFfFfc xd$If^xFf&} d$Ifccccccccccddddddd'd(d4d5d@dAdDdEdFdLdFfFf݉ d$If xd$If^xLdMd`dadudvddddddddddddddddddddFf d;$If xd$If^xFfW d$Ifdddddddddddee#e$e5e6e9e:e;eAeBeQeReieFf xd$If^xFfњ d;$If d$If#e$e9e;eAeBeQeReiejeeeeeeeeeeeeeeeeeeeeeeffff$f&f,f-f7f8fFfGfVfXf^f_fifjfxfyfffffffffffffffffgg g ggg#g$g0gCgh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJLieje~eeeeeeeeeeeeeeeeeeeeeee d;$IfFf xd$If^xFfK d$Ifeeeeeeeffff f!f$f%f&f,f-f7f8f?fFfGfRf dd$If^dFf d$If xd$If^xFfūRfSfVfWfXf^f_fifjfqfxfyfffffffffffffFf dd$If^d d$If xd$If^xFf_fffffffffffffggg g ggg#g$g/g0g1g2gFfFf d$If xd$If^xFfY2g3g4g5g6g7g8g9g:g;gg?g@gAgBgCgFgGggggggHd^H$Hd^Ha$gdR[ddFfv d$IfCgEgGgggggggggggggghhhhhh.h1h2h6hsasasasasasUA&h>mS5B*CJOJPJQJRHaphh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUggggg(kd$$Ifֈx0lp&xx`d 4ap< 0d$If^0 d$If d$If^ggggggggggggggggggggggggghh $d=$Ifa$Ff d$Ifhhhhhhhh.h/h0h1h2h6h7h8h9h:h;hh?h $d$Ifa$Ff d$If^  d$If^  \d$If^\ d$If?h@hAhBhChDhEhFhGhHhIhJhKhLhMhNhOhPhQhRhShThUhVhWhXhYhZhFfFf d$If6hFhYhZh\h^h`hbhdhfhhhjhlhphshuh{h|hhhhhhhhhhhhhhhhhhhhhiiiii i#i%i+i,i=i>iRiSidifiiikiqiriiiiiiiiiiܾh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJBZh\h]h^h`hahbhdhehfhhhihjhlhmhnhohphsh$d$If]a$Ff d$If^ 8d$If^8 d$If^ @d$If^@ d$If $d$Ifa$shthuh{h|hhhhhhhhhhhhhhhhhhhhhhFf$d$If]a$Ff[ d$Ifhhhhiiiiii i#i$i%i+i,i=i>iRiSidieifiiijiFf d;$If$d$If]a$Ffu d$IfjikiqiriiiiiiiiiiiiiiiiiiiiiiFf$d$If]a$Ff  d;$If d$Ifiiiiiiiiiiii j jjj$j&j)j+j1j2j>j?jJjKjWjYj\j^jdjejpjqj}j~jjjjjjjjjjjjjjjjjjkk kk#k%k3k6k8k>k?kJkKkXkYkekgkjklkrksk~kkkkh>mSCJ OJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJMiiii j jjj$j%j&j)j*j+j1j2j>j?jJjKjWjXjYj\j]jFf6$d$If]a$Ff d;$If d$If]j^jdjejpjqj}j~jjjjjjjjjjjjjjjjjjjFfP $d$If]a$Ff d$Ifjjjjjjjjjjjjjjjkkk k k k k kkk#k$d$If]a$Ff1% d=$If d$If#k$k%k&k'k(k)k*k+k,k-k.k/k0k1k2k3k6k7k8k>k?kJkKkXk d;$If$d$If]a$Ff/Ff* d$IfXkYkekfkgkjkkklkrksk~kkkkkkkkkkkkkkkFf19 d;$If$d$If]a$Ff4 d$Ifkkkkkkkkkkkkkkkkkkkkkkll l#l%l+l,l7l8lJlKl_laldlflllmlxlylllllllllllllllllllllm m mmmmm%m&m+m?m@mضضh>mSB*CJOJPJQJph"h>mS5B*CJOJPJQJphh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJHkkkkkkkkkkkkkkkklllllllllFfKB d;$If$d$If]a$Ff= d$Iflllllllllll l#l$l%l+l,l7l8lJlKl_l`laldlelFf+O$d$If]a$Ff|H d$IfelflllmlxlylllllllllllllllllllllFfEX$d$If]a$FfS d$Ifllllm m mmmmmmm%m&m?m@mLmMmXmYmZm]m^m_mFf_a$d$If]a$Ff\ d;$If d$If@mLmMmXmZm]m_memfmmmmmmmmmmmmmmmmmmmmmmn nn#n%n(n*n0n1n@nAnMnNnYn[n^n`nfngntnunnnnnnnnnnnnnnnnnnnnnnnoo o oooo o+o,o7o9ooDoEoPoQohoioh>mSCJOJPJQJh>mSCJOJPJQJ\_memfmmmmmmmmmmmmmmmmmmmmmmmFfyj$d$If]a$Ffe d;$If d$Ifmmmmn nn#n$n%n(n)n*n0n1n@nAnMnNnYnZn[n^n_n`nFfs$d$If]a$Ffo d;$If d$If`nfngntnunnnnnnnnnnnnnnnnnnnnnFf|$d$If]a$Ff x d;$If d$Ifnnnnnnnooo o o oooo o+o,o7o8o9ooFfDž$d$If]a$Ff: d;$If d$If>oDoEoPoQohoio}o~oooooooooooooooooFf$d$If]a$FfT d;$If d$Ifio}oooooooooooooooooooo p p!p#p&p(p.p/p=p>pSpTpipkpnpppvpwppppppppppppp.q6qVqWqtqzqqqqqqrr&rbrjrvrwrrrrrʾʾʾʾh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJHoooooooooooooooooooooooo p p d;$If$d$If]a$Ff d$If p!p"p#p&p'p(p.p/p=p>pSpTpipjpkpnpopppvpwpppppFfN d;$If$d$If]a$Ff d$IfppppppppppppppppppppppppppppFfFfۤ d$Ifppppppppppppppppqqqqqq,q-q.q/qFf$d$If]a$Ff d$If/q0q1q2q3q4q5q6qVqWqtquqvqwqxqyqzq{q|q}q~qqqqqqqqqFf d$IfqqqqqqqqqqqqqqqqqqqqqqqqqqFfU$d$If]a$Ff d$Ifqqqqqrrrrrrrrrrrrrrrrrr r!r"r#r$r%rFff d$If%r&r)r*r+r1r2r3r4r5rErFr`rarbrcrdrerfrgrhrirjrvrwrrFf* d$If$d$If]a$FfZrrrrrrrrrrrrrrrrrrrrrrrrrr$d$If]a$Ff/Ff; d$IfrrrrrrrrrrrrrrrrrrrrrrrssssssFf d$Ifrrrrsss!s's*s3s4sNsPs]s`sbshsistsusvswssssssssssss"t$tĬtb"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJ OJPJQJUhWCJ OJPJQJh>mSCJ OJPJQJhWCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ#sss s!s's(s)s*s3s4sNsOsPsQsRsSsTsUsVsWsXsYsZs[s\sFff d$If$d$If]a$Ff\s]s`sasbshsisssssssssssssssssssFf d;$If d$If$d$If]a$Ff-ssssssssssss#t$t%t&t't]t^tlt 0d$If^0 d$If^Hd^HdFf d$If$t't;t=t\t]t^tmttttttttttttttttttttttttttttttʾth^h>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJ&h>mS5B*CJOJPJQJRHaphh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ$ltmtntotptqtrtstKBBBBBB d$Ifkdf$$Ifֈx0lp&xx`d 4ap<stttutvtwtxtytzt{t|t}t~tttttttttttttt \d$If^\ $d=$Ifa$Ff d$Iftttttttttttttttttttttttt $d$Ifa$Ff d$If^ d$If  d$If^ tttttttttttttttttttttttttt $d$Ifa$FfFf d$Ifttttttttttttttttttuuu xd$If^xFf& d$If^ 8d$If^8 d$If^ d$If @d$If^@tuuuuuu*u,u4u?u@u_ueuhujupusuuuuuuuuuuuuuuuuuuuuuuuv v vv v!v:v@vCvEvKvNvXvYvsvuvvvvvvvvvvvvvvh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJDuuuu*u+u,u-u.u/u0u1u2u3u4u?u@u_u`uaubucudueuhu xd$If^xFf2Ff- d;$If d$Ifhuiujupuqurusuuuuuuuuuuuuuuuuuuuuu xd$If^xFf<Ff7 d$Ifuuuuuuuuuuuuuuuuuuuv v v vvvvvFfE xd$If^xFfcA d$Ifvvvvv v!v:v;vv?v@vCvDvEvKvLvMvNvXvYvsvtvuvvvFf'P xd$If^xFfJ d$Ifvvwvxvyvzv{v|v}v~vvvvvvvvvvvvvvvvvvvFfY xd$If^xFfT d$Ifvvvvvvvvvvv w w wwwwwwwwwww'w(w xd$If^xFfO^ d=$If d$Ifvvvv w wwwww'w)w7w:wmSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ?(w)w*w+w,w-w.w/w0w1w2w3w4w5w6w7w:w;wmSCJOJPJQJh>mSOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJLxxxxxxxxxxxxxxxxxxxxxxxxxxx xd$If^xFfkFf: d$Ifxxxxxyyyyyyyy&y'y8y9yIyJyKyNyOyPyVyWycydyFf xd$If^xFf d$IfdysytyyyyyyyyyyyyyyyyyyyyyyyyyFf xd$If^xFf4 d$Ifyyzzzzzzz z z zzzzz%z&z:z;zz?z@zFf d;$If xd$If^xFf d$If@zAzBzCzDzfzgzhzizjzkzlzmznzozrzsztzzz{zzzzzzz xd$If^xFf d>$If d$Ifzzzzzzzzzzzzzzzzzzzzzzzzz xd$If^xFf d>$If d$IfFfzzz{{{{{{{{ {!{"{#{${F{G{H{I{J{K{L{M{N{O{Ff\ d=$IfFfc d$IfO{S{T{U{[{\{`{a{s{t{{{{{{{{{{{{{{{{{{Ff  d$If xd$If^x{{{{{{{{{{{{{{{{{|||||||(|Ff_ d;$If xd$If^xFf d$If{{{{{{{{{{{|(|)|D|J|N|P|V|W|[|\|`|a|l|n|r|t|z|{||||||||||||||| }}}}!}'}(}5}6}D}E}P}R}V}X}^}_}l}m}{}|}}}}}}}}}}}}}}}h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJN(|)|D|E|F|G|H|I|J|N|O|P|V|W|[|\|`|a|l|m|n|r|s|t|z|Ff d;$If xd$If^xFf8 d$Ifz|{||||||||||||||||| } }}}}}}}}Ff xd$If^xFfB d$If}}}}}}}}} }!}'}(}5}6}D}E}P}Q}R}V}W}X}^}_}l}m}Ff' xd$If^xFfg d$Ifm}{}|}}}}}}}}}}}}}}}}}}}}}}}}}FfA xd$If^xFf d$If}}}}}}}~~ ~ ~~~~~.~/~G~I~M~O~U~V~`~a~p~q~~~~~~~~~~~~~~~~  -.FHLNTUkl}~h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJM}~~~ ~ ~ ~~~~~.~/~G~H~I~M~N~O~U~V~`~a~p~q~Ff[ d;$If xd$If^xFf d$Ifq~~~~~~~~~~~~~~~~~~~~~~~~~~~ xd$If^xFfFf  d$If~~~~~~~~~~~~~~    xd$If^xFfFf d$If-.FGHLMNTUkl}~Ff3% xd$If^xFf  d$If d;$If67MNFfM. xd$If^xFf) d$If67MNfhlntu€̀΀$%(xz}|rhCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ,Nfghlmntu€̀΀Ffg7 xd$If^xFf2 d$If Ff@ d$IfFf; !"#$&'(yz{|} 0d$If^0 d$If^Hd^HddFfE d$IfÁׁ؁ہށ';<>@BDFIKMOSWY_`lmւǻǩǩǩǩǩDž{{{{{DžDžDžh>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSCJOJPJQJh>mSB*CJph$hm`B*CJph$0ÁāŁƁǁȁɁKBBBBBB d$Ifkd8I$$Ifֈx0lp&xx`d 4ap<Ɂʁˁ́́΁ρЁсҁӁԁՁցׁ؁ہ܁݁ށ \d$If^\$2d=$If]2a$FfL d$If !"#$$ d$If] a$Ff(T d$If^ $d$Ifa$ d$If$%&'()*+,-./0123456789:;<>$Zd$If]Za$Ff:dFf[ d$If>?@BCDFGHIKLMOPQRSWX$Zd$If]Za$Ffl d$If^$d$If]a$ d$If^ @d$If^@ d$IfXY_`lmւׂFfw$Zd$If]Za$Ffs d$Ifւׂ 34LN[_aghtuƒÃރ߃ ;<TVdhjpq|}DŽȄӄԄ  "()78HI`bfhnh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJR 34LMNOPQFfM$Zd$If]Za$Ff| d$IfQRSTUVWXYZ[_`aghtuFfԊ$Zd$If]Za$Ff d$IfƒÃރ߃ $Zd$If]Za$FfFf2 d$If *;<TUVWXYZ[\]^_`abcdh$Zd$If]Za$Ff˝Ff d$Ifhijpq|}$Zd$If]Za$FfSFf d$IfDŽȄӄԄ  $Zd$If]Za$FfFf d$If !"()78HI`abfghno}~Ff$Zd$If]Za$Ffk d$Ifno}~ŅƅхӅׅم߅!#')/0>?QRdfjlrsʆˆنچ#%)+12>?MNY[_aghtuh>mSCJOJPJQJh>mSCJOJPJQJXŅƅх҅Ӆׅ؅م߅!"#'()Ff$Zd$If]Za$Ff d$If)/0>?QRdefjklrsFf,$Zd$If]Za$Ff d$Ifʆˆنچ#$%)*+12FfF$Zd$If]Za$Ff d$If2>?MNYZ[_`aghtuFf`$Zd$If]Za$Ff d$IfLJȇ %&>@DFLMYZhiuw{}Ĉƈ͈̈ֈ׈ "#03>@HijЮ#h>mSB*CJOJPJQJRHcphh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJALJȇ$Zd$If]Za$FfFf d$If %&>?@DEFLMYZhiuvw{|}Ff$Zd$If]Za$FfE d$IfĈňƈ͈̈ֈ׈ "#Ff$Zd$If]Za$Ff_ d$If#0123>?@ABCDEFGHijFfFf d$If d;$If‰Éĉ$Zd$If]Za$Ff  d$Ifĉωщ &,4GOSU[^jmɊˊϊъ׊؊()78CEIKQR]^qrĴĴĴĴh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJGĉωЉщ҉ӉԉՉ։׉؉ىډۉ܉݉މ߉ FfFfi d$If &'()*+,-./01234GHIJKLMNOFf FfD d$IfOSTU[\]^jklmFf% d$If$Zd$If]Za$ɊʊˊϊЊъ׊؊ d;$IfFf:0$Zd$If]Za$Ff+ d$If()78CDEIJKQR]^qrFfT9 d;$If$Zd$If]Za$Ff4 d$IfrӋԋՋًڋۋFfnB d;$If$Zd$If]Za$Ff= d$IfӋՋًۋ!%'-.89JK^`dflmwxȌɌҌԌ،ڌ  .1IKOQWXbcsh>mSB*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJL !%&'-.89JK$Zd$If]Za$FfKFfF d$IfK^_`deflmwxȌɌҌFfT$Zd$If]Za$FfSP d$IfҌӌԌ،ٌڌ  ./01Ff]$Zd$If]Za$FfmY d$If1IJKOPQWXbcst Pd$If^PFfg$Zd$If]Za$Ffb d$IfstЍҍ:<?VXvwx°~th\J"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJЍэҍӍԍՍ֍׍؍ٍڍۍ܍ݍލߍdFfqFfal d$If;<=>?wx 0d$If^0 d$If^ d$IfHd^Hd KBBBBBB d$IfkdZu$$Ifֈx0lp&xx`d 4ap< \d$If^\$2d=$If]2a$Ffx d$IfҎՎ֎ڎ  !/0>?JLPRXYghÏ؏ڏޏʾ⾲h>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJ=ҎӎԎՎ֎ڎێ܎ݎގߎ$ d$If] a$Ff d$If^ d$If  d$If^ $Zd$If]Za$FfFf d$If  !/$Zd$If]Za$Ff d$If^ 8d$If^8 d$If^ d$If @d$If^@/0>?JKLPQRXYghFf&$Zd$If]Za$Ff d$IfÏ؏ُڏޏߏ *+9Ff@$Zd$If]Za$Ff d$If *+9:EGKMST^_pqĐƐʐ̐ҐӐސߐ'(@BJlmőԑܑ$(h>mSCJ OJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJH9:EFGKLMST^_pqFfZ$Zd$If]Za$FfͰ d$IfĐŐƐʐː̐ҐӐސߐ'(Fft d;$If$Zd$If]Za$Ff d$If(@ABCDEFGHIJlm$Zd$If]Za$Ff d>$IfFf d$IfőƑǑȑɑʑˑ̑͑ΑϑБёґӑԑՑ֑בّؑڑFfFf8 d$Ifڑۑܑ !"#$()*0123>?WXYZFfi$Zd$If]Za$Ff d>$If d$If(*03>?WYfn’ŒВђ !9;?AGHVWdeprvx~Ɠ -/<踬h>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJBZ[\]^_`abcdefghijklmn d=$IfFf0 d$If’ÒĒŒВђFf$Zd$If]Za$FfD d$If !9:;?@AGHVWdepFf! d;$If$Zd$If]Za$Ffa d$Ifpqrvwx~“ÓēœƓFf; d;$If$Zd$If]Za$Ff d$If -./01234Ffr$Zd$If]Za$Ff d$If d=$If456789:;<=>?@ABCDEFGHIJNOP$Zd$If]Za$FfFf  d$If<JNPVWuvÔĔՔ֔$%0268>?LMZ[fhlntuŕƕ "#12=h>mSCJ OJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJGPVWuvÔĔՔ֔Ff$Zd$If]Za$Ff d;$If d$If$%012678>?LMZ[fghlmnFf$$Zd$If]Za$Ff  d;$If d$IfntuŕƕFf-$Zd$If]Za$Ff)) d;$If d$If "#12=>?@ABFf7$Zd$If]Za$FfN2 d$IfBCDEFGXYZ[\]^_`abfghno~$Zd$If]Za$Ff?= d$If=GXbfhno~ǖȖՖ֖ $%9:HITVZ\bcqr—×ۗܗ$%=?Cʾh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJKǖȖՖ֖  d;$IfFf{H$Zd$If]Za$FfC d$If$%9:HITUVZ[\bcqrFfQ$Zd$If]Za$FfM d$If—×ۗܗ$Zd$If]Za$FfZ d$IfFfU$%=>?CDEKLYZghstuFfhFfd d$If$Zd$If]Za$Ffz_CEKLYZghsuy{ĘƘӘט٘ߘ -139:EF`ay{әՙ%'+-34EFTU`bfhnh>mSB*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJLuyz{ĘŘƘǘȘɘʘ˘̘͘ΘϘИјҘӘFfqFfl d$If$Zd$If]Za$Әטؘ٘ߘ !"#$%&'()*+,-Ff{FfJv d$If$Zd$If]Za$-1239:EF`ayz{|}~Ff Pd$If^P d$If$Zd$If]Za$әԙՙ֙יؙٙڙۙܙݙޙߙFf d$If$Zd$If]Za$Ffi%&'+,-34EFTU`abFfFf d$If$Zd$If]Za$Ffbfghno|}ƚǚؚٚښޚFf(Ff d$If$Zd$If]Za$no|}ƚǚؚښޚ#$56CDOQefΛЛh>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ/ޚߚ#$56CDOPQRSFfB$Zd$If]Za$Ff d$IfSTUVWXYZ[\]^_`abcdefHd^HdFf d$If(kd$$Ifֈx0lp&xx`d 4ap< 0d$If^0 d$If d$If^ ,.79JMNRbuvxz|~ǜȜ '(@BOSU[\mn۽ɽ癥癥h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$< $2d=$If]2a$Ff5 d$If ,-.789JKLMNRSTUVWXYZ$ d$If] a$Ff[ d$If^  d$If^  \d$If^\ d$IfZ[\]^_`abcdefghijklmnopqrstuFfAFf d$Ifuvxyz|}~FfA d$If^ 8d$If^8 d$If^ @d$If^@$Zd$If]Za$ d$IfǜȜ$Zd$If]Za$FfFf d$If '(@ABCDEFGHIJKLMNOST$Zd$If]Za$FfFf# d$IfTU[\mn$Zd$If]Za$FfBFf{ d$Ifɝʝߝ01IKX\^depq~Ğƞ̞͞ڞ۞  /0HJNPVWdewxh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJLɝʝߝ01IJKLMNFf`$Zd$If]Za$Ff d$IfNOPQRSTUVWX\]^depq~Ff $Zd$If]Za$Ff' d$IfĞŞƞ̞͞ڞ۞ Ff $Zd$If]Za$Fft d;$If d$If  /0HIJNOPVWdewxFf $Zd$If]Za$Ff d$If̟͟Οҟӟԟڟ۟Ff $Zd$If]Za$Ff d$If̟Οҟԟڟ۟!%'-.89UVhjw{}ƠҠ֠*.067CDYZlnrtz{h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJD !%&'-.89UVhijklmnoFf^) $Zd$If]Za$Ff$ d$Ifopqrstuvw{|} àFf2 $Zd$If]Za$Ff%. d$IfàĠŠƠҠӠԠՠ֠Ff< $Zd$If]Za$Ff7 d>$If d$If !"#$%&'()*./067CDYZlmnrFfSF $Zd$If]Za$FfA d$Ifrstz{ȡɡء١FfmO $Zd$If]Za$FfJ d;$If d$Ifȡɡء١ &(,.45?@OP\^bdjkuvâĢϢѢ٢ +,8:GKMSTh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJH &'(,-.45?@OP\]^bcFfX $Zd$If]Za$FfS d$IfcdjkuvâĢϢТѢҢӢԢFfa $Zd$If]Za$Ff] d$IfԢբ֢עآ٢ +,89$Zd$If]Za$Ffbf d<$If d$If9:;<=>?@ABCDEFGKLMST`a}~$Zd$If]Za$FfOp d$IfFfk T`a}~̣ͣޣ>?NT̤ΤҤԤڤۤ  01IKSbc~¥ĥʥ˥ڥۥĸh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJḌͣޣߣ d>$IfFfy d$IfFft ߣFfP $Zd$If]Za$Ff~ d$If>?NOPQRSTXYZ`apqrstFf $Zd$If]Za$FfY d>$If d$If̤ͤΤҤӤԤڤۤFf@ $Zd$If]Za$Ff d$If  01IJKLMNOPQRSbc~Ff͜ d;$If d$IfFf d$If$Zd$If]Za$Ff ¥åĥʥ˥ڥۥ Ff\ d$If$Zd$If]Za$Ff˫ ۥ!%'-.89FGRT\ghz{Ǧ˦ͦӦԦڦۦ 359;ADST`bosu{|ǧh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJD !%&'-.89FGRSTUVWXYZ[\ghFf d;$If d$If$Zd$If]Za$Ff# hz{Ff $Zd$If]Za$Ff d$If d=$If¦æĦŦƦǦ˦̦ͦӦԦڦۦFf $Zd$If]Za$Ff d$If 3459:;ABCDST`abcFf~ $Zd$If]Za$FfX d=$If d$Ifcdefghijklmnostu{|Ff $Zd$If]Za$FfE d$Ifǧȧا٧ "#$%&Ff $Zd$If]Za$Ff d$Ifǧȧا٧ "78;ĨŨƨըμth\h>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJ&'()*+,-./012345679:;Hd^HddFf d$IfŨƨԨը(kd $$Ifֈx0lp&xx`d 4ap< 0d$If^0 d$If d$If^ը֨רب٨ڨۨܨݨިߨ$2d=$If]2a$Ff d$If #$(8KLNOQSUWY[]bfgmn{|©өթ٩ک !,-ʾh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJph=  !"#$()*+,-./0$ d$If] a$FfH d$If^  d$If^  d$If \d$If^\0123456789:;<=>?@ABCDEFGHIJKFf Ff d$IfKLNOQRSUVWYZ[]^_`abfgFf d$If^ 8d$If^8 d$If^ d$If^$Zd$If]Za$ d$Ifgmn{|©өԩթ٩کFf $Zd$If]Za$Ffe d$If dd$If^d !,-FG_`aeflmwxFf' dd$If^d$Zd$If]Za$Ff# d$If-FG_aeflmwxŪǪ˪̪ҪӪުߪ  !12CEIJPQ[\op«ëͫΫ۫ܫ $h>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJUxŪƪǪ˪̪ҪӪުߪFf 0 dd$If^d$Zd$If]Za$Ff+ d$If d;$If  !12CDEIJPQ[\opFfL8 dd$If^d$Zd$If]Za$Ff+4 d$If«ëͫΫ۫ܫFf@ d;$If dd$If^d$Zd$If]Za$Ffm< d$If $%+,89HIUVFfH d;$If dd$If^d d$If$Zd$If]Za$FfD $%+,89HIUW[\bcopάϬ')-.45ABTUfo~­ȭɭԭխ!#'(."h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJTVW[\bcopάϬ d;$IfFfbQ dd$If^d d$If$Zd$If]Za$FfAM '()-.45ABTUfghFf] FfY dd$If^d d$If$Zd$If]Za$FfU hijklmno~ dd$If^d$Zd$If]Za$Ffc d$If­ȭɭԭխFfPn d;$If dd$If^d$Zd$If]Za$Ff/j d$If!"#'(./:;QR[\]abhituFfv dd$If^d$Zd$If]Za$Ffqr d$If d;$If./:;QR[]abhituɮʮܮޮ&(,-34CDXYjlpqwx¯ׯد#$57;<BC[\hitvz{h>mSCJOJPJQJh>mSCJOJPJQJ\ɮʮܮݮޮ&Ff~ dd$If^d$Zd$If]Za$Ffz d$If&'(,-34CDXYjklpqwxFf d;$If dd$If^d$Zd$If]Za$Ff d$If¯ׯد#$567Ffy FfX dd$If^d d$If$Zd$If]Za$Ff7 7;<BC[\hituvz{Ff Ff dd$If^d d$If$Zd$If]Za$ѰҰ()46:;ABKLXYdfjkqr{|ȱԱ !"01>?JLPQWXeftu"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJPѰҰ()456:;ABFf $Zd$If]Za$Ffܟ d$If dd$If^dBKLXYdefjkqr{|Ff? dd$If^d$Zd$If]Za$Ff d$If±ñıűƱDZȱԱձֱױرٱڱFf d:$If d$Ifڱ۱ܱݱޱ߱ !"01>?Ff dd$If^d$Zd$If]Za$FfE d$If?JKLPQWXeftuFf dd$If^d$Zd$If]Za$Ff d$If˲̲زٲ #$12>?JLPQWXcdrsҳݳ%&<=OQUV"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJT˲̲زٲ  d;$IfFf0 dd$If^d d$If$Zd$If]Za$Ff #$12>?JKLPQWXcdrsFf Ffr dd$If^d d$If$Zd$If]Za$FfQ ҳӳԳճֳ׳Ff dd$If^d d$If$Zd$If]Za$׳سٳڳ۳ܳݳ%&Ff dd$If^d$Zd$If]Za$Ff d$If&<=OPQUV\]opFf( dd$If^d$Zd$If]Za$Ff? d$If d;$IfV\]op9:;J\]`b°~th\P>P"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJ OJPJQJUh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ:; d$If^Hd^HddFf d$If;IJKLMN>5555 d$Ifkd $$Ifֈx0lp&xx`d 4ap< 0d$If^0NOPQRSTUVWXYZ[\]`abghiuv \d$If^\ dd$If^d$2d=$If]2a$Ff d$Ifbgiuwõŵǵɵ˵͵ϵѵյܵMOUVxyǶȶӶնٶ۶ ʾh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphmSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJNDEFGHXYZ[\]^_`abfghno}~ d;$If$Zd$If]Za$Ff E d$If·÷ηϷзԷշַܷݷ FfP d;$If$Zd$If]Za$FfsK d$If"#$*+BCPQhijnopvw d;$IfFfY $Zd$If]Za$FfT d$Ifɸʸ׸ظ&Ff4b d;$If$Zd$If]Za$Ff] d$If&'()*+,-./0123456789:;<FGHIJFfYk Fff d$If(5<FPTV\]pq~¹չ׹۹ݹ !#')/0@A]^vxºܺ0289JK_`qswyʾʾʾʾʾʲh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJ OJPJQJFJKLMNOPTUV\]pq~Ffw $Zd$If]Za$Ffq d$If¹չֹ׹۹ܹݹ !"#'()/0@A]Ff $Zd$If]Za$Ff| d$If]^vwxyz{|}~$Zd$If]Za$Ff9 Ffr d$Ifºܺݺ޺ߺ$Zd$If]Za$Ff d>$IfFf d$If*+,01289JK_`qrswxyFf $Zd$If]Za$Ff] d$IfyĻŻֻ׻ #$78PRVX^_pqӼռټۼ %&:;KMQSYZstȽɽս׽۽ݽh>mSCJOJPJQJh>mSCJOJPJQJZĻŻֻ׻ Ff $Zd$If]Za$Ffw d$If#$78PQRVWX^_pqFf $Zd$If]Za$Ff d$IfӼԼռټڼۼ %&Ff8 $Zd$If]Za$Ff d$If&:;KLMQRSYZstFfR d;$If$Zd$If]Za$FfŽ d$IfȽɽսֽ׽۽ܽݽ !%&'-.@AFfl $Zd$If]Za$Ff d$Ifݽ!%'-.@ATUfhlntuʾԾؾھ !-.;<GIMOUVbcnoſȿ̿οԿտ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphNATUfghlmntuFf $Zd$If]Za$Ff d$If d;$Ifʾ˾̾;ξϾоѾҾӾԾؾپھFf $Zd$If]Za$Ff d$If !-.;<GHIMNOUVbcnoFf $Zd$If]Za$Ff d$Ifſƿǿȿ̿ͿοԿտFfx $Zd$If]Za$Ff d$If )*=?CEKLXYhi|~89TUmp~ʾh>mSOJPJQJjh>mSCJ OJPJQJUh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJ9 )*=>?CDEKLXYhi|}~Ff $Zd$If]Za$Ff d$IfFf $Zd$If]Za$Ff d$If 89TUmno$Zd$If]Za$Ff d$Ifopqrstuvwxyz{|}~Hd^Hdd8dFf, d$IfFf  347:?AMOXZknosƼƲЦ|||||p|pd|||||h>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz$ 0d$If^0 d$If^ d$If !"#$%&KBBBBBB d$Ifkd $$Ifֈx0lp&xx`d 4ap<&'()*+,-./01234789:?@AMNO \d$If^\$2d=$If]2a$Ff_ d$IfOXYZklmnostuvwxyz{|}~$ d$If] a$Ff$ d$If^ d$If  d$If^ $Zd$If]Za$Ffk4 FfI, d$If$Zd$If]Za$Ffk< d$If^ 8d$If^8 d$If^ d$If @d$If^@!#)*67GH`bfhno|} "$(*01>?LMXZ^`fgsth>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJL!"#)*6$Zd$If]Za$FfG FfB d$If67GH`abfghno|}Ff Q $Zd$If]Za$Ff|L d$If "#$()*01>?Ff#Z $Zd$If]Za$FfU d$If d;$If?LMXYZ^_`fgstFf=c $Zd$If]Za$Ff^ d$If d;$If #$12?@KMQSYZghop !'(34ABMWfptv|}"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJT #$12FfWl $Zd$If]Za$Ffg d$If d;$If2?@KLMQRSYZghopFfqu $Zd$If]Za$Ffp d$If d;$IfFf/ Ffy d$If d;$If  !'(34ABMNOPFfk Ffކ d$If$Zd$If]Za$PQRSTUVWfghijklmnoptuv|}$Zd$If]Za$Ff d$IfFf؜ $Zd$If]Za$FfK d$If#$@FJLRUabv $%=?LPRXYef~貦貦h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJA#$@ABCDE dA$IfFf d$IfEFJKLRSTUabvwxyz{|}~Ffb d$If$Zd$If]Za$Ff Ff d$If$Zd$If]Za$Ff)  $%=>?@ABCDEFGHIJKFf d$If$Zd$If]Za$Ff KLPQRXYef~Ff& Ff d$If$Zd$If]Za$Ff ()78CDEFf@ Ff d;$If d$If$Zd$If]Za$()78CEIKQR]^mny(2:VWtz~農h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJFEIJKQR]^mnyz{|}~Ff d$If$Zd$If]Za$Ff $Zd$If]Za$Ff d$If ()*+,-./0123456Ffk Ff: d$If6789:VWtuvwxyz~Ff $Zd$If]Za$Ffn d$IfFfK $Zd$If]Za$Ff d$If+,9:EGKMSTcdst ()78CEIKQR]^no"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJT+,9:EFGKFfe Ff d$If$Zd$If]Za$KLMSTcdstFf $Zd$If]Za$Ff d$If$Zd$If]Za$Ff# d$If ()78CDEIJKQR]^noFf. $Zd$If]Za$Ff_* d$IfFf8 $Zd$If]Za$Ffy3 d$If"#.046<=GHVWbdwy|°~th>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ,"#./0456<=GHVWbcFf A d;$If d$If$Zd$If]Za$Ff< cdefghijklmnopqrstuvwz{|Hd^HddFfJ d$IfFfE  0d$If^0 d$If^ d$IfKBBBBBB d$Ifkd&N $$Ifֈx0lp&xx`d 4ap<'(+-24@BKM^abfu #$./;<۽ɽ祛h>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$8 !"#$%&'(+,-234@AB \d$If^\ dd$If^d$2d=$If]2a$FfnQ d$IfBKLM^_`abfghijklmnopqrst$ d$If] a$FfX d$If^ d$If  d$If^ tuvwxyz{|}~ @d$If^@$Zd$If]Za$Ffg d$IfFf_ $Zd$If]Za$Ffxn d$If^ 8d$If^8 d$If^ d$If #$./;<GHFfy $Zd$If]Za$Fft d$If<GIMOUVbcst $&,-9:DEVX_ijh>mSCJ OJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJMHIMNOUVbcstFf) Ff d$If$Zd$If]Za$Ff~  FfC Ff d;$If d$If$Zd$If]Za$ $%&,-9:DEVWXYZ[\]^_ij d>$IfFfД d$If$Zd$If]Za$Ff $Zd$If]Za$Ff d$IfFf d;$If$Zd$If]Za$Ff d$If"$(*01;<HI^`dflmyz $%0268>?KLXYdfjlrs"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJT"#$()*01;<HI^_`deflmyzFf d;$If$Zd$If]Za$Ff d$IfFfƺ d;$If$Zd$If]Za$Ff9 d$If $%012678>?KLXFf d;$If$Zd$If]Za$FfS d$IfXYdefjklrsFf $Zd$If]Za$Ffm d$If Ff (d$If^($Zd$If]Za$Ff d$If 89GH`bfhnowx #$23>?TVZ\bc}~h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJG89GH`abfghnowxFf2 $Zd$If]Za$Ff d;$If d$If Ff $Zd$If]Za$Ff d<$If d$If #$23>?TUVFf^ d;$If$Zd$If]Za$Ff d$IfVZ[\bc}~Ffx d;$IfFf d$If$Zd$If]Za$'()-./56?@NOhijFf d;$IfFf d$If$Zd$If]Za$')-/56?@NOhjnpvw!'(23DEUW[]cdyzh>mSB*CJOJPJQJph h>mSCJOJPJQJh>mSCJOJPJQJUjnopvwFfFf  d;$If d$If$Zd$If]Za$ !'(23DEUVWFfFf9 d;$If d$If$Zd$If]Za$W[\]cdyzFf"FfS d;$If d$If$Zd$If]Za$"#$%&'()*+ABCDE d:$IfFfm' d;$If d$If$Zd$If]Za$"$+AJQU^e{ !BDHJPQmn諛菛wwwwwh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJ"h>mS5B*CJOJPJQJph% *h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ.EFGHIJKLMNOPQUVWXYZ[\]^_`abcFf4Ff- d$Ifcde{|}~Ff?$Zd$If]Za$Ff: d$If !BCDHIJFfuI$Zd$If]Za$FfD d$IfJPQmn$Zd$If]Za$FfRFfM d$If/01567Ff[$Zd$If]Za$FfZW d;$If d$If/157=>YZef{} %&23QSV[ǽ"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJph=7=>YZef{|}Ffe$Zd$If]Za$Fft` d;$If d$If %&23QRSWXYd8dFfn$Zd$If]Za$Ffi d$IfYZ[ 0d$If^0 d$If^ d$IfHd^Hdd8  !*,=ABFWklnprtvxz|~⸬vjjjh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz)KBBBBBB d$Ifkdqp$$Ifֈx0lp&xx`d 4ap<  \d$If^\$2d=$If]2a$Ff t d$If !*+,=>?@ABFGHIJKLMNOPQR$ d$If] a$Ff{ d$If^  d$If^  d$IfRSTUVWXYZ[\]^_`abcdefghijklFfFf d$Iflnoprstvwxz{|~FfW d$If^ 8d$If^8 d$If^ @d$If^@ d$If$Zd$If]Za$$Zd$If]Za$Ff؟Ff d$If!+8CGIOP\]klwy} !'(45HI\^bоЮЮЮЮh>mSB*CJOJPJQJph"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJD!"#$%&'()*+89:;<=>?@AFf d$IfABCGHIOP\]klwxy}~ d;$IfFfȱ$Zd$If]Za$Ff d$If Ff$Zd$If]Za$FfU d$If !'(45HI\]^bcdjkwxFfFf d$If$Zd$If]Za$Ffobdjkwx"$*+67EFQSWY_`klz{-.<=HJNPV"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJT"FfFf d$If$Zd$If]Za$"#$*+67EFQRSWXY_`klz{Ff$Zd$If]Za$Ff0 d;$If d$If$Zd$If]Za$Ff d$If-.<Ffz$Zd$If]Za$Ff d$If<=HIJNOPVWefuvFf$Zd$If]Za$Ff d$IfVWefuv "#12=?CEKLVWdeprvx~"$(*01>"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJTFf d;$If$Zd$If]Za$Ff! d$If "#12=>?CDFf $Zd$If]Za$Ff d$IfDEKLVWdepqrvwx~Ff$Zd$If]Za$Ffk d$If"#$()*0Ff$Zd$If]Za$Ff d$If01>?MNYZ[_`aghuvFf,'$Zd$If]Za$Ff" d$If>?MNY[_aghuv!"/0>?JLPRXYfgyz!"h>mS5B*CJOJPJQJphh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJN!"/FfF0$Zd$If]Za$Ff+ d$If/0>?JKLPQRXYfgyzFf`9$Zd$If]Za$Ff4 d$IfFfzB$Zd$If]Za$Ff= d$If!"#)*78DEPQRVFfO$Zd$If]Za$FfH d$If!#)*78DEPRVX^_jkyz /0@CGIOP[\klwh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJRHWh>mSCJOJPJQJh>mSCJOJPJQJJVWX^_jkyzFfX$Zd$If]Za$Ff7T d$If /0@ABCGHFfa$Zd$If]Za$FfQ] d$IfHIOP[\klwxyz{|}~Fff d$IfFfs$Zd$If]Za$Ff m d$If,0289CD`ay{ `beĴzh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ- !"#$%&'()*+,01289CD`ayz$Zd$If]Za$Ff} d$IfFfIxz{|}~$Zd$If]Za$Ffh d$IfFfFfo d$If$Zd$If]Za$Ff( abcde 0d$If^0 d$If^Hd^HddFf~ d$Ifez~&')+-/13579>BDJKWXefqswɽ{q{q{q{q{q{h>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSCJOJPJQJh>mSB*CJph$hCfB*CJph$hm`B*CJph$,KBBBBBB d$IfkdT$$Ifֈx0lp&xx`d 4ap< \d$If^\$2d=$If]2a$Ff d$If $ d$If] a$Ffd d$If^  d$If^  d$If  !"#$%&'FfFfx d$If')*+-./1235679:;<=>BCFf: d$If^ 8d$If^8 d$If^ @d$If^@ d$If$Zd$If]Za$CDJKWXefqrswxyFf$Zd$If]Za$Ff# d$Ifwy!"-7LW[]cdtu01EGKMST_`mnh>mS5CJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJO!"-./0123Ff$Zd$If]Za$Ff= d$If34567LMNOPQRSTUVW[\]cdtu$Zd$If]Za$Ff d$If d;$IfFf$Zd$If]Za$Ff d$If01EFGKLMST_`mny d;$IfFf$Zd$If]Za$Ff d$Ifny{ "()23DEPRVX^_hivw "&(h>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJTyz{Ff$Zd$If]Za$Ff. d$If !"()23DEP d;$IfFf%$Zd$If]Za$Ffh d$IfPQRVWX^_hivwFf? d;$If$Zd$If]Za$Ff d$If d;$IfFfY$Zd$If]Za$Ff  d$If !"&'(./;<JKVWXYZ[\]^_`~Ffs d;$If$Zd$If]Za$Ff d$If(./;<JKVX`~ $%34?AEGMNVWefqswy˿˿˿h>mSCJ OJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphFFf$$Zd$If]Za$Fft d$If d<$If Ff.$Zd$If]Za$Ff') d$If$%34?@AEFGMNVWefqrswxFf17$Zd$If]Za$Ff2 d;$If d$IfxyFfK@$Zd$If]Za$Ff; d$If!'(12EFY[_aghrs}~ )*<=OQUW]^rs!#h>mSCJOJPJQJh>mSCJOJPJQJ\ !'(12EFYZ[_`agFfeI$Zd$If]Za$FfD d$Ifghrs}~FfR$Zd$If]Za$FfM d;$If d$If )*<=OPQUVW]Ff[$Zd$If]Za$Ff W d;$If d$If]^rsFfd d;$If$Zd$If]Za$Ff&` d$If!"#)*:;LM`abfghnFfm$Zd$If]Za$Ff@i d;$If d$If#)*:;LM`bfhnoz{ #%268>?PQhiz| "h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJRnoz{Ffv$Zd$If]Za$FfZr d;$If d$If #$%&'()*+,-./012678>$Zd$If]Za$Ff FfE{ d$If>?PQhiz{|FfY$Zd$If]Za$Ff̄ d;$If d$If "Ffs$Zd$If]Za$Ff d;$If d$If"#./ABSTUYZ[abmn{|Ff$Zd$If]Za$Ff d$If"#./ABSUY[abmn{| 01=>IKOQWXcdrs~°"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJ OJPJQJUh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ> Ff$Zd$If]Za$Ff d;$If d$If01=>IJKOPQWXcdrs~Ff{$Zd$If]Za$Ff4 d;$If d$If% d$If^Hd^HddFf d$If$%&5IJMPUWcfoq ʾ|r|r|r|r|rh>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hCfB*CJph$hm`B*CJph$h>mSCJOJPJQJ,%&456785kd`$$Ifֈx0lp&xx`d 4ap< 0d$If^0 d$If89:;<=>?@ABCDEFGHIJMNOPUVW$2d=$If]2a$Ff d$IfWcdefopq$ d$If] a$Ff| d$If^ d$If^ d$If \d$If^\Ff d$If d$If^ d$If^ d$If^ @d$If^@$Zd$If]Za$ d$IfFf2 "#12=> d;$IfFf d$If$Zd$If]Za$Ff "#12=?CEKLVWefqswy "()34BCNPTV\]jkwxh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJL>?CDEKLVWefqrswxyFf d;$If d$If$Zd$If]Za$FfFf d;$If d$If$Zd$If]Za$Ff6 !"()34BCNOPTUV\]jkwxFf d;$If d$If$Zd$If]Za$FfP$Zd$If]Za$FfK d>$If d$IfFfj #%)+12=>KLWYapq '(56ACGIOP[\ijuw{}h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJM$Zd$If]Za$Ff>Ff  d$If #$%)*+12=>EKLWX$Zd$If]Za$Ff~ Pd;$If^P d;$If d$IfXYZ[\]^_`apq$Zd$If]Za$Ffl  d>$If d$IfFf[$Zd$If]Za$Ff_+Ff% d$If '(56ABCGHIFf 5$Zd$If]Za$Ff0 d$IfIOP[\ijuvw{|}Ff&>$Zd$If]Za$Ff9 d;$If d$If 359;ABLMYZegkmst~ 2=ERacijxy"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJP 3459:;Ff@G$Zd$If]Za$FfB d;$If d$If;ABLMYZefgklmst~FfZP d;$If$Zd$If]Za$FfK d$If FfY Pd;$If^P$Zd$If]Za$FfT d;$If d$If 23456789:;<=>?@ABCDEFf_ d:$If d$IfERSTUVWXYZ[\]abcijxyFfo$Zd$If]Za$Ffh d$If23GHIMFfx$Zd$If]Za$Fft d;$If d$If23GIMOUVcdop#$AGKMSThimp{}h>mSB*CJOJPJQJphh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJQMNOUVcdopFf$Zd$If]Za$Ff(} d$If #$ABCDEFGFfFfB d$IfGKLMSThimnop{|}Ffؐ d;$If d$If$Zd$If]Za$-.<Ff$Zd$If]Za$Ff d$If-.<>BDJK]^op{}!%'-.9:GHSUY[abqr~h>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJR<=>BCDJK]^op{|}Ff $Zd$If]Za$Ff d$If !FfFf& d$If$Zd$If]Za$Ff!%&'-.9:GHSTUYZ[abqr~FfͺFf@ d$If$Zd$If]Za$$Zd$If]Za$FfFf+ d$If !"23456789:Ff d$If"2=ACIJVWdeprvx~PRUiʺvhm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJ.:;<=ABCIJVWdepqrvwx~Ff d;$If$Zd$If]Za$Ff d$IfFf4 Pd$If^P$Zd$If]Za$Ff d$IfQRSTU d$If^Hd^HddFfW d$Ifik!#&(*,157=>LMgh}ɽ{{{{{oh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSCJOJPJQJh>mSB*CJph$hm`B*CJph$hCfB*CJph$+>5555 d$Ifkd-$$Ifֈx0lp&xx`d 4ap< 0d$If^0$2d=$If]2a$Ff d$If$ d$If] a$Ff d$If^ d$If \d$If^\     Ff5 d$If !#$%&()*,-./ d$If^ ,d$If^, d$If^ @d$If^@$Zd$If]Za$Ff d$If/01567=>LMgh}~Ff$Zd$If]Za$Ff  d$If FfD d;$If$Zd$If]Za$Ff d$If *+67BDHJPQno/157=>QRef~h>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJU  *+67BCDHIJPQno d;$IfFf^'$Zd$If]Za$Ff" d$If/0Ffx0$Zd$If]Za$Ff+ d$If01567=>QRef~Ff>Ff9 d$If$Zd$If]Za$Ff5)*+/Ff9GFfB d$If$Zd$If]Za$)+/178VW`cz   (78U\`bhjmpy{蠬h>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJRHc"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJ@DFLM\]ijsu}&(,.²ܲܲh>mSCJ OJPJQJh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJRHch>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJA    )*+,>?@DEFLM\]iFf3}$Zd$If]Za$Fffx d$Ifijstuvwxyz{|}$Zd$If]Za$Ff! d<$IfFf  d$IfFfDFf d$If&'(,-.45EFXYklmFfFfd d;$If d$If$Zd$If]Za$.45EFXYku  !56IKOQWXcdqr}&(,.45"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJTmnopqrstu$Zd$If]Za$Ffn d$If  Ff$Zd$If]Za$Ff d;$If d$If !56IJKOPQWXcdqr}~Ff0$Zd$If]Za$Ff d$IfFfJ d;$If$Zd$If]Za$Ff d$If&'(,-.45?@JOPcdeijkqFf d;$If^$Zd$If]Za$Ff d;$If d$If5?@OPceikqr|}      ! ; < O Q U W ] ^ l m ~                          # $ . / A B T V Z \ b c ~  "h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJTqr|}Ff$Zd$If]Za$FfA d;$If d$If               ! ; < $Zd$If]Za$FfK d$If< O P Q U V W ] ^ l m ~               Ff$Zd$If]Za$Fff d$If                   # $ . / A B Ff] d;$If$Zd$If]Za$Ff d$IfB T U V Z [ \ b c ~               Ffw d;$If$Zd$If]Za$Ff d$If                       / 1 5 7 = > I J ^ _ t v z |                        ! . / A C X Z ]  °"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJD                / 0 1 5 6 7 = > I Ff$Zd$If]Za$Ff$ d$If dd$If^dI J ^ _ t u v z { |                 FfK $Zd$If]Za$Ff d$If            ! . / A B C D E F G H I J K Ff$Zd$If]Za$Ff d$IfK L M N O P Q R S T U V W X [ \ ]         d$If^Hd^HddFfN d$If             ' * 3 5 F J K O a v w y { }                ¶tjtjtjtjh>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz)       >5555 d$IfkdT$$Ifֈx0lp&xx`d 4ap< 0d$If^0                          $2d=$If]2a$Ff  d$If ' ( ) * 3 4 5 F G H I J K O P Q R S T U V W X $ d$If] a$Ff' d$If^ d$If \d$If^\X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t Ff\0 d$Ift u v w y z { } ~              d$If^ ,d$If^, d$If^ @d$If^@$Zd$If]Za$Ff69 d$If                      FfI$Zd$If]Za$FfA d$If         !"./ABY[_aghxy  01IKOQWXijqt޺h>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJE!"./ABYZ[_`aghxy d;$IfFf-R d$If$Zd$If]Za$FfMFf[ d$If$Zd$If]Za$FfV  01IJKOPQWXijqrstFfd d$If$Zd$If]Za$Ff_$Zd$If]Za$FfnFfli d$If+268>ALMacpx $%:;QSWY_`ĸh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ3FfyFft d$If+,-./012678>?@ALMa$Zd$If]Za$Ff d<$If d$IfabcdefghijklmnopqrstuvwxFfۉFf d$If d>$If^ d>$IfFf d$IfFf+$Zd$If]Za$Ff: d$If  $%/:;QRSWXYFfͨ d;$If^ d;$If$Zd$If]Za$Ff d$IfY_`opzFfg$Zd$If]Za$Ff d;$If^ d;$If d$If`op*,0289OPZ]oqy%&BI\¶h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJRHah>mSCJOJPJQJh>mSCJOJPJQJ>*+,01289OPZ[\]op$Zd$If]Za$Ff d;$If d$Ifpqrstuvwxy$Zd$If]Za$Ff" d$IfFfFfoFf d$If%&BCDEFGHIJKLMNOPQRSTUVWXYZ[Ff d$If[\`abhijklFf d$If$Zd$If]Za$Ff    Ff$Zd$If]Za$Ff d$If)*JQdjpt !#)*;<OPdfjlrsдh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJB  )*JKLMNOPQRSFfFfe d$IfSTUVWXYZ[\]^_`abcdhijpqrst$Zd$If]Za$Ff d$If d;$IfFf$Zd$If]Za$Ff d$If !"#)*;<OPdefjklrsFfT $Zd$If]Za$Ffg d$IfFfn d;$If$Zd$If]Za$Ff d$If!'(89JK^`dflm}~45CDOQUW]^sth>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJU !'(89JK^_`deflm}~Ff d;$If$Zd$If]Za$Ff d$If~Ff'$Zd$If]Za$Ff# d$If d;$If45CDOPQUVW]^stFf0$Zd$If]Za$Ff/, d$If d;$IftFf&:$Zd$If]Za$Ffi5 d$If d;$If&*,23@ANOZ\`bhivw 23JK]_ceklh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJI !"#$%Ff> d;$If d$If%&*+,23@ANOZ[\`abhivwFfPFfKL d$If$Zd$If]Za$Ff0E  FfYFfeU d$If$Zd$If]Za$23JK]^_cdeklFfb$Zd$If]Za$Ff^ d;$If d$If  Hd^HddFfg d$If  BCDSghknsu}k}k}k}k}k}_k_Skkkh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJU    CDR 0d$If^0 d$If^ d$IfRSTUVWXYKBBBBBB d$Ifkdk$$Ifֈx0lp&xx`d 4ap<YZ[\]^_`abcdefghklmnstu \d$If^\$2d=$If]2a$Ffo d$If$ d$If] a$Ff w d$If^  d$If^  d$IfFfFf d$IfFf d$If^ 8d$If^8 d$If^ @d$If^@ d$If$Zd$If]Za$!#')/0EFST_aegmn~$%>@DFh>mSB*CJOJPJQJph""""h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJph3!"#'()/0EFST_`aefFfW$Zd$If]Za$Ffʖ d;$If d$Iffgmn~ d:$IfFf d;$If d$If$Zd$If]Za$FfFf d$If$%>?@DEFLM`auvFf$Zd$If]Za$Ffq d;$If d$IfFLM`auv$&*,23JKYZoquw}~,379?BUVgivh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJH$%&*Ff d;$If$Zd$If]Za$Ff d$If*+,23JKYZopquvw}~Ff2$Zd$If]Za$Ff d;$If d$If,-./01 d<$IfFf d$If123789?@ABUVghijklmnopqrstFfF$Zd$If]Za$Ff d$Iftuvwxyz{|}~FfFf d$Ifv-.AHLNTWopy{ * 4 M T g k m s z    ܨܴܜܜ܄܄܄h>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ2Ff$Zd$If]Za$Ff= d$If d=$If     FfVFfD d$If-.ABCDEFGHLMNTUVWopyz$Zd$If]Za$Ff d=$If d$Ifz{|}~Ff d$IfFf@FfO d>$If d$IfFf   # $ % & ' Ff d$If' ( ) * + , - . / 0 1 2 3 4 M N O P Q R S T U V W X Y Z Ff2&Ff  d$IfZ [ \ ] ^ _ ` a b c d e f g k l m s t u v w x y z   $Zd$If]Za$Ffv, d$If                          Ff7 d$If$Zd$If]Za$Ff2                 ! !!!(!*!.!0!6!7!A!B!S!T!_!a!e!g!m!n!x!y!!!!!!!!!!!!!!!!!!!!! " " "*"="H"L"N"T"U"^"_"s"t"""""""""""""""h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJT               ! !!!(!)!*!.!/!0!6!7!FfD$Zd$If]Za$Ff= d$If7!A!B!S!T!_!`!a!e!f!g!m!n!x!y!!!!!!!!!!!FfM d;$If$Zd$If]Za$Ff@I d$If!!!!!!!!!!!!!!! " " "!"""#"$"%"&"'"("FfV$Zd$If]Za$FfZR d$If(")"*"=">"?"@"A"B"C"D"E"F"G"H"L"M"N"T"U"^"_"s"t""$Zd$If]Za$Ff8] Pd$If^P d$If""""""""""""""""""""""""##Ffh$Zd$If]Za$Ffd d$If""""""""#####5#<#n#p#v#w############### $ $$$$$%$&$<$=$O$Q$U$W$]$^$i$j$w$x$$$$$$$$$$$$$$$$$$$$$%%%9%:%V%]%a%h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJP## # # # # ######5#6#7#8#9#:#;#<#@#A#B#H#I#J#$Zd$If]Za$Ff*r d$IfFf1mJ#K#L#T#U#h#i#j#n#o#p#v#w##############Ff|$Zd$If]Za$Ffw d$If#### $ $ $$$$$$%$&$<$=$O$P$Q$U$V$W$]$^$i$j$Ff΅$Zd$If]Za$FfA d$Ifj$w$x$$$$$$$$$$$$$$$$$$$$$$$$Ff$Zd$If]Za$Ff[ d$If$$$%%%%%%%%%%%9%:%V%W%X%Y%Z%[%\%]%a%b%$Zd$If]Za$FfƘFfœ d$Ifb%c%i%j%k%l%{%|%%%%%%%%%%%%%%%%%%%$Zd$If]Za$FfFfL d$Ifa%c%i%l%{%|%%%%%%%%%%%%%%%%%%%%&&&&&!&'&(&2&3&@&A&L&N&R&T&Z&[&e&f&r&s&~&&&&&&&&&&&&&&&&&&&&&&'''Ƹjh>mSOJPJQJUh>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJG%%%%%%%%%%%%%%%%%%&&&&&& &!&Ff`$Zd$If]Za$Ffӧ d$If!&'&(&2&3&@&A&L&M&N&R&S&T&Z&[&e&f&r&s&~&&&&&&&Ffz$Zd$If]Za$Ff d$If&&&&&&&&&&&&&&&&&&&&&&&'''FfN$Zd$If]Za$Ff d$If''''''' ' ' ' ' ''''''''g'h'i'j'k'' d$If^Hd^HddFf] d$If'f'h'k'''''''''''''''''((('(((*(+(-(/(1(3(5(7(9(>(E(Ƽаzznbh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz#'''''''5kd3$$Ifֈx0lp&xx`d 4ap< 0d$If^0 d$If''''''''''''''''''''''''' \d$If^\$2d=$If]2a$Ff d$If'''''''''''(((((( ( ( ( ( ((($ d$If] a$Ff d$If^ d$If^ d$If((((((((((((((((( (!("(#($(%(&('(((FfFf d$If((*(+(-(.(/(1(2(3(5(6(7(9(:(;(<(=(>(?(@(A(Ff d$If^ d$If^ d$If^ d$If^ d$If$Zd$If]Za$A(B(C(D(E(c(d(e(f(g(h(i(j(k(l(m(n(r(s(y(z((( Pd$If^P dd$If^d$Zd$If]Za$Ff d$IfE(c(n(r(s(y(z((((((((((((((((((()) ) ))))))*)5)>)O)Z)^)_)e)f)|)})))))))))))))))))))**** *!*,*.*2*3*9*:*Q*R*]*_*c*d*h>mS5CJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphO((((((((((((((((((((Ffx d;$If^ Pd;$If^P dd$If^d$Zd$If]Za$FfW d$If d$If^((((())) ) ))))))*)5)6)7)8)9):);)<)Ff dd$If^d$Zd$If]Za$Ff] Pd$If^P d$If<)=)>)O)P)Q)R)S)T)U)V)W)X)Y)Z)^)_)e)f)p)w)|) d$If^ Pd$If^P dd$If^d$Zd$If]Za$Ff  d$If|)}))))))))))))))))))))))Ff1 Pd$If^P dd$If^d$Zd$If]Za$FfL d$If)))***** *!*,*-*.*2*3*9*:*D*K*Q*R*]* Pd$If^PFf Pd;$If^P dd$If^d$Zd$If]Za$Ff d$If]*^*_*c*d*j*k*v****************Ff# Pd;$If^P dd$If^d$Zd$If]Za$Ff d$Ifd*j*k***********************++#+$+8+:+>+?+E+F+\+]+h+j+n+o+u+v+++++++++++++++++, ,,,,,!,",7,8,C,E,I,J,P,Q,f,g,r,t,x,y,,,,,,h>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJU**************+++#+$+8+9+:+>+Ff.Ff++ Pd$If^P dd$If^d d$If$Zd$If]Za$Ffv'>+?+E+F+Q+\+]+h+i+j+n+o+u+v++++++++++FfJ6$Zd$If]Za$Ff2 Pd;$If^P dd$If^d d$If+++++++++++++, ,,,,,,!,",,,Ff= dd$If^d$Zd$If]Za$Ff9 Pd;$If^P d$If,,7,8,C,D,E,I,J,P,Q,[,f,g,r,s,t,x,y,,,,,,FfE dd$If^d$Zd$If]Za$FfiA d$If Pd;$If^P,,,,,,,,,,,,,,,,,,,,,--FfL Pd;$If^P dd$If^d$Zd$If]Za$FfH d$If,,,,,,,,,,,,,,,,---- --#-$-/-1-5-6-<-=-S-T-_-a-e-f-l-m---------------------.. . .$.%.0.2.6.7.=.>.X.Y.d.f.j.k.q.r.........h>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJU---- ---#-$-/-0-1-5-6-<-=-G-S-T-_-`-a-e-FfWFfS Pd;$If^P dd$If^d d$If$Zd$If]Za$Ff=Pe-f-l-m-w------------------FfM_ d;$If^$Zd$If]Za$Ff\[ Pd;$If^P dd$If^d d$If----------.. . .. .$.%.0.1. d$If^ Pd$If^P$Zd$If]Za$Ff2c Pd;$If^P dd$If^d d$If1.2.6.7.=.>.M.X.Y.d.e.f.j.k.q.r.~..... Pd;$If^PFfk Pd$If^P dd$If^d d$If$Zd$If]Za$Ff#g..................... Pd$If^PFfrr Pd;$If^P dd$If^d d$If$Zd$If]Za$Ffn............//(/,/-/3/4/[/\/q/s/w/x/~//////////////////0000!0"0(0)0=0>0T0V0]0t0~000000躪h>mSCJOJPJQJh>mSB* CJOJPJQJphh>mSCJOJPJQJh>mSB*CJOJPJQJph"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJ>..////////// /!/"/#/$/%/&/'/(/,/-/3/4/ dd$If^d$Zd$If]Za$Ff{ d$IfFf'v4/L/[/\/q/r/s/w/x/~/////////////Ffڅ Pd$If^P dd$If^d$Zd$If]Za$Ff% Pd;$If^P d$If///////////00000!0"0(0)030 d;$If dd;$If^dFfD dd$If^d$Zd$If]Za$Ff d$If Pd$If^P30=0>0T0U0V0W0X0Y0Z0[0\0]0t0u0v0w0x0y0z0{0|0}0~0Ff d@$IfFfϐ d;$If d$If Pd;$If^P~00000000000000000000000000000Ff d$If000000000000000000000000111Ff Pd$If^PFf  d$If00001%1/161P1f11111111111111222(2*2.2/25262M2U2X2j2l2p2q2w2x22222222̢̼̼h>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJRHch>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJh>mSB* CJOJPJQJphh>mSCJOJPJQJ/111111%1&1'1(1)1*1+1,1-1.1/101112131415161P1Q1R1S1T1Ff d$IfT1U1V1W1X1Y1Z1^1_1e1f11111111111111Ffb dd$If^d$Zd$If]Za$Ffѳ d$If1111111111222(2)2*2.2/25262M2U2Ff, Pd$If^P dd$If^d$Zd$If]Za$Ffw d$If Pd;$If^PU2V2W2X2j2k2l2p2q2w2x2222222222222FfR Pd$If^P dd$If^d$Zd$If]Za$Ff= d$If2222222222222222233333K3L3M3 d$If^Hd^HddFf d$If2333J3K3M3\3p3q3t3v3{3}3333333333333333333333ƼаzznZ&h>mS5B*CJOJPJQJRHXphh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz"M3[3\3]3& d$Ifkdy$$If֞x0ll p&xx`d4apF 0d$If^0]3^3_3`3a3b3c3d3e3f3g3h3i3j3k3l3m3n3o3p3q3t3u3v3{3|3}3$2d=$If]2a$FfA d$If}3333333333333333333333$ d$If] a$Ff d$If^  d$If^  d$If \d$If^\3333333333333333333333333333FfS d$If33333333333333333333 d$If^ 8d$If^8 d$If^ d$If^$Zd$If]Za$ d$IfFf33333344 4!424344454647484<4=4C4D4S4T4[4Ff d;$If dd$If^d d$If$Zd$If]Za$Ff3333344 4!42484<4=4C4D4S4T4[4\4n4t4v4z4{44444444444444444455 5 55555%5&585>5@5D5E5K5L5X5Y5e5f5v5|5555555ааааааааh>mSB*CJOJPJQJphh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJRHch>mSOJPJQJh>mSCJOJPJQJE[4\4n4t4u4v4z4{4444444444444444Ff dd$If^d$Zd$If]Za$Ff d$If^ d$If44444444555 5 55555%5&585>5?5$Zd$If]Za$Ff  d$If^ d;$If d$If dd$If^d?5@5D5E5K5L5X5Y5e5f5v5w5x5y5z5{5|555555Ff d;$If dd$If^d d$If$Zd$If]Za$FfJ5555555555555555555566Ff dd$If^d$Zd$If]Za$Ff d$If^ d$If Pd;$If^P555555555555566 6 666%6&686>6@6D6E6K6L6Y6Z6b6c6u6z6|66666666666666666666 777777 7-7.78797K7P7R7V7W7]7^7s7t77777777h>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJRHcP6 6 666%6&686>6?6@6D6E6K6L6Y6Z6b6c6u6z6{6$Zd$If]Za$Ff! d$If^ d;$If d$If dd$If^d{6|666666666666666666666Ff* d$If^ d;$If dd$If^d d$If$Zd$If]Za$Ffo&6 77777777 7-7.78797K7P7Q7R7V7W7]7^7Ff4 d;$If dd$If^d$Zd$If]Za$Ffq/ d$If^ d$If^7s7t77777777777777777777Ff< dd$If^d$Zd$If]Za$Ff8 d$If^ d;$If d$If777777777777778888"8$8(8)8/808I8J8b8c8{8}88888888888888888888888899999$9%97999=9>9D9E9U9V9_9`9r9x9z9~99999999h>mSB*CJOJPJQJph"""h>mSCJOJPJQJRHch>mSCJOJPJQJh>mSCJOJPJQJP77778888"8#8$8(8)8/808I8J8b8c8{8|8}888FffE d;$If$Zd$If]Za$FfEA dd$If^d d$If8888888888888888888888 d;$If$Zd$If]Za$FfI d$If^ d$If dd$If^d88899999$9%9798999=9>9D9E9U9V9_9`9r9x9 d$If^FfiR dd$If^d d$If$Zd$If]Za$FfNx9y9z9~999999999999999999::Ff[ d$If^ dd$If^d$Zd$If]Za$FfV d$If9999999999:::: :$:%:+:,:H:I:W:X:j:o:q:u:v:|:}::::::::::::::::;;; ; ;;;+;,;:;;;L;R;V;W;];^;h;i;p;q;;;;;;;;;;;<<<<<<h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJRHcQ:::: :$:%:+:,:H:I:W:X:j:o:p:q:u:v:|:}:::Ffc dd$If^d$Zd$If]Za$Ff_ d$If^ d$If:::::::::::::::;;;; ; ;;;Ffl dd$If^d$Zd$If]Za$Ffnh d$If^ d$If;+;,;:;;;L;M;N;O;P;Q;R;V;W;];^;h;i;p;q;;;; d$If^ d;$If dd$If^d$Zd$If]Za$Ffq d$If;;;;;;;;;;;;;;;;;;;;;;$Zd$If]Za$Ff{ Pd>$If^P d>$If d$IfFfv;;;;;;;;;;;;<<<<<<<</<4<5< d;$If$Zd$If]Za$Ffi d$If^ d$If dd$If^d<<</<4<6<:<;<A<B<N<O<X<Y<k<p<r<v<w<}<~<<<<<<<<<<<<<<<<<<<<<< = ===1=6=8=<===C=D=R=S=\=]=o=u=w={=|=============h>mSB*CJOJPJQJphh>mSCJOJPJQJRHch>mSCJOJPJQJh>mSCJOJPJQJI5<6<:<;<A<B<N<O<X<Y<k<p<q<r<v<w<}<~<<<<<<Ff{ d$If^ dd$If^d d$If$Zd$If]Za$Ff <<<<<<<<<<<<<<<<<<< = ===Ff= dd$If^d$Zd$If]Za$Ff d$If d$If^=1=6=7=8=<===C=D=R=S=\=]=o=u=v=w={=|=====Ff dd$If^d$Zd$If]Za$Ff~ d$If^ d$If======================Ff d$If^ dd$If^d$Zd$If]Za$Ff d$If d;$If==========>>>>%>&>8>>>@>D>E>K>L>a>b>i>j>|>>>>>>>>>>>>>>>>>>>>>>?? ? ???? ?'?(?:?@?B?F?G?M?N?`?a?m?n?y??????????h>mSCJOJPJQJRHch>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJph"""O===>>>>%>&>8>>>?>@>D>E>K>L>a>b>i>j>|>>Ff2 d$If^ d;$If dd$If^d d$If$Zd$If]Za$>>>>>>>>>>>>>>>>>>>>>>Ff d$If^ d;$If dd$If^d$Zd$If]Za$Ff d$If>>??? ? ???? ?'?(?:?@?A?B?F?G?M?N?`?a?Ff d$If^ dd$If^d$Zd$If]Za$Ffe d$Ifa?m?n?y?z?{?|?}?~??????????????Ffx d$If^ dd$If^d$Zd$If]Za$Ffw d$If d;$If??????????????@@@@@@@ @2@7@9@=@>@D@E@P@Q@_@`@r@t@x@y@@@@@@@@@@@@@@@@AAAAA0A2A5Aھh>mSOJPJQJjh>mSCJ OJPJQJUh>mSCJ OJPJQJh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJRHc;????????????@@@@@@@ @2@7@8@ d$If^Ff dd$If^d d$If$Zd$If]Za$8@9@=@>@D@E@P@Q@_@`@r@s@t@x@y@@@@@@@@@ d$If^Ff[ dd$If^d d$If$Zd$If]Za$Ff @@@@@@@@@AAAAAAAAA A!A"A#A$AFf d$If^ dd$If^d$Zd$If]Za$Ff d$If$A%A&A'A(A)A*A+A,A-A.A/A0A3A4A5AAAAAAAAA d$If^Hd^HddFf d$If5AAAAAAAAAAAAAABB B BB"B#B'B8BMBNBPBRBTBVBXBZB\B^B`BfBjBƼаzznbh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz#AAAA& d$Ifkd$$If֞x0l p&xx`d4apF d$If^AAAAAAAAAAAAAAAAAAAAAAAAAAA$2d=$If]2a$Ff d$IfAAABBB B B BBB B!B"B#B'B(B)B*B+B,B-B$ d$If] a$FfH d$If^ d$If^ \d$If^\ d$If-B.B/B0B1B2B3B4B5B6B7B8B9B:B;BB?B@BABBBCBDBEBFBGBHBIBFf\ d$IfIBJBKBLBMBNBPBQBRBTBUBVBXBYBZB\B]B^B`BaBbB d$If^ d$If^ d$If^ @d$If^@$Zd$If]Za$Ff d$IfbBcBdBeBfBjBkBlBrBsBBBBBBBBBBBBBBB CFf Pd$If^P$Zd$If]Za$Ff d$IfjBlBrBsBBBBBBBBBBBCCCCCCNCOCfChClCnCtCuCCCCCCCCCCCCCCCCCDDD"D#D5D;D?DADGDHDcDsDtDDDDDDDDDDDDDDDDDE EEh>mSCJOJPJQJh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJL CCCCCCCCCE?E@EAEEEFEGEMERESE dd$If^d$Zd$If]Za$Ff9 Pd>$If^P d>$If d$IfE7EAEuEwE}E~EEEEEEEEEEEEEE F FFFFF9F:FTFVF^FFFFFFFFFFFFG G GGG6G8GGGKGMGSGTGmGnGGGGGGGGGGܺh>mSCJ OJPJQJh>mSCJ OJPJQJ"h>mS5B*CJOJPJQJphh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ@SETEUEVEWEiEoEpEqEuEvEwE}E~EEEEEEEEEEEEFfD Pd;$If^P$Zd$If]Za$Ff[? d$IfEEEEEEEEEEEEEEEEEEEEEEEEEE$Zd$If]Za$FfeK d$IfEEEF F F FFFFFF-F9F:FLFTFUFVFWFXFYFZF[F\FFfV$Zd$If]Za$FfdR d$If Pd;$If^P\F]F^FvFFFFFFFFFFFFFFFFFFFFFF$Zd$If]Za$Ff[ Pd=$If^P d$IfFFFFFFFFFFFFFFFFFFFFFFFFFFFFffFfa d$IfFFFFGGGGGG G G GGGGGGGG)G6G7G8G9GFfAr$Zd$If]Za$Ff{l d$If Pd>$If^P9G:G;GG?G@GAGBGCGDGEGFGGGKGLGMGSGTGaGmGnGGG Pd;$If^P$Zd$If]Za$Ffw d$IfGGGGGGGGGGGGGGGGGGGGGGH HHFf̀ Pd;$If^P d$If$Zd$If]Za$Ff|GGGGGGGG HHHHHH>H?HWHYH]H_HeHfHHHHHHHHHHHHHI IIEIMIIIIIIIIIIIIIIIIIJJ J J*J+J6JmSCJOJPJQJRHbh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJJHHHHHHH+H>H?HWHXHYH]H^H_HeHfHuHHHHHHFf Pd$If^P d$If$Zd$If]Za$Ff>HHHHHHHHHHHHHHHHHHHHHHHHHH$Zd$If]Za$FfM d$IfFfЍHHHHHHHII I I I I IIIIIIIII4I d>$IfFf d;$If^ Pd;$If^P d$If4IEIFIGIHIIIJIKILIMIQIRISIYIZIbIcIdIeIfIyIzI{IIIFf`$Zd$If]Za$Ff d$If Pd>$If^PIIIIIIIIIIIIIIIIIIIIIIIII$Zd$If]Za$Ffa Pd$If^P d$IfIIIIIJJJ J JJ*J+J6J7J8J9J:J;JmSCJOJPJQJh>mSCJOJPJQJ\JJJJJJJJJJJJJJJJJJJJJJJK$Zd$If]Za$Ff d;$If^ Pd;$If^P d$IfKKKKKKKKKKKK"K#K.K5K:K;KFKGKHKIKJKKK d;$If^ Pd;$If^P$Zd$If]Za$Ff d$IfKKLKPKQKRKXKYKcKqKrK}K~KKKKKKKKKKKKKKFf) Pd$If^P d$If$Zd$If]Za$FfKKKKKKKKKKKKKKKKLLLLLL LFf d$If^ Pd$If^P$Zd$If]Za$Ff  d$If LLLL"L'L(L3L4L5L6L7L8L9L=L>L?LELFLPLcLdLxLyL$Zd$If]Za$Ff d$If^ Pd$If^P d$IfyLzL~LLLLLLLLLLLLLLLLLLLLLFf d$If^ Pd$If^P d$If$Zd$If]Za$FfLLLLLLLLLLLLLM MMMMMMMM d;$If^ Pd;$If^P$Zd$If]Za$Ff Pd$If^P d$IfMM M$M%M&M,M-MmS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ>zMMMMMMMMMMMMMMMMMMMMMMMM d;$If^$Zd$If]Za$Ff d$If Pd;$If^PMMMMMMMMMMMMNNNNNNN N N NNFf< d;$If^ Pd;$If^P$Zd$If]Za$Ffo  d$IfNNN-N.N9N:N;NN?NCNDNENKNLNXNfNgNrNsNtNuNvN$Zd$If]Za$Ff Pd$If^P d$IfvNwNxN|N}N~NNNNNNNNNNNNNNNNNNNNFf! Pd$If^P$Zd$If]Za$Ff. d$IfNNNNNNNNNNNNNN(O)O*O+O,ObOcOqO 0d$If^0 d$If^Hd^HddFf& d$If)O,OaObOcOrOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOPPPP P!P5P7P;P=PȼȪȪȪȪȪȆ|||||ph>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJRH`ph$h>mSB*CJph$hm`B*CJph$h>mSCJOJPJQJ,qOrOsOtOuOvOwOxOKBBBBBB d$Ifkd*$$Ifֈx0lp&xx`d 4ap<xOyOzO{O|O}O~OOOOOOOOOOOOOOOO \d$If^\ dd$If^d$2d=$If]2a$Ff$. d$IfOOOOOOOOOOOOOOOOOOOOOOOO$ d$If] a$Ff4 d$If^ d$If  d$If^ OOOOOOOOOOOOOOOOOOOOOOOOO @d$If^@$Zd$If]Za$FfC d$IfFf6<OOOOOOOOOOOOOOOPPPP P!P5P$Zd$If]Za$Ff.K d$If^ 8d$If^8 d$If^ d$If5P6P7P;PmSCJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJKPPPPPPPPPPPPPQQQQ Q QQQ/Q0Q;QmS5B*CJOJPJQJphh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ;lRRRRRRRRRRRRRRRRRRRRRRRRRR$Zd$If]Za$FfTFf  d$IfRRRRRRRRRRRRRRRRRRRRRRRRRR$Zd$If]Za$FfFfJ d$IfRRRRSSSSSSSSSSSSS S!S"S#S$S(S)S*S0S$Zd$If]Za$FfiFf d$If0S1SGSHSZS[SmSnSoSsStSuS{S|SSSSSSSSSSSSFf d;$If$Zd$If]Za$Ff) d$IfSSSSSSSSSSSSSSSSTTTTTTTTTTFf*FfC d;$If d$IfTTT T&T'T2T3TBTCTNTOTPTTTUTVT\T]TpTqT~TTTTFfa d;$If <d$If^< d$If$Zd$If]Za$T T&T'T2T3TBTCTNTPTTTVT\T]TpTqT~TTTTTTTTTTTTTTTTTTTTTTTTUU U UUU1U2UFUHULUNUTUUUbUcUrUsUUUUUUUUUUUUUUUUVV V VVV V"Vh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJPTTTTTTTTTTTTTTTTTTTTTTTTTFf{ d;$If d$If$Zd$If]Za$FfTTUUU U UUU1U2UFUGUHULUMUNUTUUUbUcUrUsUUU d;$IfFf d$If$Zd$If]Za$FfUUUUUUUUUUUUUUUUUUUUUUUUU d;$If$Zd$If]Za$Ff d$IfFf"UUVVV V V VVV V!V"V1V2V3V?V@VAVBVCVDVEVFVGVFf d>$If$Zd$If]Za$Ff d$If"V1V3V?VAVOVSVUV[V\VgVhVuVvVVVVVVVVVVVVVVVVVVVVVVVVVWWWWWW)W+W/W1W7W8WVWWWmWnWWWWWWWWWWWWWWWWWWWXX$X&X׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿׿h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJph"""KGVHVIVJVKVLVMVNVOVSVTVUV[V\VgVhVuVvVVVVVVVVVFf$Zd$If]Za$Ff d$IfVVVVVVVVVVVVVVVVVVVVVVVWWFf d;$If$Zd$If]Za$FfX d$IfWWWWW)W*W+W/W0W1W7W8WVWWWmWnWWWWWWWWWFf$Zd$If]Za$Ffr d;$If d$IfWWWWWWWWWWWWWWWXX$X%X&X'X(X)X*X+XFf$Zd$If]Za$Ff d;$If d$If+X,X-XKXLXeXfXgXhXiXjXnXoXpXvXwXxXyXzX{X|XXXXXFf $Zd$If]Za$Ff d>$If d$If&X-XKXLXeXjXnXpXvX|XXXXXXXXXXXXXXXXXXXXXXYYYY"Y#Y-Y.YmSOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJ OJPJQJh>mSB*CJOJPJQJph"""h>mSCJOJPJQJh>mSCJOJPJQJ9XXXXXXXXXXXXXXXXXXXXXXXXX d;$If$Zd$If]Za$Ff d$IfXXXXXXXXXXXYYYYYY"Y#Y-Y.YmS5CJOJPJQJhCfCJOJPJQJh>mSCJOJPJQJh>mS5>*CJOJPJQJh>mS5CJOJPJQJh>mS5>*CJOJPJQJh>mSB*CJph$h>mSOJPJQJhCfB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz!sZ[[j\k\]]`a}d~dees$ l{df]^`{a$d$ l~df]^`~a$d$ l{de]^`{a$d$ l{dd]^`{a$d$ cde]^`ca$ ]]"]]]]]^^^^^^^^^^^B`C``aaaaqara*b1b7b8b9bbbbcccc dddd}d~dddddddeeeee@fAffܭܡҕhm`CJOJPJQJhqCJOJPJQJh0LCJOJPJQJh~bCJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJh>mSCJOJPJQJhCfCJOJPJQJhl4tCJOJPJQJ:effyg{g|g}g~ggghhhii$ 0{dd]^0`{a$d 8"ld^lHd^Hdd8d$ l{d{]^`{a$d$ l{d[]^`{a$fffygzg~ggggghhhhhhiiiiijj"j'j(j0j5jjjjjmmmm/omSCJOJPJQJh>mSB*CJph$hqB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjh>mSOJPJQJUh>mS5CJOJPJQJh>mSOJPJQJ)ijjmmoorr u!uEvGvHvIvJvKvd2d8dddd$ 0{de]^0`{a$d$ 0{df]^0`{a$d$ 0{da]^0`{a$ooopppqqqrrrrrrr@s`s u!u&u'uEvFvKvvvvvvvܷܷܫܟ܏}kaWahqB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjh>mSCJOJPJQJUh0LCJOJPJQJhCJOJPJQJh>mS6CJOJPJQJhqCJOJPJQJhl4tCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJh>mS5CJOJPJQJKvvvvvvxx{{||2~3~d$ 0{dc]^0`{a$dd$ 0{de]^0`{a$dd8 8"ld^ld^vvvvvxxxxyyy{{{{{{{||||>}F}J}K}L}$~,~0~2~3~6~7~G~M~U~Y~Z~~~z^_ƺƺƺҺƺƺƢҒjh>mSCJOJPJQJUh+(CJOJPJQJh~bCJOJPJQJhqCJOJPJQJhl4tCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJh>mSB*CJph$8opd$0{df]^0`{a$d 8"ld^ld^d2d8d$ 0{da]^0`{a$d$ 0{df]^0`{a$np*+ijU]bopwx$PX\Ҍӌ׌،.Ҿwk_whgw=CJOJPJQJh>mSCJOJPJQJh+(CJOJPJQJhqCJOJPJQJhl4tCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSB*CJph$h>mSOJPJQJhqB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz%opҌӌ^_\]Z\]^_dd8d$ 0{dd]^0`{a$d$ 0{de]^0`{a$d$0{df]^0`{a$d$0{de]^0`{a$.Zaj^_cd\]ab!bjoZ[_Ŕܭܭ܅saWhm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjh>mSCJOJPJQJUh4CJOJPJQJh+(CJOJPJQJhl4tCJOJPJQJhqCJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJh>mSCJOJPJQJhCJOJPJQJhgw=CJOJPJQJ!_ĖŖ$%@A$ 0{dc]^0`{a$d$ 0{dd]^0`{a$d$ 0{de]^0`{a$dd8 8"ld^ld^ ŔǔckoĖŖɖʖ`$%@Әۘ2:>@Aeghۛᾲʙʾʾʾᾲʾʾʾʾhm`CJOJPJQJhl4t5CJOJPJQJh4CJOJPJQJhl4tCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSB*CJph$h>mSOJPJQJhm`B*CJph$hqB*CJph$7AϝНxssnd8d$ 0{dd]^0`{a$$ 0{df]^0`{a$d$ 0{dc]^0`{a$d$ 0{de]^0`{a$d$ 0{d^]^0`{a$ glϝН;<%*/7;ty}şǠˠӠؠ?AUĸĸĸĸЊxnhm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjh>mSCJOJPJQJUhgw=CJOJPJQJh4CJOJPJQJhl4tCJOJPJQJh>mSOJPJQJhOlCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJ'@Aߣ78GH~yd${de]^`{a$d$ l{dc]^`{a$d} ldd$ l{dd]^`{a$dd8 "d^d^dqUWvwߣ78<=GHO%z{-IJ*+FHIQʾʾʾʾʾʾᾦʾၾh&d5CJOJPJQJh0LCJOJPJQJhBSCJOJPJQJhl4tCJOJPJQJhQ6oCJOJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSB*CJph$h>mSOJPJQJhm`B*CJph$hBSB*CJph$-IJ*+HI¬ìp & F ]d]^`]dt & F ]d^`]dd ldd$dc]^a$d$ l{df]^`{a$d${da]^`{a$ ì$MOce  z{ܭ}pddh&dCJOJPJQJh&d5CJOJPJQJh>mSB*CJph$hBSB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjh>mSCJOJPJQJUh>mS5CJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJ*H*OJPJQJ'NO  d d^]^d "d^Hd^Hdqd8d${d[]^`{a$d${dd]^`{a$dx ,-δ|w|d & F ]d^]^`]d & F ]d[]^`]d$ & F ]dc]^`]a$d{dd ldd{d^]^`{ }ϴҴ<Gijҹ|qchwhw5OJQJ^Jhw5OJQJ^J0j%hWhWCJOJPJQJUmHnHuhwCJOJPJQJh4CJOJPJQJhl4tCJOJPJQJhm`CJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJhgw=CJOJPJQJh&dCJOJPJQJh>mSCJOJPJQJ%δϴ;< !d$ & F ]dc]^`]a$dd{ & F ]d^`]d & F ]d^]^`]d$ & F ]da]^`]a$d ºvvmHd^H $da$gdwd $d]a$d$a$gdw$ U"^`a$gdw$ l{dc]^`{a$gdW$ l{dc]^`{a$d${dc]^`{a$ º(*HIWXYefųzdzdzOzO:O(hsVfh>mS5B*CJOJPJQJph(hsVfh>mS5B*CJOJPJQJph+hsVfh>mS5>*B*CJOJPJQJph!hsVfh>mSB*OJPJQJphh>mSB*CJph$h>mSOJPJQJhBSB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphzhwh>mSOJPJQJ"hm`5B*CJOJPJQJphzhwOJPJQJ"jhw5CJOJPJQJUWXYef#$67efd & F ]d^`]d| dd$ wdj]^`wa$dds $d]a$dd8 "d^ٻڻ !cd"#$'(67SdfԽ׽ĠxexeeTFh4B*OJPJQJph!hsVfhOlB*OJPJQJph%hsVfh>mSB*CJOJPJQJph$hsVfh>mS5B*OJPJQJph(hsVfh>mS5B*CJOJPJQJph!hsVfh>mSB*OJPJQJph%hsVfhOlB*CJOJPJQJph(hsVfh>mS5B*CJOJPJQJph%hsVfhQ6oB*CJOJPJQJph%hsVfh>mSB*CJOJPJQJphֽ׽89pq:;_`¿dfdd & F ]d=]^`]dedrddz & F ]d^`]d79nq,48;`a+,RSjkmn཭͚|q||͚\LhBSB*CJOJPJQJph(jhBSB*CJOJPJQJUphhsVfh>mSB*phjhsVfh>mSB*Uphh4B*OJPJQJph%hsVfh>mSB*CJOJPJQJphh4B*CJOJPJQJphhl4tB*CJOJPJQJph%hsVfh>mSB*CJOJPJQJph!hsVfh>mSB*OJPJQJphhBSB*OJPJQJph¿&'lmHJKLxxsd8 dz]^d$ & F ]dv]^`]a$d$ & F ]dY]^`]a$d & F ]d]]^`]d & F ]dZ]^`] HIOǶǣ}m}}]Q?"hm`5B*CJOJPJQJphzh>mSCJOJPJQJjh>mSCJOJPJQJUhBSB*CJOJPJQJph%hsVfh>mSB*CJOJPJQJph%hsVfhQ6oB*CJOJPJQJph%hsVfh>mSB*CJOJPJQJph h hBS0JCJOJPJQJ(jhBSB*CJOJPJQJUphhBSB*CJOJPJQJph%hBShBSB*CJOJPJQJphLMNONO\]wxd$ & F ]da]^`]a$did^d & F ]d^`]d "d^Hd^H$Hd^Ha$gd4dd8MOZ] .|}е|iVHh:B*OJPJQJph$jh:B*OJPJQJUph$hsVfh>mS5B*OJPJQJph(hsVfh>mS5B*CJOJPJQJph%hsVfh>mSB*CJOJPJQJph!hsVfh>mSB*OJPJQJph!hsVfhBSB*OJPJQJphh>mSB*CJph$h>mSOJPJQJhBSB*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphzx"#{|*+fgd8d~d & F gd^`gdHd^Hd 4dd$ & F ]dM]^`]a$d & F ]dZ]^`])+eh #$)*;ͭyfU!hsVfhQ6oB*OJPJQJph$hsVfh>mS5B*OJPJQJphh0LB*OJPJQJph%hsVfh>mSB*CJOJPJQJph%hsVfh>mSB*CJOJPJQJph!hsVfh>mSB*OJPJQJphh h:0JOJPJQJ$jh:B*OJPJQJUphh:B*OJPJQJph!hsVfh:B*OJPJQJph+,EF| $d8a$gd4$\d^\a$gd4d dd1$|H d]]|^H` a$gd:d"$PH dS]P^H` a$gd:d.d8$|H d`]|^H` a$d *+,/08CE !#7ηġėăwmmmmmmmmw`h>mSCJ,H*OJPJQJh:OJPJQJh>mSCJOJPJQJhJoOJPJQJhOlOJPJQJhl4tOJPJQJh4OJPJQJh>mSCJOJPJQJh>mS5CJOJPJQJh>mSOJPJQJh>mS5CJOJPJQJ!hOlh>mSB*OJPJQJph%h:h>mSB*CJOJPJQJph%"#9H;<>?}}r $da$gdw $d8a$gdw$ U"^`a$gdw$|d]|a$gdw p&gdWgdW$a$gdW $da$gdW & F ]d^`]d & F |]d]|^`] 78,.H;<=>?Vͯ{hVL:"h,?5B*CJOJPJQJphzh:OJPJQJ"jhwCJ,H*OJPJQJU$hsVfhw5B*OJPJQJphhW5OJQJ^Jh:5OJQJ^Jh>mSOJPJQJhw5OJQJ^Jhw5OJQJ;jA3hWhWCJ,H*OJPJQJUmHnHsH tH u,hWCJ,H*OJPJQJmHnHsH tH uh:h>mSCJ,H*OJPJQJh>mSCJOJPJQJVjkҾsgUC7sh>mSCJOJPJQJ"h>mS5B*OJPJQJRHaph"h>mS5B*OJPJQJRHcphh>mSCJOJPJQJh>mS5B*OJPJQJph/h>mS5B*OJPJQJfH`phq [hQ6oOJPJQJh>mS5>*CJOJPJQJh>mSB*CJph$h>mSOJPJQJh:B*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz?  d$If^ dd$If^dddd^dd$d $<d]<a$dd8 " d^ Hd^Hdgd,? $d$Ifa$ d$If^ d$If d$If^" d$Ifkd@$$IfֈD$x"%DX Tt ``````<[[[[[[4a p<[[[[[[ $d$Ifa$ Td$If^T d$If" dd$If^dkd2B$$If>ֈD$x"%DX Tt ``````<[[[[[[[[[[[[4a p<[[[[[[!%,swx%*+01MUZ[`g?BDdg䔊䞴~rffh4CJOJPJQJh4CJOJPJQJh>mSCJOJPJQJh4OJPJQJhl4tOJPJQJh>mSCJOJPJQJh!uDOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJ"h>mS5B*OJPJQJRHaph& !"#$ d$If dd$If^d$Pd$If]^Pa$gd4$%&'()I@-@@$d$If]a$gd4 d$IfkdC$$IfֈD$x"%DX Tt4a p<)*+,.@3 dd$If^dkdD$$IfzֈD$x"%DX Tt4a p< d$If.\stuv d$If dd$If^d$Pd$If]^Pa$gd4vwxI@)@$Pd$If]^Pa$gd4 d$Ifkd.F$$IfֈD$x"%DX Tt4a p<@kdZG$$If ֈD$x"%DX Tt4a p< d$If d$If$d$If]a$gd4I<%<$Pd$If]^Pa$gd4 dd$If^dkdH$$If(ֈD$x"%DX Tt4a p<@kdI$$IfֈD$x"%DX Tt4a p< d$If+,-./ d$If$Pd$If]^Pa$gd4/01[\I@)@$Pd$If]^Pa$gd4 d$IfkdJ$$If ֈD$x"%DX Tt4a p<\]^_`a@kdL$$IfֈD$x"%DX Tt4a p< d$Ifabcdef d$If$d$If]a$gd4fgiqI<%<$Pd$If]^Pa$gd4 dd$If^dkdDM$$If(ֈD$x"%DX Tt4a p<@kd~N$$IfֈD$x"%DX Tt4a p< d$If d$If$d$If]a$gd4I<%<$Pd$If]^Pa$gd4 dd$If^dkdO$$IfDֈD$x"%DX Tt4a p<@kdP$$IfֈD$x"%DX Tt4a p< d$If d$If Pd$If^P$d$If]a$gd4I@-@@$d$If]a$gd4 d$IfkdR$$If ֈD$x"%DX Tt4a p<?XK4K$Pd$If]^Pa$gd4 dd$If^dkdmSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh:OJPJQJh>mSOJPJQJh4CJOJPJQJh4CJOJPJQJh4OJPJQJh4OJPJQJRHch4CJOJPJQJ$i d$If$<d$If]<a$ Pd$If^PG>+$d$If]a$gd4 d$IfkdRV$$If4ֈD$x"%D X Tt4a p<I6$d$If]a$gd4kdW$$If4rDx"%D X t4a p2 d$If Pd$If^P1kdX$$If4 ֈD$x"%D X Tt4a p< d$If Pd$If^P$d$If]a$gd4 d$IfG:#$Pd$If]^Pa$gd4 dd$If^dkdY$$If4(ֈD$x"%D X Tt4a p< d$Ifdd$If]^dgd: .I@)$Pd$If]^Pa$gd4 d$Ifkd[$$IfֈD$x"%DX Tt4a p<./01230kd.\$$IfֈD$x"%DX Tt4a p< d$Ifd$If]gd:3456789d$If]gd: d$If9:<iI</ Pd$If^P dd$If^dkdZ]$$If*ֈD$x"%DX Tt4a p<i d$Ifdd$If]^dgd:I@3 Pd$If^P d$Ifkd^$$IfֈD$x"%DX Tt4a p< d$IfPd$If]^Pgd:I@3 Pd$If^P d$Ifkd_$$IfֈD$x"%DX Tt4a p<0kd`$$If ֈD$x"%DX Tt4a p< d$Ifd$If]gd:@kdb$$If(ֈD$x"%DX Tt4a p< d$If<WXYZ d$If Pd$If^P dd$If^dZ[\I@33@ Pd$If^P d$IfkdRc$$IfֈD$x"%DX Tt4a p<@3 Pd$If^Pkd~d$$If ֈD$x"%DX Tt4a p< d$If3kde$$IfֈD$x"%DX Tt4a p< d$If dd$If^d !" Pd$If^P d$If#$?DKN?DKN05<k $%UZaҺҺܮҢҺҺ~Ҋ܊ҊҢh>mSOJPJQJRH`h>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJRHch>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJRHb1"#$?@AI@3@@ Pd$If^P d$Ifkdf$$IfֈD$x"%DX Tt4a p<ABCDEFGH@kdh$$IfֈD$x"%DX Tt4a p< d$IfHIJKN@3 dd$If^dkd.i$$If(ֈD$x"%DX Tt4a p< d$IfN d$If dd$If^d Pd$If^PI@33@ Pd$If^P d$Ifkdhj$$IfֈD$x"%DX Tt4a p<@kdk$$IfֈD$x"%DX Tt4a p< d$If@3 dd$If^dkdl$$If(ֈD$x"%DX Tt4a p< d$If d$If dd$If^d Pd$If^P?@AI@3@@ Pd$If^P d$Ifkdm$$IfֈD$x"%DX Tt4a p<ABCDEFGH@kd&o$$IfֈD$x"%DX Tt4a p< d$IfHIJKN@3 dd$If^dkdRp$$IfֈD$x"%DX Tt4a p< d$IfN d$If dd$If^d Pd$If^PI@@@@@@ d$Ifkdq$$IfֈD$x"%DX Tt4a p<I</< Pd$If^P dd$If^dkdr$$If_ֈD$x"%DX Tt4a p<@kds$$IfֈD$x"%DX Tt4a p< d$If01234 d$If Pd$If^P456789:;I@@@@@@ d$Ifkdu$$IfֈD$x"%DX Tt4a p<;<?kI</< Pd$If^P dd$If^dkdJv$$If*ֈD$x"%DX Tt4a p<@kdw$$IfֈD$x"%DX Tt4a p< d$If d$If Pd$If^P  !I@33@ Pd$If^P d$Ifkdx$$If ֈD$x"%DX Tt4a p<!"#$%U@3 Pd$If^Pkdy$$IfֈD$x"%DX Tt4a p< d$IfUVWXYZ[\@kd{$$If ֈD$x"%DX Tt4a p< d$If\]^_`a@kd4|$$If(ֈD$x"%DX Tt4a p< d$Ifad d$If Pd$If^P dd$If^dI@3& Pd$If^P d$If^ d$Ifkdn}$$IfֈD$x"%DX Tt4a p<"#$XK Pd$If^Pkd~$$IfrDx"%DX t4a p2 d$If"&-.5  ްހqYI7"h>mS5B*OJPJQJRHcphh>mS5B*OJPJQJph/h>mS5B*OJPJQJfH`phq [jh>mSB*CJUph$h>mSB*CJph$h:B*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ$%&'()*+@kd$$IfֈD$x"%DX Tt4a p< d$If+,-/012@;;66d8dkdĀ$$If(ֈD$x"%DX Tt4a p< d$If2345   d$If^ d$If d$If^ d$If^ dd$If^ddd " d^ d^$d^a$gd4dd8 "#&Wtuvwx <d$If^< dd$If^dFf Td$If^T d$IfFfu $d$Ifa$ #tyz$*+^e 16>9>?[ai ȼȰȘȰȰȰȼȼȼȼȘȼȀh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJRHch>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJh>mS5B*OJPJQJphh>mSCJOJPJQJ"h>mS5B*OJPJQJRHaph2xyz3* dd$If^d d$Ifkd$$If֞0dx""%0 `4apF d$If3* dd$If^d d$Ifkd!$$If֞0dx""%0 `4apF d$If$3* dd$If^d d$Ifkd>$$If֞0dx""%0 `4apF$%&'() d$If)*+^3* dd$If^d d$Ifkd[$$If ֞0dx""%0 `4apF^_`abc d$Ifcde3* dd$If^d d$Ifkdx$$If֞0dx""%0 `4apF d$If3* dd$If^d d$Ifkd$$If֞0dx""%0 `4apF d$If3*** d$Ifkd$$If֞0dx""%0 `4apF d$If3&& dd$If^dkdϐ$$If(֞0dx""%0 `4apF  d$If <d$If^<3** d$Ifkd$$If֞0dx""%0 `4apF12345 d$If <d$If^<567893*** d$Ifkd$$If֞0dx""%0 `4apF9:;<= d$If=>Ac3&& dd$If^dkd4$$If*֞0dx""%0 `4apFc d$If <d$If^<3*** d$Ifkd_$$If֞0dx""%0 `4apF d$If3&& dd$If^dkd|$$If,֞0dx""%0 `4apF d$If <d$If^<3*** d$Ifkd$$If֞0dx""%0 `4apF d$If3&& dd$If^dkdĘ$$If,֞0dx""%0 `4apF9:;<= d$If <d$If^<=>?[3* dd$If^d d$Ifkd$$If֞0dx""%0 `4apF[\]^_` d$If`abcd3*** d$Ifkd $$If ֞0dx""%0 `4apFdefgh d$Ifhil|3&& dd$If^dkd)$$If(֞0dx""%0 `4apF| d$If <d$If^<3.$Pd$If]Pa$dkdT$$If֞0dx""%0 `4apF  ypp d$Ifkkdq$$IfF`%H    4ap d$If^ d$If^  d$Ifkkd$$IfF`%H    4ap<Yvi d$If^ d$If^$Pd$If]Pa$kkd$$If*F`%H    4ap<Z[hj}ƶsi_iUFh>mS5>*CJOJPJQJh>mSB*CJph$h:B*CJph$hm`B*CJph$"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphz"jh>mS5CJOJPJQJUh>mS5CJOJPJQJjh>mSCJOJPJQJUh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSOJPJQJYZ[} d$If^ d$IfkkdV$$IfF`%H    4ap d$Ifkkd$$IfF`%H    4apvm d$If d$If^$Pd$If]Pa$kkd$$If*F`%H    4ap{vmhmcdddd^ddd^d4d8dkkd;$$IfF`%H    4ap      d8d $<d]<a$ijdddd $d]a$d "d^d^dd8st*269:>˿禛{i]SIS?]h>mSB*CJph$h:B*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzjh>mSOJPJQJUh>mS>*OJPJQJh>mS5>*OJPJQJh4CJOJPJQJhl4tCJOJPJQJh>mSCJOJPJQJh!uDh>mS5CJOJPJQJh>mSOJPJQJh>mS5>*CJOJPJQJstabxmx $da$gd4$ & F ]d^`]a$gd4 $da$gd4$ & F ]d]^`]a$gd4dd^d$d]^a$gd4 $da$gd4$d]^a$gd4 OPQRSvw~dddd@d^@dd8$ & F ]d^`]a$gd4 $da$gd4d8:;<=>LMNOPQRST dd$If^d d$IfHd^H$Hd^Ha$gd4d>LY#ѿѣїwk__C_C_7h>mS5B*CJOJPJQJRHcfH`phq h>mSCJOJPJQJhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHcphh>mSCJOJPJQJhO]+CJ OJPJQJ7h>mS5B*CJOJPJQJRHbfH`phq "h>mS5B*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJph$TUVWXYZ[\]^_`abcdefghijklmnopFf d$Ifpqrstuvwxyz{|}~Ff d$If $dk$Ifa$ $d$Ifa$ d$IfFfq d$IfFf $d$Ifa$ d$If ! $d$Ifa$ d$If!"#$%&'(-./;<=FGHSTUfgh d$If^ d$If^ Xd$If^X $d$Ifa$Ff d$If#$(-/;=FHSUfhrwxxl`L``&h>mS5B*CJOJPJQJRH`phh>mSCJOJPJQJhO]+CJOJPJQJ7h>mS5B*CJOJPJQJRHafH`phq 3h>mS5B*CJOJPJQJfH`phq &h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJph&h>mS5B*CJOJPJQJRHbphh>mSCJOJPJQJhO]+CJOJPJQJhrstuvwFf d$If $d$Ifa$ $d$Ifa$ d$IfFf d$If  6:JKdp}~ֶ趪ւււււււււ‚‚h>mSCJOJPJQJ7h>mS5B*CJOJPJQJRHcfH`phq hO]+CJOJPJQJh>mSCJOJPJQJ&h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJphhO]+CJOJPJQJh>mSCJOJPJQJ+    !"#$%&Fft $d$Ifa$ d$If&'()*+,-./0123456:;<=>?@ABCD $d$Ifa$ d$IfDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`Ff' d$If`abcdpqrstuvwxyz{|}~Ff 9 $d$Ifa$ d$If d$If$rd$If]ra$ d$If^ d$If^$d$If]a$ $d$Ifa$FfK d$If $d$Ifa$$d$If]a$ d$If^ d$If:;=>DEQR`do¶ththththth\tPtPtPtPth>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJhO]+CJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJ&h>mS5B*CJOJPJQJRHUphFf>\ d$If$d$If]a$     Ff+n d$If !"#$%&'()*+,-./0123456789: d$If:;=>DEQR`abcdopqrstuvwxyz{ Pd$If^P d$If dd$If^dFf{|}~Ff d$If Pd$If^P dd$If^dFf, d$IfFf d$If!(8WXZ[abno{+A$7MOPVWefw{ܾ貦覲h>mSCJ OJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJhO]+CJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ<      d$If !"#$%&'(89:;<=>?@ABCDEFGFfv d$IfGHIJKLMNOPQRSTUVWXZ[abno{ dm$If Pd$If^P dd$If^dFf d$If{|}~Ff< d$If d$IfFf d$If dk$If Pd$If^P dd$If^dFf d$If+,-./0123456789:;<=>?@ABCDEFf d$IfEFGHIJKLMNOPQRSTUVWXYZ[\]^_`a d$Ifabcdefghijklmnopqrstuvwxyz{|}Ff d$If}~ dk$IfFfO d$IfFf d$If    da$If d$If    !"#$789:; da$If Pda$If^P dda$If^dFf' d$If;<=>?@ABCDEFGHIJKLMOPVWefw Pd$If^P dd$If^dFf35 d$Ifwxyz{Ff9A d$If d$If Pd$If^P dd$If^dFfM d$If:<=CDRSdhs )*6:E[~ $:]`aghqrh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJG      !"#$FfY d$If$%&'()*+,-./0123456789:<=C Pd$If^P dd$If^dFfe d$IfCDRSdefghstuvwxyz{|}~ d$IfFfq d$If Pd$If^P dd$If^dFf>~ d$IfFf d$If     Ff d$If )*6789:EFGHIJKLMNOPQR Pd$If^P d$If dd$If^dRSTUVWXYZ[\]^_`abcdefghijklmnFfa d$Ifnopqrstuvwxyz{|}~ Pd$If^P dd$If^dFfҮ d$IfFf d$If d$If $%&'()*+,- Pd$If^P dd$If^dFf d$If-./0123456789:;<=>?@ABCDEFGHIFf d$IfIJKLMNOPQRSTUVWXYZ[\]`aghq Pd$If^P dd$If^dFff d$Ifqr d$If d$IfFf?     dk$If Pd$If^P dd$If^dFf d$If  gjkqr}~ *@  #'2Hknouvh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJD !"#$%&'()*Ff d$If*+,-./0123456789:;<=>?@ABCDEFFfR d$IfFGHIJKLMNOPQRSTUVWXYZ[\]^_`ab d$Ifbcdefgjkqr}~ dj$If Pd$If^P dd$If^dFf d$IfFf( d$IfFf3 d$If d$If *+,-./01234 dk$If Pd$If^P dd$If^dFf@ d$If456789:;<=>?@ABCDEFGHIJKLMNOPFfL d$IfPQRSTUVWXYZ[\]^_`abcdefghijklFfnX d$Iflmnopqrstuvwxyz{|}~Ff*e d$If Pd$If^P d$If dd$If^dFf3q d$If  #$% Pd$If^P dd$If^dFf} d$If%&'23456789:;<=>?@ABCDEFGHIJKFf} d$IfKLMNOPQRSTUVWXYZ[\]^_`abcdefg d$Ifghijknouv Pd$If^P dd$If^dFf d$IfFfǡ d$If Pd$If^P dd$If^dFf8 d$If "EHIOP\]jny "Eilmst&ILMSTbcr˿˿˿˿˿˳˳˳˳˳˛˛˛˛˛˛˛˛˛˛h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJph=   ! d$If!"#$%&'()*+,-./0123456789:;<= d$IfFf=>?@ABCDEHIOP\]jklmnyz{|} dk$If Pd$If^P dd$If^dFf d$If}~Ff[ d$IfFf$ d$If d$If   di$If Pd$If^P dd$If^dFf d$If !"#$%&'()*+,-./Ff d$If/0123456789:;<=>?@ABCDEFGHIJKFf d$IfKLMNOPQRSTUVWXYZ[\]^_`abcdefg d$Ifghilmst Pd$If^P dd$If^dFfn d$IfFfw d$If Pd$If^P dd$If^dFf' d$If !"#$%&'Ff3 d$If'()*+,-./0123456789:;<=>?@ABC d$IfCDEFGHILMSTbcrstuv Pd$If^P dd$If^dFf2@ d$Ifrv256<=KL]ar#$tv|ܶ|r|h:B*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ,Ff L d$If Pd$If^P dd$If^dFf|X d$If     d$If   !"#$%&'(FfUd d$If()*+,-./01256<=KL]^_`arstu Pd$If^P dd$If^dFfp d$Ifuvwxyz{|}~Ff| d$IfFf d$If Pd$If^P d$If dd$If^d     Ff d$If !"#$uvwxyz{|d^d'FfZ d$If|FfF dd$If^d d$If -.HQVZ\bfghkѿѣїwk__C_C_7h>mS5B*CJOJPJQJRHcfH`phq h>mSCJOJPJQJhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHcphh>mSCJOJPJQJhO]+CJ OJPJQJ7h>mS5B*CJOJPJQJRHbfH`phq "h>mS5B*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJph$ d$If     Ff] d$If !"#$%&'()*+,-./01234Ff $dk$Ifa$ $d$Ifa$ d$If456789:;<=>?@ABCDEFGHQRSTUVZ $d$Ifa$ d$IfZ[\bcdefghklmnopqrstuvwxyz{Ff $d$Ifa$ d$If{|}~Ff $d$Ifa$ d$If ()*+/DNSUxxl`L``&h>mS5B*CJOJPJQJRH`phh>mSCJOJPJQJhO]+CJOJPJQJ7h>mS5B*CJOJPJQJRHafH`phq 3h>mS5B*CJOJPJQJfH`phq &h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJph&h>mS5B*CJOJPJQJRHbphh>mSCJOJPJQJhO]+CJOJPJQJ d$If^$^d$If]^a$ Xd$If^X $d$Ifa$ d$If ()*+/01234567Ff} $d$Ifa$ d$If789:;<=>?@ABCDNOPQRSUVWXYZ[\ $d$Ifa$ d$If\]^_`abcdefghijklmnopqrstuvwxFfc  d$IfU_`z%&')+-/1468:<>@BDFHJLOQTVֶ趪ւււււււււ‚‚h>mSCJOJPJQJ7h>mS5B*CJOJPJQJRHcfH`phq hO]+CJOJPJQJh>mSCJOJPJQJ&h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJphhO]+CJOJPJQJh>mSCJOJPJQJ+xyzFf& $d$Ifa$ d$If $d$Ifa$ d$IfFf/ d$IfFfA $d$Ifa$ d$If      ! d$If!"#$%&')*+-./1234678$Rd$If]Ra$ d$If^$d$If]a$ $d$Ifa$FfS d$If8:;<>?@BCDFGHJKLOPQTUVY $d$Ifa$$d$If]a$ d$If^ d$If$rd$If]ra$VY[^_`&*:Psvw}~  ¶zjzjzjzjzh>mSB*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJ&h>mS5B*CJOJPJQJRHUph)YZ[^_`abcdefghijklmnopqrstuFfe$d$If]a$ d$Ifuvwxyz{|}~ Pd$If^P$d$If]a$Ffw d$If d$IfFfĆ d$If&'()*:;<= Pd$If^P$d$If]a$Ff5 d$If=>?@ABCDEFGHIJKLMNOPQRSTUVWXYFf d$IfYZ[\]^_`abcdefghijklmnopqrsFf d$Ifsvw}~ dk$If Pd$If^P d$If$d$If]a$FfX d$IfFfA d$If FfM d$If   "#12345@ABCDEFGHIJKL di$If Pd$If^P d$If$d$If]a$  "#15@Vz &'67NRf|()>BKah>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSCJ OJPJQJ=LMNOPQRSTUVWXYZ[\]^_`abcdefghFf d$Ifhijklmnopqrstuvwxyz{|}~Ffo d$IfFf{ d$If Pd$If^P d$If$d$If]a$    Ff d$If   &'67NO Pd$If^P$d$If]a$Ff% d$IfOPQRfghijklmnopqrstuvwxyz{|}~Ff d$If~ d$If Pd$If^P$d$If]a$Ffo& d$IfFfH2 d$If     $d$If]a$Ff> d$If()>?@ABKLMNOPQRSTUVWXYZ[ dk$If d$If Pd$If^P[\]^_`abcdefghijklmnopqrstuvwFfJ d$Ifwxyz{|}~Ff{V d$If$d$If]a$Ffc d$If d$If Pd$If^P *+9=H^,Behiopz{%HKLRS^_nr~ -h>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJR Ffo d$If      *+29:;< <d$If^< Pd$If^P$d$If]a$Ff1| d$If<=HIJKLMNOPQRSTUVWXYZ[\]^_`abFf/ d$Ifbcdefghijklmnopqrstuvwxyz{|}~ d$If~ <d$If^< Pd$If^P$d$If]a$Ff d$IfFf# d$If$d$If]a$Ff d$If,-./0123456789:;<= d$If Pd$If^P=>?@ABCDEFGHIJKLMNOPQRSTUVWXYFf d$IfYZ[\]^_`abcdehiopz{ Pd$If^P$d$If]a$Ffc d$IfFf< d$If d$If Pd$If^P d$If$d$If]a$Ff  !"#$%&'()*+,-./0123456Ff d$If6789:;<=>?@ABCDEFGHKLRS^_ Pd$If^P$d$If]a$Ff d$If_nopqr~Ff! d$If d$If Pd$If^P$d$If]a$FfA! d$If     Ff! d$If !"#$%&'()*+,-01$d$If]a$Ff'! d$If-0178IJ[_jHKLRSde}$(3I%()/0<=HLXnh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJH178IJ[\]^_jklmnopqrstuvwxyz{ d$If Pd$If^P{|}~Ffd3! d$If dk$If Pd$If^P$d$If]a$Ff?! d$IfFfK! d$If       d$If !"#$%&'()*+,-./0123456789:;<FfW! d$If<=>?@ABCDEFGHKLRSde}~ dk$If Pd$If^P$d$If]a$Ffd! d$IfFfp! d$If d$IfFf|! d$If$%&'( dk$If Pd$If^P$d$If]a$Ffщ! d$If(3456789:;<=>?@ABCDEFGHIJKLMNFf ! d$IfNOPQRSTUVWXYZ[\]^_`abcdefghij d$Ifjklmnopqrstuvwxyz{|}~Ff! d$If di$If Pd$If^P$d$If]a$Ff! d$IfFf8! d$If d$If     Ff!! d$If !"#$%()/0<=HIJKL dk$If Pd$If^P$d$If]a$Ff-! d$IfLXYZ[\]^_`abcdefghijklmnopqrsFff! d$Ifstuvwxyz{|}~ d$IfFfO! d$If <d$If^< Pd$If^P$d$If]a$Ff[! d$If#&'-.9:FJUk    " 6 L O P V W b c p t             ) M r u v | }     ĸĬĜĜĜh>mSB*CJOJPJQJphh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ=Ff" d$If      d$If !"#&'-.9:FGHIJUVWXYZ[\] Pd$If^P$d$If]a$Ff" d$If]^_`abcdefghijklmnopqrstuvwxyFf" d$Ifyz{|}~Ff*" d$If dk$If d$IfFfi7" d$If                      Pda$If^P$da$If]a$FfD" d$If      ! " 6 7 8 9 : ; < = > ? @ A B C D E F G H I  da$If d$IfI J K L O P V W b c p q r s t           dk$If Pd$If^P$d$If]a$FfmR" d$If                             Ff^" d$If                             Ffj" d$If                              d$If                         dk$If Pd$If^P$d$If]a$Ffw" d$If      ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 Ffу" d$If7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S Ff" d$IfS T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o  d$Ifo p q r u v | }                  dk$If Pd$If^P$d$If]a$FfƜ" d$If          & * 6 L p          % : ˿˿˿˿˿קm[OEhm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz"hm`5B*CJOJPJQJphzh>mSOJPJQJhO]+CJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSB*CJOJPJQJph                             Ff" d$If                             Ff" d$If                              d$If          & ' ( ) * 6 7 8 9 : ; < = >  dj$If Pd$If^P$d$If]a$Ff" d$If> ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Ff-" d$IfZ [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v Ff" d$Ifv w x y z { | } ~                      d$If                             Ff"" d$If                      ! " # d^$d^a$gdY@d'Ff" d$If# $ % [ \ ] ^ _ m n o p q r s t u v w x y z { | } ~  Ff# dd$If^d d$If: < Z [ _ m z                  ' ɽwwcwwWKKh>mSCJOJPJQJhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHcphh>mSCJOJPJQJhO]+CJ OJPJQJ7h>mS5B*CJOJPJQJRHbfH`phq "h>mS5B*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSB*CJph$hm`B*CJph$h=B*CJph$                              d$If                             Ff # d$If                          Ff# $dk$Ifa$ $d$Ifa$ d$If                             $d$Ifa$ d$If                       ! " # $ Ffm.# $d$Ifa$ d$If$ % & ' 1 2 3 4 5 6 : ; < = > ? @ A B C D E F G H I N Ff?# $d$Ifa$ d$If' 1 6 : D E I N P \ ^ g i t v             ˿kOO7h>mS5B*CJOJPJQJRHafH`phq 3h>mS5B*CJOJPJQJfH`phq &h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJph&h>mS5B*CJOJPJQJRHbphh>mSCJOJPJQJhO]+CJOJPJQJh>mSCJOJPJQJ7h>mS5B*CJOJPJQJRHcfH`phq N O P \ ] ^ g h i t u v             d$If^ $d$Ifa$ d$If^ Xd$If^X d$If                           FfFQ# $d$Ifa$ d$If        ',35<@AW[kl袖–z袖nnnnnnnnh>mSCJOJPJQJ7h>mS5B*CJOJPJQJRHcfH`phq h>mSCJOJPJQJhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJph&h>mS5B*CJOJPJQJRH`phh>mSCJOJPJQJhO]+CJOJPJQJ+                       $d$Ifa$ d$If      d$IfFfb#'()*+,345<=>?@ABCDEFGHIJKLFft# d$If $d$Ifa$LMNOPQRSTUVW[\]^_`abcdefghij $d$Ifa$ d$Ifjklmnopqrstuvwxyz{|}~Ffp# d$IfFf# d$If $d$Ifa$ d$If d$If^$rd$If]ra$ d$If^ d$If^$d$If]a$ $d$Ifa$ d$IfFf#$d$If]a$ $d$Ifa$$d$If]a$ d$If'(+,23>?QUi #$*+~~~~~r~~~~~rffh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHUph&h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJphh>mSCJOJPJQJ(      d$IfFf# !"#$%&'(+,23>?QRSTU Pd$If^P$d$If]a$Ff# d$IfUijklmnopqrstuvwxyz{|}~Ffy# d$If d$If Pd$If^P$d$If]a$Ff# d$If     Ff# d$If  #$*+6 Pd$If^P$d$If]a$Ff4# d$If+67EITj*-.45:NO[_j/vyzФh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSB*CJOJPJQJphh>mSB*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ767EFGHITUVWXYZ[\]^_`abcdefghi d$Ifijklmnopqrstuvwxyz{|}~ d$IfFf $ di$If Pd$If^P$d$If]a$Ff~$ d$IfFfW#$ d$IfFf /$ d$If      !"#$ d$If$%&'()*-.45NO[\]^_jklmno dk$If Pd$If^P$d$If]a$Ff;$ d$Ifopqrstuvwxyz{|}~FfG$ d$IfFfS$ d$If d$If  dk$If Pd$If^P$d$If]a$Ffj`$ d$If !"#$%&'()*+,-./0123456789:;<Ffsl$ d$If<=>?@ABCDEFGHIJKLMNOPQRSTUVWXFf"#01>BMcJMNTUdept #jmntuh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJM()*+,-./0123456789:;< dk$If d$If<=>?@ABCDEFGHIJKLMNOPQRSTUVWXFfK$ d$IfXYZ[\]^_`abcdefghijklmnopqrstFf$ d$Iftuvwxyz{|}~ Pd$If^P$d$If]a$Ff$ d$If d$If di$If d$IfFf$Ff$ d$If     "#01> dk$If Pd$If^P$d$If]a$Ff^$ d$If>?@ABMNOPQRSTUVWXYZ[\]^_`abcdFfg$ d$Ifdefghijklmnopqrstuvwxyz{|}~ d$IfFf0$ d$If dk$If Pd$If^P$d$If]a$Ff % d$IfFf% d$If      !" d$If"#$%&'()*+,-./0123456789:;<=>Ff"% d$If>?@ABCDEFGHIJMNTUdepqrst dk$If Pd$If^P$d$If]a$Ffz/% d$IftFf;% d$If d$IfFfLG% d$If  dk$If Pd$If^P$d$If]a$FfT% d$If !"#$%&'()*Ff`% d$If*+,-./0123456789:;<=>?@ABCDEFFfk% d$IfFGHIJKLMNOPQRSTUVWXYZ[\]^_`ab d$Ifbcdefghijmntu dj$If Pd$If^P$d$If]a$Ffx% d$IfFf% d$IfFfh% d$If $%;?Rh\_`fguv3VzIJĦܚܚܚܚܚܚܚܚܚܚܚܚܚܚܚh>mSCJOJPJQJh>mSCJ OJPJQJhO]+CJOJPJQJ"h>mS5B*CJOJPJQJphh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ3 d$If     $%;<=>?RSTUVWX Pd$If^P$d$If]a$Ff$% d$IfXYZ[\]^_`abcdefghijklmnopqrstFf-% d$Iftuvwxyz{|}~Ff% d$If d$If dm$If Pd$If^P$d$If]a$Ff% d$If     Ffd% d$If !"#$%&'()*+,-./0123456789:;Ff-% d$If;<=>?@ABCDEFGHIJKLMNOPQRSTUVW d$IfWXYZ[\_`fguv dk$If Pd$If^P$d$If]a$Ff% d$IfFf% d$If$d$If]a$Ff& d$If !"#$%&'()*+, dk$If Pd$If^P d$If,-./0123456789:;<=>?@ABCDEFGHFf& d$IfHIJKLMNOPQRSTUVWXYZ[\]^_`abcdFf& d$Ifdefghijklmnopqrstuvwxyz{|}~FfM)& d$If d$Ifz?@]aw(>ABHL\`dz<COܺ订h>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ; dh$If Pdh$If^P$dh$If]a$Ff5& d$If     ?@]^_FfB& d$If_`awxyz{|}~$dh$If]a$FfO& d$If dh$If Pdh$If^P d$If()*+,-Ff[& d$If-./0123456789:;<=>ABHIJKL Pdh$If^P$dh$If]a$Ff%h& d$IfL\]^_`defghijklmnopqrstuvwxy d$If dh$Ifyz{|}~ d$IfFf u& Pd$If^P$d$If]a$Ffa& d$If      Ffύ& d$If !"#$%&'()*+,-./0123456789:;<Ff@& d$If<=>?@ABCOPhijkl d$IfOPhl (>&'Fbeflo#и謢"hm`5B*CJOJPJQJphzh>mSOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJ OJPJQJh>mSCJ OJPJQJh>mSCJOJPJQJh>mSCJOJPJQJ3 da$If Pda$If^P$da$If]a$Ffp& d$If Pd$If^P$d$If]a$FfW& d$If ()*+,-./0123456789: dk$If d$If:;<=>?@ABCDEFGHIJKLMNOPQRSTUVFf-& d$IfVWXYZ[\]^_`abcdefghijklmnopqrFf& d$Ifrstuvwxyz{|}~ Pd$If^P$d$If]a$Ff& d$If dk$If d$IfFf& d$IfFf& d$If     &'F dk$IfFf@& d$IfFGHIJKLMNOPQRSTUVWXYZ[\]^_`abFf' d$Ifbeflmno Pd$If^P d$If$d$If]a$Ff6' d$If$%&'()*+d^dFf!' d$If#%+?A_`dr      ⸬~rffRffFhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHcphh>mSCJOJPJQJhO]+CJ OJPJQJ7h>mS5B*CJOJPJQJRHbfH`phq "h>mS5B*CJOJPJQJphh>mSCJ OJPJQJh>mSCJOJPJQJh>mSB*CJph$h=B*CJph$hm`B*CJph$h>mSCJOJPJQJ"h>mS5B*CJOJPJQJphz+`abcdrstuvwxyz{|}~Ff+' dd$If^d d$If d$IfFf5' d$IfFfD' $dk$Ifa$ d$If $d$Ifa$        $d$Ifa$ d$If                 ! " # $ % & ' ( ) * Ff=V' d$If $d$Ifa$   , 6 ; ? I J N S U a c l n y {             ⮆lPP7h>mS5B*CJOJPJQJRHafH`phq 3h>mS5B*CJOJPJQJfH`phq &h>mS5B*CJOJPJQJRHcph&h>mS5B*CJOJPJQJRHbphh>mSCJOJPJQJhO]+CJOJPJQJ7h>mS5B*CJOJPJQJRHcfH`phq "h>mS5B*CJOJPJQJphh>mSCJOJPJQJ* + , 6 7 8 9 : ; ? @ A B C D E F G H I J K L M N S T Ffg' $d$Ifa$ d$IfT U a b c l m n y z {              d$If^ $d$Ifa$ d$If^ Xd$If^X d$If                           Ffy' $d$Ifa$ d$If         ! !#!,!1!8!:!A!E!F!\!`!p!q!!!!!!!!!!!!!!!!!!!!!!!袖–z袖nnnnnnnnh>mSCJOJPJQJ7h>mS5B*CJOJPJQJRHcfH`phq h>mSCJOJPJQJhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJph&h>mS5B*CJOJPJQJRH`phh>mSCJOJPJQJhO]+CJOJPJQJ+                !!!!!!!!! ! !Ff' $d$Ifa$ d$If ! ! ! !!!!!!!!!!!!!!!!!!! !!!"!#!,!-! $d$Ifa$ d$If-!.!/!0!1!8!9!:!A!B!C!D!E!F!G!H!I!J!K!L!M!N!O!P!Q!R!S!Ff' $d$Ifa$ d$IfS!T!U!V!W!X!Y!Z![!\!`!a!b!c!d!e!f!g!h!i!j!k!l!m!n!o!p! $d$Ifa$ d$Ifp!q!r!s!t!u!v!w!x!y!z!{!|!}!~!!!!!!!!!!!!! d$IfFf@'!!!!!!!!!!!!!!!!!!!!!!!!!!!Ff' d$If $d$Ifa$!!!!!!!!!!!!!!!!!!!!!!!!!!!!! d$If!!!!!!!!!!!!!!!!!!! d$If^$rd$If]ra$ d$If^ d$If^$d$If]a$ $d$Ifa$ d$IfFf'!!!!!!!!!!!!!!!!!!!!"""$d$If]a$ $d$Ifa$$d$If]a$ d$If!!!!!!!!!"""","-"0"1"7"8"C"D"P"T"_"u""""""""""""# ###0#~~~~~r~~~~~rffh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJh>mSCJOJPJQJhO]+CJOJPJQJ&h>mS5B*CJOJPJQJRHUph&h>mS5B*CJOJPJQJRHcph"h>mS5B*CJOJPJQJphh>mSCJOJPJQJ(""""" " " " " """"""""""""""""""" " d$IfFf'